Mechanical devices used to produce or assist pulmonary ventilation.
Infection of the lung often accompanied by inflammation.
Techniques for effecting the transition of the respiratory-failure patient from mechanical ventilation to spontaneous ventilation, while meeting the criteria that tidal volume be above a given threshold (greater than 5 ml/kg), respiratory frequency be below a given count (less than 30 breaths/min), and oxygen partial pressure be above a given threshold (PaO2 greater than 50mm Hg). Weaning studies focus on finding methods to monitor and predict the outcome of mechanical ventilator weaning as well as finding ventilatory support techniques which will facilitate successful weaning. Present methods include intermittent mandatory ventilation, intermittent positive pressure ventilation, and mandatory minute volume ventilation.
Inflammation of the lung parenchyma that is caused by bacterial infections.
Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2).
Inflammation of the lung parenchyma that is caused by a viral infection.
A febrile disease caused by STREPTOCOCCUS PNEUMONIAE.
Serious INFLAMMATION of the LUNG in patients who required the use of PULMONARY VENTILATOR. It is usually caused by cross bacterial infections in hospitals (NOSOCOMIAL INFECTIONS).
An interstitial lung disease of unknown etiology, occurring between 21-80 years of age. It is characterized by a dramatic onset of a "pneumonia-like" illness with cough, fever, malaise, fatigue, and weight loss. Pathological features include prominent interstitial inflammation without collagen fibrosis, diffuse fibroblastic foci, and no microscopic honeycomb change. There is excessive proliferation of granulation tissue within small airways and alveolar ducts.
A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis.
Pneumonia caused by infections with bacteria of the genus STAPHYLOCOCCUS, usually with STAPHYLOCOCCUS AUREUS.
RESPIRATORY MUSCLE contraction during INHALATION. The work is accomplished in three phases: LUNG COMPLIANCE work, that required to expand the LUNGS against its elastic forces; tissue resistance work, that required to overcome the viscosity of the lung and chest wall structures; and AIRWAY RESISTANCE work, that required to overcome airway resistance during the movement of air into the lungs. Work of breathing does not refer to expiration, which is entirely a passive process caused by elastic recoil of the lung and chest cage. (Guyton, Textbook of Medical Physiology, 8th ed, p406)
A method of mechanical ventilation in which pressure is maintained to increase the volume of gas remaining in the lungs at the end of expiration, thus reducing the shunting of blood through the lungs and improving gas exchange.
The volume of air inspired or expired during each normal, quiet respiratory cycle. Common abbreviations are TV or V with subscript T.
A type of lung inflammation resulting from the aspiration of food, liquid, or gastric contents into the upper RESPIRATORY TRACT.
Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)
The capability of the LUNGS to distend under pressure as measured by pulmonary volume change per unit pressure change. While not a complete description of the pressure-volume properties of the lung, it is nevertheless useful in practice as a measure of the comparative stiffness of the lung. (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p562)
Body ventilators that assist ventilation by applying intermittent subatmospheric pressure around the thorax, abdomen, or airway and periodically expand the chest wall and inflate the lungs. They are relatively simple to operate and do not require tracheostomy. These devices include the tank ventilators ("iron lung"), Portalung, Pneumowrap, and chest cuirass ("tortoise shell").
The physical or mechanical action of the LUNGS; DIAPHRAGM; RIBS; and CHEST WALL during respiration. It includes airflow, lung volume, neural and reflex controls, mechanoreceptors, breathing patterns, etc.
Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.
Methods of creating machines and devices.
Interstitial pneumonia caused by extensive infection of the lungs (LUNG) and BRONCHI, particularly the lower lobes of the lungs, by MYCOPLASMA PNEUMONIAE in humans. In SHEEP, it is caused by MYCOPLASMA OVIPNEUMONIAE. In CATTLE, it may be caused by MYCOPLASMA DISPAR.
A procedure involving placement of a tube into the trachea through the mouth or nose in order to provide a patient with oxygen and anesthesia.
Hospital units providing continuous surveillance and care to acutely ill patients.
Pneumonia due to aspiration or inhalation of various oily or fatty substances.
Application of positive pressure to the inspiratory phase when the patient has an artificial airway in place and is connected to a ventilator.
Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.
A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
The hospital unit in which patients with respiratory conditions requiring special attention receive intensive medical care and surveillance.
Events that overwhelm the resources of local HOSPITALS and health care providers. They are likely to impose a sustained demand for HEALTH SERVICES rather than the short, intense peak customary with smaller scale disasters.
The number of times an organism breathes with the lungs (RESPIRATION) per unit time, usually per minute.
Respiratory support system used primarily with rates of about 100 to 200/min with volumes of from about one to three times predicted anatomic dead space. Used to treat respiratory failure and maintain ventilation under severe circumstances.
A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
The total volume of gas inspired or expired per unit of time, usually measured in liters per minute.
Physiologically, the opposition to flow of air caused by the forces of friction. As a part of pulmonary function testing, it is the ratio of driving pressure to the rate of air flow.
Failure of equipment to perform to standard. The failure may be due to defects or improper use.
A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.
That part of the RESPIRATORY TRACT or the air within the respiratory tract that does not exchange OXYGEN and CARBON DIOXIDE with pulmonary capillary blood.
Surgical formation of an opening into the trachea through the neck, or the opening so created.
Techniques for administering artificial respiration without the need for INTRATRACHEAL INTUBATION.
Any infection which a patient contracts in a health-care institution.
The exchange of OXYGEN and CARBON DIOXIDE between alveolar air and pulmonary capillary blood that occurs across the BLOOD-AIR BARRIER.
Devices that cover the nose and mouth to maintain aseptic conditions or to administer inhaled anesthetics or other gases. (UMDNS, 1999)
Substances that reduce the growth or reproduction of BACTERIA.
Ventilatory support system using frequencies from 60-900 cycles/min or more. Three types of systems have been distinguished on the basis of rates, volumes, and the system used. They are high frequency positive-pressure ventilation (HFPPV); HIGH-FREQUENCY JET VENTILATION; (HFJV); and high-frequency oscillation (HFO).
The act of BREATHING in.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
A group of interstitial lung diseases with no known etiology. There are several entities with varying patterns of inflammation and fibrosis. They are classified by their distinct clinical-radiological-pathological features and prognosis. They include IDIOPATHIC PULMONARY FIBROSIS; CRYPTOGENIC ORGANIZING PNEUMONIA; and others.
The visual display of data in a man-machine system. An example is when data is called from the computer and transmitted to a CATHODE RAY TUBE DISPLAY or LIQUID CRYSTAL display.
Lung damage that is caused by the adverse effects of PULMONARY VENTILATOR usage. The high frequency and tidal volumes produced by a mechanical ventilator can cause alveolar disruption and PULMONARY EDEMA.
The removal of secretions, gas or fluid from hollow or tubular organs or cavities by means of a tube and a device that acts on negative pressure.
Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung.
An infant during the first month after birth.
Washing out of the lungs with saline or mucolytic agents for diagnostic or therapeutic purposes. It is very useful in the diagnosis of diffuse pulmonary infiltrates in immunosuppressed patients.
The force per unit area that the air exerts on any surface in contact with it. Primarily used for articles pertaining to air pressure within a closed environment.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
A system in which the functions of the man and the machine are interrelated and necessary for the operation of the system.
A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.
The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine.
Care of patients with deficiencies and abnormalities associated with the cardiopulmonary system. It includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways.
Health care provided to a critically ill patient during a medical emergency or crisis.
The presence of an infectious agent on instruments, prostheses, or other inanimate articles.
A type of stress exerted uniformly in all directions. Its measure is the force exerted per unit area. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
Surgical incision of the trachea.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
A species of the genus PNEUMOVIRUS causing pneumonia in mice.
HYPOVENTILATION syndrome in very obese persons with excessive ADIPOSE TISSUE around the ABDOMEN and DIAPHRAGM. It is characterized by diminished to absent ventilatory chemoresponsiveness; chronic HYPOXIA; HYPERCAPNIA; POLYCYTHEMIA; and long periods of sleep during day and night (HYPERSOMNOLENCE). It is a condition often related to OBSTRUCTIVE SLEEP APNEA but can occur separately.
A species of PNEUMOCYSTIS infecting humans and causing PNEUMOCYSTIS PNEUMONIA. It also occasionally causes extrapulmonary disease in immunocompromised patients. Its former name was Pneumocystis carinii f. sp. hominis.
The closeness of a determined value of a physical dimension to the actual value.
Coordination of nursing services by various nursing care personnel under the leadership of a professional nurse. The team may consist of a professional nurse, nurses' aides, and the practical nurse.
Conveying ill or injured individuals from one place to another.
A disease or state in which death is possible or imminent.
The maximum volume of air that can be inspired after reaching the end of a normal, quiet expiration. It is the sum of the TIDAL VOLUME and the INSPIRATORY RESERVE VOLUME. Common abbreviation is IC.
The act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration (= OXYGEN CONSUMPTION) or cell respiration (= CELL RESPIRATION).
A genus of ascomycetous FUNGI, family Pneumocystidaceae, order Pneumocystidales. It includes various host-specific species causing PNEUMOCYSTIS PNEUMONIA in humans and other MAMMALS.
The act of BREATHING out.
A measure of the amount of WATER VAPOR in the air.
An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration.
Freedom of equipment from actual or potential hazards.
Complete or severe weakness of the muscles of respiration. This condition may be associated with MOTOR NEURON DISEASES; PERIPHERAL NERVE DISEASES; NEUROMUSCULAR JUNCTION DISEASES; SPINAL CORD DISEASES; injury to the PHRENIC NERVE; and other disorders.
Helium. A noble gas with the atomic symbol He, atomic number 2, and atomic weight 4.003. It is a colorless, odorless, tasteless gas that is not combustible and does not support combustion. It was first detected in the sun and is now obtained from natural gas. Medically it is used as a diluent for other gases, being especially useful with oxygen in the treatment of certain cases of respiratory obstruction, and as a vehicle for general anesthetics. (Dorland, 27th ed)
Continuous recording of the carbon dioxide content of expired air.
A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.
Elements of limited time intervals, contributing to particular results or situations.
An acute, sometimes fatal, pneumonia-like bacterial infection characterized by high fever, malaise, muscle aches, respiratory disorders and headache. It is named for an outbreak at the 1976 Philadelphia convention of the American Legion.
A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals.
Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments.
Computer systems utilized as adjuncts in the treatment of disease.
Measurement of oxygen and carbon dioxide in the blood.
Application of positive pressure to the inspiratory phase of spontaneous respiration.
The evaluation of incidents involving the loss of function of a device. These evaluations are used for a variety of purposes such as to determine the failure rates, the causes of failures, costs of failures, and the reliability and maintainability of devices.
X-ray visualization of the chest and organs of the thoracic cavity. It is not restricted to visualization of the lungs.
Pathological processes involving any part of the LUNG.
Hospital units providing continuous surveillance and care to acutely ill infants and children. Neonates are excluded since INTENSIVE CARE UNITS, NEONATAL is available.
The period of confinement of a patient to a hospital or other health facility.
Short filamentous organism of the genus Mycoplasma, which binds firmly to the cells of the respiratory epithelium. It is one of the etiologic agents of non-viral primary atypical pneumonia in man.
Inhalation of oxygen aimed at restoring toward normal any pathophysiologic alterations of gas exchange in the cardiopulmonary system, as by the use of a respirator, nasal catheter, tent, chamber, or mask. (From Dorland, 27th ed & Stedman, 25th ed)
Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents.
Endoscopic examination, therapy or surgery of the bronchi.
Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc.
Three-dimensional representation to show anatomic structures. Models may be used in place of intact animals or organisms for teaching, practice, and study.
Community health and NURSING SERVICES providing coordinated multiple services to the patient at the patient's homes. These home-care services are provided by a visiting nurse, home health agencies, HOSPITALS, or organized community groups using professional staff for care delivery. It differs from HOME NURSING which is provided by non-professionals.
Damage to any compartment of the lung caused by physical, chemical, or biological agents which characteristically elicit inflammatory reaction. These inflammatory reactions can either be acute and dominated by NEUTROPHILS, or chronic and dominated by LYMPHOCYTES and MACROPHAGES.
Mechanical ventilation delivered to match the patient's efforts in breathing as detected by the interactive ventilation device.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
Injury following pressure changes; includes injury to the eustachian tube, ear drum, lung and stomach.
A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.
Treatment of food with physical methods such as heat, high pressure, radiation, or electric current to destroy organisms that cause disease or food spoilage.
This drug combination has proved to be an effective therapeutic agent with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.
These include the muscles of the DIAPHRAGM and the INTERCOSTAL MUSCLES.
Inflammation of the lung parenchyma that is associated with BRONCHITIS, usually involving lobular areas from TERMINAL BRONCHIOLES to the PULMONARY ALVEOLI. The affected areas become filled with exudate that forms consolidated patches.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
Devices that control the supply of electric current for running electrical equipment.
The confinement of a patient in a hospital.
A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.
Any hindrance to the passage of air into and out of the lungs.
Chronic respiratory disease caused by the VISNA-MAEDI VIRUS. It was formerly believed to be identical with jaagsiekte (PULMONARY ADENOMATOSIS, OVINE) but is now recognized as a separate entity.
A transient absence of spontaneous respiration.
Paired but separate cavity within the THORACIC CAVITY. It consists of the space between the parietal and visceral PLEURA and normally contains a capillary layer of serous fluid that lubricates the pleural surfaces.
Severe or complete loss of motor function in all four limbs which may result from BRAIN DISEASES; SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; or rarely MUSCULAR DISEASES. The locked-in syndrome is characterized by quadriplegia in combination with cranial muscle paralysis. Consciousness is spared and the only retained voluntary motor activity may be limited eye movements. This condition is usually caused by a lesion in the upper BRAIN STEM which injures the descending cortico-spinal and cortico-bulbar tracts.
A human infant born before 37 weeks of GESTATION.
A respiratory support system used to remove mucus and clear airway by oscillating pressure on the chest.
Tracheitis is an inflammation of the trachea, often caused by viral or bacterial infections, characterized by symptoms such as cough, sore throat, and difficulty swallowing.
Application of a life support system that circulates the blood through an oxygenating system, which may consist of a pump, a membrane oxygenator, and a heat exchanger. Examples of its use are to assist victims of smoke inhalation injury, respiratory failure, and cardiac failure.
'Infant, Premature, Diseases' refers to health conditions or abnormalities that specifically affect babies born before 37 weeks of gestation, often resulting from their immature organ systems and increased vulnerability due to preterm birth.
Hospital units providing continuing surveillance and care to acutely ill newborn infants.
An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
An accumulation of air or gas in the PLEURAL CAVITY, which may occur spontaneously or as a result of trauma or a pathological process. The gas may also be introduced deliberately during PNEUMOTHORAX, ARTIFICIAL.
Disease having a short and relatively severe course.
The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract.
Barriers used to separate and remove PARTICULATE MATTER from air.
The outer margins of the thorax containing SKIN, deep FASCIA; THORACIC VERTEBRAE; RIBS; STERNUM; and MUSCLES.
In the medical field, manikins are realistic, full-size models of human bodies used for teaching and practicing medical skills, such as CPR, intubation, or surgical procedures, as they provide a realistic and safe training environment without the use of actual patients.
Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
Burns of the respiratory tract caused by heat or inhaled chemicals.
Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
The musculofibrous partition that separates the THORACIC CAVITY from the ABDOMINAL CAVITY. Contraction of the diaphragm increases the volume of the thoracic cavity aiding INHALATION.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
Pulmonary injury following the breathing in of toxic smoke from burning materials such as plastics, synthetics, building materials, etc. This injury is the most frequent cause of death in burn patients.
A chronic, clinically mild, infectious pneumonia of PIGS caused by MYCOPLASMA HYOPNEUMONIAE. Ninety percent of swine herds worldwide are infected with this economically costly disease that primarily affects animals aged two to six months old. The disease can be associated with porcine respiratory disease complex. PASTEURELLA MULTOCIDA is often found as a secondary infection.
A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).
Infections with bacteria of the genus PSEUDOMONAS.
Vaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE.
A vital statistic measuring or recording the rate of death from any cause in hospitalized populations.
The cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi.
The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.
Measurement of the amount of air that the lungs may contain at various points in the respiratory cycle.
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
The prototype species of PNEUMOCYSTIS infecting the laboratory rat, Rattus norvegicus (RATS). It was formerly called Pneumocystis carinii f. sp. carinii. Other species of Pneumocystis can also infect rats.
Presence of pus in a hollow organ or body cavity.
Small polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place.
Absence of air in the entire or part of a lung, such as an incompletely inflated neonate lung or a collapsed adult lung. Pulmonary atelectasis can be caused by airway obstruction, lung compression, fibrotic contraction, or other factors.
A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
A class of statistical methods applicable to a large set of probability distributions used to test for correlation, location, independence, etc. In most nonparametric statistical tests, the original scores or observations are replaced by another variable containing less information. An important class of nonparametric tests employs the ordinal properties of the data. Another class of tests uses information about whether an observation is above or below some fixed value such as the median, and a third class is based on the frequency of the occurrence of runs in the data. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1284; Corsini, Concise Encyclopedia of Psychology, 1987, p764-5)
A species of gram-negative, aerobic bacteria that is the causative agent of LEGIONNAIRES' DISEASE. It has been isolated from numerous environmental sites as well as from human lung tissue, respiratory secretions, and blood.
The pressure that would be exerted by one component of a mixture of gases if it were present alone in a container. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
Apparatus for removing exhaled or leaked anesthetic gases or other volatile agents, thus reducing the exposure of operating room personnel to such agents, as well as preventing the buildup of potentially explosive mixtures in operating rooms or laboratories.
A specialty concerned with the study of anesthetics and anesthesia.
Programs of disease surveillance, generally within health care facilities, designed to investigate, prevent, and control the spread of infections and their causative microorganisms.
Non-therapeutic positive end-expiratory pressure occurring frequently in patients with severe airway obstruction. It can appear with or without the administration of external positive end-expiratory pressure (POSITIVE-PRESSURE RESPIRATION). It presents an important load on the inspiratory muscles which are operating at a mechanical disadvantage due to hyperinflation. Auto-PEEP may cause profound hypotension that should be treated by intravascular volume expansion, increasing the time for expiration, and/or changing from assist mode to intermittent mandatory ventilation mode. (From Harrison's Principles of Internal Medicine, 12th ed, p1127)
The posture of an individual lying face down.
A technique of respiratory therapy, in either spontaneously breathing or mechanically ventilated patients, in which airway pressure is maintained above atmospheric pressure throughout the respiratory cycle by pressurization of the ventilatory circuit. (On-Line Medical Dictionary [Internet]. Newcastle upon Tyne(UK): The University Dept. of Medical Oncology: The CancerWEB Project; c1997-2003 [cited 2003 Apr 17]. Available from: http://cancerweb.ncl.ac.uk/omd/)
Supplying a building or house, their rooms and corridors, with fresh air. The controlling of the environment thus may be in public or domestic sites and in medical or non-medical locales. (From Dorland, 28th ed)
Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
The term "United States" in a medical context often refers to the country where a patient or study participant resides, and is not a medical term per se, but relevant for epidemiological studies, healthcare policies, and understanding differences in disease prevalence, treatment patterns, and health outcomes across various geographic locations.
Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
Gram-negative aerobic rods, isolated from surface water or thermally polluted lakes or streams. Member are pathogenic for man. Legionella pneumophila is the causative agent for LEGIONNAIRES' DISEASE.
Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.
Precise and detailed plans for the study of a medical or biomedical problem and/or plans for a regimen of therapy.
Child hospitalized for short term care.
A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.
Ratings that express, in numerical values, the degree of impairment or abnormality in the function of specific organs.
Interfacility or intrahospital transfer of patients. Intrahospital transfer is usually to obtain a specific kind of care and interfacility transfer is usually for economic reasons as well as for the type of care provided.
Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
Pneumonia caused by infections with the genus CHLAMYDIA; and CHLAMYDOPHILA, usually with CHLAMYDOPHILA PNEUMONIAE.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.
Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing.
Bovine respiratory disease found in animals that have been shipped or exposed to CATTLE recently transported. The major agent responsible for the disease is MANNHEIMIA HAEMOLYTICA and less commonly, PASTEURELLA MULTOCIDA or HAEMOPHILUS SOMNUS. All three agents are normal inhabitants of the bovine nasal pharyngeal mucosa but not the LUNG. They are considered opportunistic pathogens following STRESS, PHYSIOLOGICAL and/or a viral infection. The resulting bacterial fibrinous BRONCHOPNEUMONIA is often fatal.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people.
Inhalation anesthesia where the gases exhaled by the patient are rebreathed as some carbon dioxide is simultaneously removed and anesthetic gas and oxygen are added so that no anesthetic escapes into the room. Closed-circuit anesthesia is used especially with explosive anesthetics to prevent fires where electrical sparking from instruments is possible.
Disorders affecting the organs of the thorax.
A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus.
A state of prolonged irreversible cessation of all brain activity, including lower brain stem function with the complete absence of voluntary movements, responses to stimuli, brain stem reflexes, and spontaneous respirations. Reversible conditions which mimic this clinical state (e.g., sedative overdose, hypothermia, etc.) are excluded prior to making the determination of brain death. (From Adams et al., Principles of Neurology, 6th ed, pp348-9)
Studies determining the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. For drugs and devices, CLINICAL TRIALS AS TOPIC; DRUG EVALUATION; and DRUG EVALUATION, PRECLINICAL are available.
Hospitals maintained by a university for the teaching of medical students, postgraduate training programs, and clinical research.
Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.
Infections with bacteria of the genus KLEBSIELLA.
A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
A condition in which albumin level in blood (SERUM ALBUMIN) is below the normal range. Hypoalbuminemia may be due to decreased hepatic albumin synthesis, increased albumin catabolism, altered albumin distribution, or albumin loss through the urine (ALBUMINURIA).
Agents that cause an increase in the expansion of a bronchus or bronchial tubes.
The right of the patient or the patient's representative to make decisions with regard to the patient's dying.
Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.
Conformity in fulfilling or following official, recognized, or institutional requirements, guidelines, recommendations, protocols, pathways, or other standards.
A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.
Physiological processes and properties of the RESPIRATORY SYSTEM as a whole or of any of its parts.

Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia. (1/345)

This randomized, double-blind, multicenter study compared the efficacy and safety of piperacillin/tazobactam (P/T) and imipenem/cilastatin (IMP), both in combination with an aminoglycoside, in hospitalized patients with acute nosocomial pneumonia (NP). Patients with acute NP, defined as pneumonia with symptoms > or = 48 h after admission or < or =7 days after hospital discharge, received infusions of 4 g/500 mg P/T or 500 mg/500 mg IMP every 6 h. Endpoints were clinical cure and microbiological response rates; pathogen eradication rates; length of hospital stay; hospital readmissions; and adverse events (AEs). Of 437 patients in the intent-to-treat population, 197 were efficacy evaluable. At test-of-cure, response rates were similar between groups. Within the efficacy evaluable population, 68% of P/T patients and 61% of IMP patients were clinically cured (P = 0.256). Microbiological responses for P/T and IMP patients were: eradication, 64% versus 59%; persistence, 29% versus 21%; relapse, 0% versus 5%; and superinfection, 7% versus 15%, respectively. Gram-positive isolates were eradicated in 83% of P/T patients and 75% of IMP patients; Gram-negative pathogens were eradicated in 72% of P/T patients and 77% of IMP patients. Treatment groups had similar number of mean hospital days, readmission rates, and frequency of AEs. This study showed that P/T administered four times per day was as safe and efficacious as IMP in treating hospitalized patients with NP.  (+info)

Decline in ICU adverse events, nosocomial infections and cost through a quality improvement initiative focusing on teamwork and culture change. (2/345)

BACKGROUND: Nosocomial infections occur in approximately 10% of patients in intensive care units (ICUs). Several studies have shown that a quality improvement initiative can reduce nosocomial infections, mortality, and cost. CONTEXT: Our hospital is located in Northern Mississippi and has a 28 bed Medical-Surgical ICU unit with 95% occupancy. We joined the ICU collaborative with the IMPACT initiative of the Institute of Healthcare Improvement (IHI) in October 2002. A preliminary prospective before (fiscal year (FY) 2001-2) and after (FY 2003) hypothesis generating study was conducted of outcomes resulting from small tests of change in the management of ICU patients. KEY MEASURES FOR IMPROVEMENT: Nosocomial infection rates, adverse events per ICU day, average length of stay, and average cost per ICU episode. STRATEGY FOR CHANGE: Four changes were implemented: (1) physician led multidisciplinary rounds; (2) daily "flow" meeting to assess bed availability; (3) "bundles" (sets of evidence based best practices); and (4) culture changes with a focus on the team decision making process. EFFECTS OF CHANGE: Between baseline and re-measurement periods, nosocomial infection rates declined for ventilator associated pneumonia (from 7.5 to 3.2 per 1000 ventilator days, p = 0.04) and bloodstream infections (from 5.9 to 3.1 per 1000 line days, p = 0.03), with a downward trend in the rate of urinary tract infections (from 3.8 to 2.4 per 1000 catheter days, p = 0.17). There was a strong downward trend in the rates of adverse events in the ICU as well as the average length of stay per episode. From FY 2002 to FY 2003 the cost per ICU episode fell from $3406 to $2973. LESSONS LEARNED: A systematic approach through collaboration with IHI's IMPACT initiative may have contributed to significant improvements in care in the ICU setting. Multidisciplinary teams appeared to improve communication, and bundles provided consistency of evidence based practices. The flow meetings allowed for rapid prioritization of activity and a new decision making culture empowered team members. The impact of these changes needs to be assessed more widely using rigorous study designs.  (+info)

Oral health status and development of ventilator-associated pneumonia: a descriptive study. (3/345)

BACKGROUND: Ventilator-associated pneumonia is a significant cause of morbidity and mortality and may be influenced by oral health. OBJECTIVE: To describe the relationship between ventilator-associated pneumonia and oral health status, changes in oral health status during the first 7 days after intubation, and microbial colonization of the oropharynx and trachea. METHODS: A total of 66 patients were enrolled within 24 hours of intubation and were followed up for up to 7 days. Data on oral health measures and the Clinical Pulmonary Infection Score (CPIS) were collected at baseline, day 4 (n = 37), and day 7 (n = 21). A regression model was used to predict risk of pneumonia at day 4. RESULTS: Dental plaque and oral organisms increased over time. Correlations were significant for baseline and day 4 dental plaque (P < .001), baseline salivary lactoferrin and day 4 plaque (P = .01), and lower salivary volume and higher day 4 CPIS (P = .02). Potential pathogens were identified in oral cultures for 6 patients before or at the same time as the appearance of the organisms in tracheal aspirates. Correlations were significant with day 4 CPIS for score on the Acute Physiology and Chronic Health Evaluation (APACHE) II (P = .007), day 4 salivary volume (P = .02), interaction of APACHE II score and day 1 CPIS (P<.001), and interaction of day 1 CPIS and plaque (P=.01). CONCLUSIONS: Higher dental plaque scores confer greater risk for ventilator-associated pneumonia, particularly for patients with greater severity of illness. Salivary volume and lactoferrin may affect the risk.  (+info)

Pneumonia in nonambulatory patients. The role of oral bacteria and oral hygiene. (4/345)

BACKGROUND: Considerable evidence exists to support a relationship between poor oral health, the oral microflora and bacterial pneumonia, especially ventilator-associated pneumonia in institutionalized patients. Teeth or dentures have nonshedding surfaces on which oral biofilms (that is, dental plaque) form that are susceptible to colonization by respiratory pathogens. Subsequent aspiration of respiratory pathogens shed from oral biofilms into the lower airway increases the risk of developing a lung infection. In addition, patients may aspirate inflammatory products from inflamed periodontal tissues into the lower airway, contributing to lung insult. TYPES OF STUDIES REVIEWED: The author reviewed laboratory studies, clinical trials and review articles. CONCLUSIONS: A number of studies have shown that the mouth can be colonized by respiratory pathogens and serve as a reservoir for these organisms. Other studies have demonstrated that oral interventions aimed at controlling or reducing oral biofilms can reduce the risk of pneumonia in high-risk populations. Taken together, the evidence is substantial that improved oral hygiene may prevent pneumonia in vulnerable patients. CLINICAL IMPLICATIONS: Institution of rigorous oral hygiene regimens for hospitalized patients and long-term-care residents may reduce the risk of developing pneumonia.  (+info)

Incidence and risk factors for ventilator-associated pneumonia in a developing country: where is the difference? (5/345)

BACKGROUND: Latin America exhibits a wide range of differences, compared to developed nations, in genetic background, health services, and clinical research development. It is valid to hypothesize that the incidence and risk factors for ventilator-associated pneumonia (VAP) in our setting may be substantially different of those reported elsewhere. We conducted a study to determine the incidence and risk factors for VAP in a University Hospital from Medellin, Colombia. METHODS: Prospective cohort study in three intensive care units (ICU) (surgical/trauma, medical, cardiovascular) in a 550-bed University Hospital. Critically ill patients (n=270) who required at least 48 h of mechanical ventilation (MV) between June 2002 and October 2003 were followed until ICU discharge, VAP diagnosis or death. RESULTS: Sixty patients (22.2%) developed VAP 5.9+/-3.6 days after admission. The overall incidence of VAP was 29 cases per 1000 ventilator-days. The daily hazard for developing VAP increased until day 8, and then decreased over the duration of stay in the ICU. The only statistically significant factor after multivariable analysis was gender, with being female reducing 57% the risk of pneumonia (hazard ratios (HR): 0.43; 95% confidence intervals (CI): 0.19-0.96). CONCLUSIONS: The epidemiologic profile of VAP in terms of incidence, length of stay and clinical course resembles the general pattern described everywhere. Surprisingly, we could not identify any potentially modifiable risk factor for VAP. A comprehensive multicenter study is warranted. It should provide deep insight about the specific microbiological, genetic and clinic features of VAP in our setting.  (+info)

Using evidence and process improvement strategies to enhance healthcare outcomes for the critically ill: a pilot project. (6/345)

BACKGROUND: Although the value of evidence-based practice may seem obvious, the process needed to produce more effective delivery of evidence-based healthcare is not obvious. Furthermore, the continuing escalation of healthcare costs fuels the desire of providers and consumers to undertake only those treatments that have benefit. One way to effect necessary changes in healthcare organizations is through focused, interdisciplinary, collaborative projects related to evidence-based practice. OBJECTIVES: To reduce rates of ventilator-associated pneumonia and catheter-related bloodstream infection in patients in the medical intensive care unit of a large, urban tertiary referral hospital in the Southwest. METHODS: The theory of planned behavior served as the basis for providing staff members with research-based, easily controllable strategies that "fit" with the usual methods of care delivery. Implementation of the strategies and data collection were accomplished through routine rounds on patients and regular reporting of objective information. RESULTS: During a 15-month period, use of the selected strategies resulted in a 54% reduction in ventilator-associated pneumonia, a 78% reduction in catheter-related bloodstream infections, and a 18% reduction in mean length of stay in the unit. Use of a multidisciplinary, environmentally tailored approach to concerns about patients' care resulted in estimated cost savings of 1.0 million US dollars to 2.3 million US dollars. CONCLUSIONS: Early, consistent communication about the project's rationale, expected behavior, and outcomes enhanced the manageability and effectiveness of this change in an adult intensive care unit.  (+info)

Nurses' knowledge and application of evidence-based guidelines for preventing ventilator-associated pneumonia. (7/345)

AIM: The aim of the study was to evaluate the nurses' knowledge and to highlight the causes that hinder guidelines implementation. METHODS: EXPERIMENTAL DESIGN: descriptive study. SETTING AND PARTICIPANTS: 106 nurses working in the ICUs of a major Italian hospital of national importance. INTERVENTION: administration of a questionnaire listing 21 non-pharmacological strategies considered the most useful in the literature. RESULTS: Eighty-four nurses responded to the questionnaire. Only 19 (22.6%) declared that their knowledge of ventilation associated pneumonia (VAP) and the strategies used to prevent it were satisfactory, whereas 46 (54.8%) declared that they were poorly informed; 68 nurses (80.9%) said that they applied one or more strategies, and 15 (17.9%) that they applied none. The reasons given for not applying the strategies were: method not foreseen in Department protocols (31.5%), lack of the necessary resources (14.3%), disagreement with the method (3.2%), high costs (2.6%), the possibility of causing discomfort (1%) or side effects (0.6%). CONCLUSIONS: In our experience, VAP preventive strategies are widely applied by nurses, but not in a responsible and informed manner. It is important to ensure that nurses receive continuous training and are involved in drawing up and updating Departmental protocols and guidelines for care and behaviour.  (+info)

Mechanical ventilation in patients with Guillain-Barre syndrome. (8/345)

BACKGROUND: Patients with Guillain-Barre syndrome are commonly exposed to prolonged mechanical ventilation. Specific data on ventilatory management of these patients have been limited. OBJECTIVE: To describe the practice of mechanical ventilation in patients with Guillain-Barre syndrome and evaluate risk factors for morbidity and mortality. METHODS: We describe a historical cohort of mechanically ventilated patients with Guillain-Barre syndrome in a tertiary-care center. We extracted database information on demographics, severity of illness, pulmonary function, and ventilatory management for the period 1976 to 1996. Primary outcomes were development of pulmonary complications, duration of ventilatory support, and mortality. RESULTS: Fifty-four patients met the inclusion criteria. After 1990, lower tidal volume (p = 0.031) and higher positive end-expiratory pressure (p = 0.003) were used than during the 1976 to 1990. Outcomes did not change significantly during the studied period. Forty-six patients (85%) survived to hospital discharge, and 39 (72%) were alive at 1-year follow-up. Ventilator-associated pneumonia was the most frequent complication (56%) and was associated with prolonged mechanical ventilation (p < 0.01). Atelectasis developed in 49%, and acute lung injury in 13%. All but 6 patients (89%) received tracheostomy. In 14 patients (30%) tracheostomy was placed > or = 14 days after intubation. When adjusted for atelectasis and severity of illness in a stepwise logistic regression analysis, delayed tracheostomy was associated with the development of ventilator-associated pneumonia (odds ratio 8.2, p = 0.029). CONCLUSIONS: Changes in ventilator practice did not affect outcomes of mechanically ventilated patients with Guillain-Barre syndrome. The majority of patients received tracheostomy, which should be considered early in the course of respiratory failure.  (+info)

Mechanical Ventilators are medical devices that assist with breathing by providing mechanical ventilation to patients who are unable to breathe sufficiently on their own. These machines deliver breaths to the patient through an endotracheal tube or a tracheostomy tube, which is placed in the windpipe (trachea). Mechanical Ventilators can be set to deliver breaths at specific rates and volumes, and they can also be adjusted to provide varying levels of positive end-expiratory pressure (PEEP) to help keep the alveoli open and improve oxygenation.

Mechanical ventilation is typically used in critical care settings such as intensive care units (ICUs), and it may be employed for a variety of reasons, including respiratory failure, sedation, neuromuscular disorders, or surgery. Prolonged use of mechanical ventilation can lead to complications such as ventilator-associated pneumonia, muscle weakness, and decreased cardiac function, so the goal is usually to wean patients off the ventilator as soon as possible.

Pneumonia is an infection or inflammation of the alveoli (tiny air sacs) in one or both lungs. It's often caused by bacteria, viruses, or fungi. Accumulated pus and fluid in these air sacs make it difficult to breathe, which can lead to coughing, chest pain, fever, and difficulty breathing. The severity of symptoms can vary from mild to life-threatening, depending on the underlying cause, the patient's overall health, and age. Pneumonia is typically diagnosed through a combination of physical examination, medical history, and diagnostic tests such as chest X-rays or blood tests. Treatment usually involves antibiotics for bacterial pneumonia, antivirals for viral pneumonia, and supportive care like oxygen therapy, hydration, and rest.

Ventilator weaning is the process of gradually reducing the amount of support provided by a mechanical ventilator to a patient, with the ultimate goal of completely withdrawing the mechanical assistance and allowing the patient to breathe independently. This process is typically initiated when the patient's underlying medical condition has improved to the point where they are able to sustain their own respiratory efforts.

The weaning process may involve reducing the frequency and duration of ventilator breaths, decreasing the amount of oxygen supplied by the ventilator, or adjusting the settings of the ventilator to encourage the patient to take more frequent and deeper breaths on their own. The rate at which weaning is attempted will depend on the individual patient's condition and overall progress.

Close monitoring of the patient's respiratory status, oxygenation, and work of breathing is essential during the weaning process to ensure that the patient is able to tolerate the decreased level of support and to identify any potential complications that may arise. Effective communication between the healthcare team and the patient is also important to provide education, set expectations, and address any concerns or questions that may arise during the weaning process.

Bacterial pneumonia is a type of lung infection that's caused by bacteria. It can affect people of any age, but it's more common in older adults, young children, and people with certain health conditions or weakened immune systems. The symptoms of bacterial pneumonia can vary, but they often include cough, chest pain, fever, chills, and difficulty breathing.

The most common type of bacteria that causes pneumonia is Streptococcus pneumoniae (pneumococcus). Other types of bacteria that can cause pneumonia include Haemophilus influenzae, Staphylococcus aureus, and Mycoplasma pneumoniae.

Bacterial pneumonia is usually treated with antibiotics, which are medications that kill bacteria. The specific type of antibiotic used will depend on the type of bacteria causing the infection. It's important to take all of the prescribed medication as directed, even if you start feeling better, to ensure that the infection is completely cleared and to prevent the development of antibiotic resistance.

In severe cases of bacterial pneumonia, hospitalization may be necessary for close monitoring and treatment with intravenous antibiotics and other supportive care.

Artificial respiration is an emergency procedure that can be used to provide oxygen to a person who is not breathing or is breathing inadequately. It involves manually forcing air into the lungs, either by compressing the chest or using a device to deliver breaths. The goal of artificial respiration is to maintain adequate oxygenation of the body's tissues and organs until the person can breathe on their own or until advanced medical care arrives. Artificial respiration may be used in conjunction with cardiopulmonary resuscitation (CPR) in cases of cardiac arrest.

Viral pneumonia is a type of pneumonia caused by viral infection. It primarily affects the upper and lower respiratory tract, leading to inflammation of the alveoli (air sacs) in the lungs. This results in symptoms such as cough, difficulty breathing, fever, fatigue, and chest pain. Common viruses that can cause pneumonia include influenza virus, respiratory syncytial virus (RSV), and adenovirus. Viral pneumonia is often milder than bacterial pneumonia but can still be serious, especially in young children, older adults, and people with weakened immune systems. Treatment typically involves supportive care, such as rest, hydration, and fever reduction, while the body fights off the virus. In some cases, antiviral medications may be used to help manage symptoms and prevent complications.

Pneumonia, pneumococcal is a type of pneumonia caused by the bacterium Streptococcus pneumoniae (also known as pneumococcus). This bacteria can colonize the upper respiratory tract and occasionally invade the lower respiratory tract, causing infection.

Pneumococcal pneumonia can affect people of any age but is most common in young children, older adults, and those with weakened immune systems. The symptoms of pneumococcal pneumonia include fever, chills, cough, chest pain, shortness of breath, and rapid breathing. In severe cases, it can lead to complications such as bacteremia (bacterial infection in the blood), meningitis (inflammation of the membranes surrounding the brain and spinal cord), and respiratory failure.

Pneumococcal pneumonia can be prevented through vaccination with the pneumococcal conjugate vaccine (PCV) or the pneumococcal polysaccharide vaccine (PPSV). These vaccines protect against the most common strains of Streptococcus pneumoniae that cause invasive disease. It is also important to practice good hygiene, such as covering the mouth and nose when coughing or sneezing, and washing hands frequently, to prevent the spread of pneumococcal bacteria.

Ventilator-associated pneumonia (VAP) is a specific type of pneumonia that develops in patients who have been mechanically ventilated through an endotracheal tube for at least 48 hours. It is defined as a nosocomial pneumonia (healthcare-associated infection occurring >48 hours after admission) that occurs in this setting. VAP is typically caused by aspiration of pathogenic microorganisms from the oropharynx or stomach into the lower respiratory tract, and it can lead to significant morbidity and mortality.

The diagnosis of VAP is often challenging due to the overlap of symptoms with other respiratory conditions and the potential for contamination of lower respiratory samples by upper airway flora. Clinical criteria, radiographic findings, and laboratory tests, such as quantitative cultures of bronchoalveolar lavage fluid or protected specimen brush, are often used in combination to make a definitive diagnosis.

Preventing VAP is crucial in critically ill patients and involves several evidence-based strategies, including elevating the head of the bed, oral care with chlorhexidine, and careful sedation management to allow for spontaneous breathing trials and early extubation when appropriate.

Cryptogenic organizing pneumonia (COP) is a type of lung disorder that is characterized by the presence of inflammation and scarring in the lungs. The term "cryptogenic" means that the cause of the condition is unknown or unclear.

Organizing pneumonia is a specific pattern of injury to the lungs that can be caused by various factors, including infections, medications, and autoimmune disorders. However, in cases of COP, there is no clear underlying cause that can be identified.

The main symptoms of COP include cough, shortness of breath, fever, and fatigue. The condition can also cause crackles or wheezing sounds when listening to the lungs with a stethoscope. Diagnosis of COP typically involves a combination of imaging studies, such as chest X-rays or CT scans, and lung biopsy.

Treatment for COP usually involves the use of corticosteroids, which can help to reduce inflammation and improve symptoms. In some cases, other medications may also be used to manage the condition. The prognosis for people with COP is generally good, with most individuals responding well to treatment and experiencing improvement in their symptoms over time. However, recurrence of the condition is possible, and long-term monitoring may be necessary.

"Pneumonia, Pneumocystis" is more commonly referred to as "Pneumocystis pneumonia (PCP)." It is a type of pneumonia caused by the microorganism Pneumocystis jirovecii. This organism was previously classified as a protozoan but is now considered a fungus.

PCP is an opportunistic infection, which means that it mainly affects people with weakened immune systems, such as those with HIV/AIDS, cancer, transplant recipients, or people taking immunosuppressive medications. The symptoms of PCP can include cough, shortness of breath, fever, and difficulty exercising. It is a serious infection that requires prompt medical treatment, typically with antibiotics.

It's important to note that PCP is not the same as pneumococcal pneumonia, which is caused by the bacterium Streptococcus pneumoniae. While both conditions are types of pneumonia, they are caused by different organisms and require different treatments.

Staphylococcal pneumonia is a type of pneumonia caused by the bacterium Staphylococcus aureus. This bacteria can colonize the upper respiratory tract and sometimes invade the lower respiratory tract, causing pneumonia.

The symptoms of staphylococcal pneumonia are often severe and may include fever, cough, chest pain, shortness of breath, and production of purulent sputum. The disease can progress rapidly, leading to complications such as pleural effusion (accumulation of fluid in the space surrounding the lungs), empyema (pus in the pleural space), and bacteremia (bacteria in the bloodstream).

Staphylococcal pneumonia can occur in otherwise healthy individuals, but it is more common in people with underlying medical conditions such as chronic lung disease, diabetes, or a weakened immune system. It can also occur in healthcare settings, where S. aureus may be transmitted from person to person or through contaminated equipment.

Treatment of staphylococcal pneumonia typically involves the use of antibiotics that are active against S. aureus, such as nafcillin or vancomycin. In some cases, surgery may be necessary to drain fluid from the pleural space.

Work of breathing (WOB) is a term used in respiratory physiology to describe the amount of energy expended by the respiratory muscles to overcome the elastic and resistive forces in the lungs and chest wall during breathing. It is usually measured in joules per liter (J/L) or in breaths per minute (BPM).

WOB can be increased in various lung diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung disease, due to increased airway resistance or decreased lung compliance. Increased WOB can lead to respiratory muscle fatigue, decreased exercise tolerance, and reduced quality of life.

WOB can be measured noninvasively using techniques such as esophageal pressure monitoring or transdiaphragmatic pressure measurement, or invasively through the use of indwelling catheters in the pleural space or within the airways. These measurements are often used in research settings to evaluate the effectiveness of various treatments for respiratory disorders.

Positive-pressure respiration is a type of mechanical ventilation where positive pressure is applied to the airway and lungs, causing them to expand and inflate. This can be used to support or replace spontaneous breathing in patients who are unable to breathe effectively on their own due to conditions such as respiratory failure, neuromuscular disorders, or sedation for surgery.

During positive-pressure ventilation, a mechanical ventilator delivers breaths to the patient through an endotracheal tube or a tracheostomy tube. The ventilator is set to deliver a specific volume or pressure of air with each breath, and the patient's breathing is synchronized with the ventilator to ensure proper delivery of the breaths.

Positive-pressure ventilation can help improve oxygenation and remove carbon dioxide from the lungs, but it can also have potential complications such as barotrauma (injury to lung tissue due to excessive pressure), volutrauma (injury due to overdistention of the lungs), hemodynamic compromise (decreased blood pressure and cardiac output), and ventilator-associated pneumonia. Therefore, careful monitoring and adjustment of ventilator settings are essential to minimize these risks and provide safe and effective respiratory support.

Tidal volume (Vt) is the amount of air that moves into or out of the lungs during normal, resting breathing. It is the difference between the volume of air in the lungs at the end of a normal expiration and the volume at the end of a normal inspiration. In other words, it's the volume of each breath you take when you are not making any effort to breathe more deeply.

The average tidal volume for an adult human is around 500 milliliters (ml) per breath, but this can vary depending on factors such as age, sex, size, and fitness level. During exercise or other activities that require increased oxygen intake, tidal volume may increase to meet the body's demands for more oxygen.

Tidal volume is an important concept in respiratory physiology and clinical medicine, as it can be used to assess lung function and diagnose respiratory disorders such as chronic obstructive pulmonary disease (COPD) or asthma.

Aspiration pneumonia is a type of pneumonia that occurs when foreign materials such as food, liquid, or vomit enter the lungs, resulting in inflammation or infection. It typically happens when a person inhales these materials involuntarily due to impaired swallowing mechanisms, which can be caused by various conditions such as stroke, dementia, Parkinson's disease, or general anesthesia. The inhalation of foreign materials can cause bacterial growth in the lungs, leading to symptoms like cough, chest pain, fever, and difficulty breathing. Aspiration pneumonia can be a serious medical condition, particularly in older adults or individuals with weakened immune systems, and may require hospitalization and antibiotic treatment.

Respiratory insufficiency is a condition characterized by the inability of the respiratory system to maintain adequate gas exchange, resulting in an inadequate supply of oxygen and/or removal of carbon dioxide from the body. This can occur due to various causes, such as lung diseases (e.g., chronic obstructive pulmonary disease, pneumonia), neuromuscular disorders (e.g., muscular dystrophy, spinal cord injury), or other medical conditions that affect breathing mechanics and/or gas exchange.

Respiratory insufficiency can manifest as hypoxemia (low oxygen levels in the blood) and/or hypercapnia (high carbon dioxide levels in the blood). Symptoms of respiratory insufficiency may include shortness of breath, rapid breathing, fatigue, confusion, and in severe cases, loss of consciousness or even death. Treatment depends on the underlying cause and severity of the condition and may include oxygen therapy, mechanical ventilation, medications, and/or other supportive measures.

Lung compliance is a measure of the ease with which the lungs expand and is defined as the change in lung volume for a given change in transpulmonary pressure. It is often expressed in units of liters per centimeter of water (L/cm H2O). A higher compliance indicates that the lungs are more easily distensible, while a lower compliance suggests that the lungs are stiffer and require more force to expand. Lung compliance can be affected by various conditions such as pulmonary fibrosis, pneumonia, acute respiratory distress syndrome (ARDS), and chronic obstructive pulmonary disease (COPD).

A negative pressure ventilator, also known as an iron lung, is a type of mechanical ventilator that creates a negative pressure environment around the patient's chest and abdomen to assist with breathing. This technology was widely used during the polio epidemic in the mid-20th century to help patients with respiratory paralysis caused by the disease.

In a negative pressure ventilator, the patient is placed inside an airtight chamber that is connected to a pump. The pump changes the air pressure within the chamber, creating a vacuum effect that causes the chest and abdomen to expand and contract, which in turn facilitates breathing. As the pressure around the chest decreases, the chest wall expands, allowing the lungs to fill with air. When the pressure increases, the chest wall contracts, pushing air out of the lungs.

Negative pressure ventilators have largely been replaced by positive pressure ventilators, which are more commonly used today. Positive pressure ventilators work by actively pushing air into the lungs, rather than relying on negative pressure to create a vacuum effect. However, negative pressure ventilators may still be used in certain situations where positive pressure ventilation is not appropriate or feasible.

Respiratory mechanics refers to the biomechanical properties and processes that involve the movement of air through the respiratory system during breathing. It encompasses the mechanical behavior of the lungs, chest wall, and the muscles of respiration, including the diaphragm and intercostal muscles.

Respiratory mechanics includes several key components:

1. **Compliance**: The ability of the lungs and chest wall to expand and recoil during breathing. High compliance means that the structures can easily expand and recoil, while low compliance indicates greater resistance to expansion and recoil.
2. **Resistance**: The opposition to airflow within the respiratory system, primarily due to the friction between the air and the airway walls. Airway resistance is influenced by factors such as airway diameter, length, and the viscosity of the air.
3. **Lung volumes and capacities**: These are the amounts of air present in the lungs during different phases of the breathing cycle. They include tidal volume (the amount of air inspired or expired during normal breathing), inspiratory reserve volume (additional air that can be inspired beyond the tidal volume), expiratory reserve volume (additional air that can be exhaled beyond the tidal volume), and residual volume (the air remaining in the lungs after a forced maximum exhalation).
4. **Work of breathing**: The energy required to overcome the resistance and elastic forces during breathing. This work is primarily performed by the respiratory muscles, which contract to generate negative intrathoracic pressure and expand the chest wall, allowing air to flow into the lungs.
5. **Pressure-volume relationships**: These describe how changes in lung volume are associated with changes in pressure within the respiratory system. Important pressure components include alveolar pressure (the pressure inside the alveoli), pleural pressure (the pressure between the lungs and the chest wall), and transpulmonary pressure (the difference between alveolar and pleural pressures).

Understanding respiratory mechanics is crucial for diagnosing and managing various respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, and restrictive lung diseases.

Community-acquired infections are those that are acquired outside of a healthcare setting, such as in one's own home or community. These infections are typically contracted through close contact with an infected person, contaminated food or water, or animals. Examples of community-acquired infections include the common cold, flu, strep throat, and many types of viral and bacterial gastrointestinal infections.

These infections are different from healthcare-associated infections (HAIs), which are infections that patients acquire while they are receiving treatment for another condition in a healthcare setting, such as a hospital or long-term care facility. HAIs can be caused by a variety of factors, including contact with contaminated surfaces or equipment, invasive medical procedures, and the use of certain medications.

It is important to note that community-acquired infections can also occur in healthcare settings if proper infection control measures are not in place. Healthcare providers must take steps to prevent the spread of these infections, such as washing their hands regularly, using personal protective equipment (PPE), and implementing isolation precautions for patients with known or suspected infectious diseases.

Equipment design, in the medical context, refers to the process of creating and developing medical equipment and devices, such as surgical instruments, diagnostic machines, or assistive technologies. This process involves several stages, including:

1. Identifying user needs and requirements
2. Concept development and brainstorming
3. Prototyping and testing
4. Design for manufacturing and assembly
5. Safety and regulatory compliance
6. Verification and validation
7. Training and support

The goal of equipment design is to create safe, effective, and efficient medical devices that meet the needs of healthcare providers and patients while complying with relevant regulations and standards. The design process typically involves a multidisciplinary team of engineers, clinicians, designers, and researchers who work together to develop innovative solutions that improve patient care and outcomes.

Mycoplasma pneumonia is a type of atypical pneumonia, which is caused by the bacterium Mycoplasma pneumoniae. This organism is not a true bacterium, but rather the smallest free-living organisms known. They lack a cell wall and have a unique mode of reproduction.

Mycoplasma pneumonia infection typically occurs in small outbreaks or sporadically, often in crowded settings such as schools, colleges, and military barracks. It can also be acquired in the community. The illness is often mild and self-limiting, but it can also cause severe pneumonia and extra-pulmonary manifestations.

The symptoms of Mycoplasma pneumonia are typically less severe than those caused by typical bacterial pneumonia and may include a persistent cough that may be dry or produce small amounts of mucus, fatigue, fever, headache, sore throat, and chest pain. The infection can also cause extrapulmonary manifestations such as skin rashes, joint pain, and neurological symptoms.

Diagnosis of Mycoplasma pneumonia is often challenging because the organism is difficult to culture, and serological tests may take several weeks to become positive. PCR-based tests are now available and can provide a rapid diagnosis.

Treatment typically involves antibiotics such as macrolides (e.g., azithromycin), tetracyclines (e.g., doxycycline), or fluoroquinolones (e.g., levofloxacin). However, because Mycoplasma pneumonia is often self-limiting, antibiotic treatment may not shorten the duration of illness but can help prevent complications and reduce transmission.

Intubation, intratracheal is a medical procedure in which a flexible plastic or rubber tube called an endotracheal tube (ETT) is inserted through the mouth or nose, passing through the vocal cords and into the trachea (windpipe). This procedure is performed to establish and maintain a patent airway, allowing for the delivery of oxygen and the removal of carbon dioxide during mechanical ventilation in various clinical scenarios, such as:

1. Respiratory failure or arrest
2. Procedural sedation
3. Surgery under general anesthesia
4. Neuromuscular disorders
5. Ingestion of toxic substances
6. Head and neck trauma
7. Critical illness or injury affecting the airway

The process of intubation is typically performed by trained medical professionals, such as anesthesiologists, emergency medicine physicians, or critical care specialists, using direct laryngoscopy or video laryngoscopy to visualize the vocal cords and guide the ETT into the correct position. Once placed, the ETT is secured to prevent dislodgement, and the patient's respiratory status is continuously monitored to ensure proper ventilation and oxygenation.

An Intensive Care Unit (ICU) is a specialized hospital department that provides continuous monitoring and advanced life support for critically ill patients. The ICU is equipped with sophisticated technology and staffed by highly trained healthcare professionals, including intensivists, nurses, respiratory therapists, and other specialists.

Patients in the ICU may require mechanical ventilation, invasive monitoring, vasoactive medications, and other advanced interventions due to conditions such as severe infections, trauma, cardiac arrest, respiratory failure, or post-surgical complications. The goal of the ICU is to stabilize patients' condition, prevent further complications, and support organ function while the underlying illness is treated.

ICUs may be organized into different units based on the type of care provided, such as medical, surgical, cardiac, neurological, or pediatric ICUs. The length of stay in the ICU can vary widely depending on the patient's condition and response to treatment.

I'm sorry for any confusion, but "Lipid Pneumonia" is not a type of pneumonia that is defined by the presence of lipids in the lungs. Instead, it refers to a condition where an abnormal amount of lipids or fatty substances accumulate in the lung tissue, which can lead to inflammation and infection, resulting in pneumonia.

Lipid pneumonia can occur due to various reasons, such as aspiration of lipid-containing materials (like oil-based nasal drops, mineral oil, or contaminated food), impaired lipid metabolism, or lung damage from certain medical conditions or treatments. The accumulation of these fatty substances in the lungs can cause an inflammatory response, leading to symptoms similar to those seen in other types of pneumonia, such as cough, fever, chest pain, and difficulty breathing.

Therefore, lipid pneumonia is not a medical definition per se but rather a term used to describe a condition where lipids accumulate in the lungs and cause inflammation and infection.

Intermittent Positive-Pressure Ventilation (IPPV) is a type of mechanical ventilation in which positive pressure is intermittently applied to the airway and lungs, allowing for inflation and deflation of the lungs. This mode of ventilation is often used in critical care settings such as intensive care units (ICUs) to support patients who are unable to breathe effectively on their own due to respiratory failure or other conditions that affect breathing.

During IPPV, a mechanical ventilator delivers breaths to the patient at set intervals, with each breath consisting of a set volume or pressure. The patient may also be allowed to take spontaneous breaths between the mechanically delivered breaths. The settings for IPPV can be adjusted based on the patient's needs and condition, including factors such as their respiratory rate, tidal volume (the amount of air moved with each breath), and positive end-expiratory pressure (PEEP), which helps to keep the alveoli open and prevent atelectasis.

IPPV can be used to provide short-term or long-term ventilatory support, depending on the patient's needs. It is an effective way to ensure that patients receive adequate oxygenation and ventilation while minimizing the risk of lung injury associated with high pressures or volumes. However, it is important to closely monitor patients receiving IPPV and adjust the settings as needed to avoid complications such as ventilator-associated pneumonia or barotrauma.

A lung is a pair of spongy, elastic organs in the chest that work together to enable breathing. They are responsible for taking in oxygen and expelling carbon dioxide through the process of respiration. The left lung has two lobes, while the right lung has three lobes. The lungs are protected by the ribcage and are covered by a double-layered membrane called the pleura. The trachea divides into two bronchi, which further divide into smaller bronchioles, leading to millions of tiny air sacs called alveoli, where the exchange of gases occurs.

Respiratory Distress Syndrome, Adult (RDSa or ARDS), also known as Acute Respiratory Distress Syndrome, is a severe form of acute lung injury characterized by rapid onset of widespread inflammation in the lungs. This results in increased permeability of the alveolar-capillary membrane, pulmonary edema, and hypoxemia (low oxygen levels in the blood). The inflammation can be triggered by various direct or indirect insults to the lung, such as sepsis, pneumonia, trauma, or aspiration.

The hallmark of ARDS is the development of bilateral pulmonary infiltrates on chest X-ray, which can resemble pulmonary edema, but without evidence of increased left atrial pressure. The condition can progress rapidly and may require mechanical ventilation with positive end-expiratory pressure (PEEP) to maintain adequate oxygenation and prevent further lung injury.

The management of ARDS is primarily supportive, focusing on protecting the lungs from further injury, optimizing oxygenation, and providing adequate nutrition and treatment for any underlying conditions. The use of low tidal volumes and limiting plateau pressures during mechanical ventilation have been shown to improve outcomes in patients with ARDS.

Respiratory Care Units (RCUs) are specialized departments within hospitals that provide comprehensive care to patients with respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, lung cancer, and sleep-disordered breathing. These units are staffed with specially trained healthcare professionals, including respiratory therapists, pulmonologists, nurses, and other specialists who work together to diagnose, treat, and manage patients' respiratory conditions.

RCUs may provide a range of services, including:

1. Diagnostic testing: This includes pulmonary function tests, arterial blood gas analysis, chest X-rays, CT scans, and other diagnostic procedures to assess the patient's lung function and identify any underlying respiratory conditions.
2. Medication management: RCUs may provide a variety of medications to help manage patients' respiratory symptoms, such as bronchodilators, corticosteroids, and antibiotics.
3. Oxygen therapy: Patients in RCUs may require oxygen therapy to help them breathe more easily. This can be delivered through various devices, including nasal cannulas, face masks, or oxygen hoods.
4. Mechanical ventilation: In severe cases of respiratory failure, patients may require mechanical ventilation to support their breathing. RCUs are equipped with advanced ventilators and other respiratory equipment to provide this care.
5. Pulmonary rehabilitation: RCUs may offer pulmonary rehabilitation programs to help patients manage their respiratory conditions and improve their overall quality of life. These programs may include exercise training, education, and counseling.
6. Sleep disorders management: Some RCUs may also provide care for patients with sleep-disordered breathing, such as obstructive sleep apnea. This can include diagnostic testing, continuous positive airway pressure (CPAP) therapy, and other treatments.

Overall, Respiratory Care Units play a critical role in the diagnosis, treatment, and management of respiratory disorders, helping patients to breathe more easily and improve their quality of life.

A Mass Casualty Incident (MCI) is a situation in which the number of injured or deceased individuals exceeds the local resources available to respond and manage the incident. It typically involves multiple victims, often resulting from natural disasters, transportation accidents, terrorist attacks, or industrial incidents. The severity and scale of injuries require additional resources, coordination, and response from regional, national, or international emergency management and healthcare systems.

Respiratory rate is the number of breaths a person takes per minute. It is typically measured by counting the number of times the chest rises and falls in one minute. Normal respiratory rate at rest for an adult ranges from 12 to 20 breaths per minute. An increased respiratory rate (tachypnea) or decreased respiratory rate (bradypnea) can be a sign of various medical conditions, such as lung disease, heart failure, or neurological disorders. It is an important vital sign that should be regularly monitored in clinical settings.

High-frequency jet ventilation (HFJV) is a type of mechanical ventilation that delivers breaths at a frequency greater than 100 times per minute, typically in the range of 240-360 breaths per minute. It uses a high-pressure jet of gas to deliver small tidal volumes (usually less than 2 ml/kg of ideal body weight) into the airway.

The jet ventilation is often combined with a low-level positive end-expiratory pressure (PEEP) to maintain some lung volume and prevent atelectasis during exhalation. HFJV can be used in both invasive and noninvasive modes, depending on the patient's condition and requirements.

This mode of ventilation is particularly useful in patients with severe respiratory distress syndrome (ARDS), bronchopleural fistula, or air leaks from lung injury, as it minimizes gas flow and reduces the risk of air leakage while still maintaining adequate oxygenation and carbon dioxide elimination. However, HFJV requires careful monitoring and expertise to ensure proper settings and avoid complications such as barotrauma, hemodynamic instability, or inadequate ventilation.

Interstitial lung diseases (ILDs) are a group of disorders characterized by inflammation and scarring (fibrosis) in the interstitium, the tissue and space around the air sacs (alveoli) of the lungs. The interstitium is where the blood vessels that deliver oxygen to the lungs are located. ILDs can be caused by a variety of factors, including environmental exposures, medications, connective tissue diseases, and autoimmune disorders.

The scarring and inflammation in ILDs can make it difficult for the lungs to expand and contract normally, leading to symptoms such as shortness of breath, cough, and fatigue. The scarring can also make it harder for oxygen to move from the air sacs into the bloodstream.

There are many different types of ILDs, including:

* Idiopathic pulmonary fibrosis (IPF): a type of ILD that is caused by unknown factors and tends to progress rapidly
* Hypersensitivity pneumonitis: an ILD that is caused by an allergic reaction to inhaled substances, such as mold or bird droppings
* Connective tissue diseases: ILDs can be a complication of conditions such as rheumatoid arthritis and scleroderma
* Sarcoidosis: an inflammatory disorder that can affect multiple organs, including the lungs
* Asbestosis: an ILD caused by exposure to asbestos fibers

Treatment for ILDs depends on the specific type of disease and its underlying cause. Some treatments may include corticosteroids, immunosuppressive medications, and oxygen therapy. In some cases, a lung transplant may be necessary.

Pulmonary ventilation, also known as pulmonary respiration or simply ventilation, is the process of moving air into and out of the lungs to facilitate gas exchange. It involves two main phases: inhalation (or inspiration) and exhalation (or expiration). During inhalation, the diaphragm and external intercostal muscles contract, causing the chest volume to increase and the pressure inside the chest to decrease, which then draws air into the lungs. Conversely, during exhalation, these muscles relax, causing the chest volume to decrease and the pressure inside the chest to increase, which pushes air out of the lungs. This process ensures that oxygen-rich air from the atmosphere enters the alveoli (air sacs in the lungs), where it can diffuse into the bloodstream, while carbon dioxide-rich air from the bloodstream in the capillaries surrounding the alveoli is expelled out of the body.

Airway resistance is a measure of the opposition to airflow during breathing, which is caused by the friction between the air and the walls of the respiratory tract. It is an important parameter in respiratory physiology because it can affect the work of breathing and gas exchange.

Airway resistance is usually expressed in units of cm H2O/L/s or Pa·s/m, and it can be measured during spontaneous breathing or during forced expiratory maneuvers, such as those used in pulmonary function testing. Increased airway resistance can result from a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), bronchitis, and bronchiectasis. Decreased airway resistance can be seen in conditions such as emphysema or after a successful bronchodilator treatment.

Equipment failure is a term used in the medical field to describe the malfunction or breakdown of medical equipment, devices, or systems that are essential for patient care. This can include simple devices like syringes and thermometers, as well as complex machines such as ventilators, infusion pumps, and imaging equipment.

Equipment failure can have serious consequences for patients, including delayed or inappropriate treatment, injury, or even death. It is therefore essential that medical equipment is properly maintained, tested, and repaired to ensure its safe and effective operation.

There are many potential causes of equipment failure, including:

* Wear and tear from frequent use
* Inadequate cleaning or disinfection
* Improper handling or storage
* Power supply issues
* Software glitches or bugs
* Mechanical failures or defects
* Human error or misuse

To prevent equipment failure, healthcare facilities should have established policies and procedures for the acquisition, maintenance, and disposal of medical equipment. Staff should be trained in the proper use and handling of equipment, and regular inspections and testing should be performed to identify and address any potential issues before they lead to failure.

Respiratory Distress Syndrome (RDS), Newborn is a common lung disorder in premature infants. It occurs when the lungs lack a substance called surfactant, which helps keep the tiny air sacs in the lungs open. This results in difficulty breathing and oxygenation, causing symptoms such as rapid, shallow breathing, grunting noises, flaring of the nostrils, and retractions (the skin between the ribs pulls in with each breath). RDS is more common in infants born before 34 weeks of gestation and is treated with surfactant replacement therapy, oxygen support, and mechanical ventilation if necessary. In severe cases, it can lead to complications such as bronchopulmonary dysplasia or even death.

Respiratory dead space is the portion of each tidal volume (the amount of air that moves in and out of the lungs during normal breathing) that does not participate in gas exchange. It mainly consists of the anatomical dead space, which includes the conducting airways such as the trachea, bronchi, and bronchioles, where no alveoli are present for gas exchange to occur.

Additionally, alveolar dead space can also contribute to respiratory dead space when alveoli are perfused inadequately or not at all due to conditions like pulmonary embolism, lung consolidation, or impaired circulation. In these cases, even though air reaches the alveoli, insufficient blood flow prevents efficient gas exchange from taking place.

The sum of anatomical and alveolar dead space is referred to as physiological dead space. An increased respiratory dead space can lead to ventilation-perfusion mismatch and impaired oxygenation, making it a critical parameter in assessing respiratory function, particularly during mechanical ventilation in critically ill patients.

A tracheostomy is a surgically created opening through the neck into the trachea (windpipe). It is performed to provide an airway in cases where the upper airway is obstructed or access to the lower airway is required, such as in prolonged intubation, severe trauma, or chronic lung diseases. The procedure involves making an incision in the front of the neck and creating a direct opening into the trachea, through which a tracheostomy tube is inserted to maintain the patency of the airway. This allows for direct ventilation of the lungs, suctioning of secretions, and prevention of complications associated with upper airway obstruction.

Noninvasive ventilation (NIV) refers to the delivery of mechanical ventilation without using an invasive airway, such as an endotracheal tube or tracheostomy. It is a technique used to support patients with respiratory insufficiency or failure, while avoiding the potential complications associated with intubation and invasive ventilation.

NIV can be provided through various interfaces, including nasal masks, full-face masks, or mouthpieces. The most common modes of NIV are continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP), which provide a constant flow of pressurized air to maintain airway patency and support breathing efforts.

NIV is commonly used in the management of chronic respiratory conditions such as obstructive sleep apnea, COPD, and neuromuscular disorders, as well as acute respiratory failure due to causes such as pneumonia or exacerbation of chronic lung disease. However, it is not appropriate for all patients and should be used under the close supervision of a healthcare provider.

Cross infection, also known as cross-contamination, is the transmission of infectious agents or diseases between patients in a healthcare setting. This can occur through various means such as contaminated equipment, surfaces, hands of healthcare workers, or the air. It is an important concern in medical settings and measures are taken to prevent its occurrence, including proper hand hygiene, use of personal protective equipment (PPE), environmental cleaning and disinfection, and safe injection practices.

Pulmonary gas exchange is the process by which oxygen (O2) from inhaled air is transferred to the blood, and carbon dioxide (CO2), a waste product of metabolism, is removed from the blood and exhaled. This process occurs in the lungs, primarily in the alveoli, where the thin walls of the alveoli and capillaries allow for the rapid diffusion of gases between them. The partial pressure gradient between the alveolar air and the blood in the pulmonary capillaries drives this diffusion process. Oxygen-rich blood is then transported to the body's tissues, while CO2-rich blood returns to the lungs to be exhaled.

In a medical context, masks are typically used as personal protective equipment (PPE) to protect the wearer from inhaling airborne particles and contaminants. They can also help prevent the spread of respiratory droplets from the wearer to others, which is particularly important in clinical settings where patients may have infectious diseases.

There are several types of masks used in medical settings, including:

1. Medical Masks: These are loose-fitting, disposable masks that create a physical barrier between the mouth and nose of the wearer and potential contaminants in the immediate environment. They are commonly used by healthcare professionals during medical procedures to protect themselves and patients from respiratory droplets and aerosols.
2. N95 Respirators: These are tight-fitting masks that can filter out both large droplets and small aerosol particles, including those containing viruses. They offer a higher level of protection than medical masks and are recommended for use in healthcare settings where there is a risk of exposure to airborne contaminants, such as during certain medical procedures or when caring for patients with infectious diseases like tuberculosis or COVID-19.
3. Surgical N95 Respirators: These are a specialized type of N95 respirator designed for use in surgical settings. They have a clear plastic window that allows the wearer's mouth and nose to be visible, which is useful during surgery where clear communication and identification of the wearer's facial features are important.
4. Powered Air-Purifying Respirators (PAPRs): These are motorized masks that use a fan to draw air through a filter, providing a continuous supply of clean air to the wearer. They offer a high level of protection and are often used in healthcare settings where there is a risk of exposure to highly infectious diseases or hazardous substances.

It's important to note that masks should be used in conjunction with other infection prevention measures, such as hand hygiene and social distancing, to provide the best possible protection against respiratory illnesses.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

High-frequency ventilation (HFV) is a specialized mode of mechanical ventilation that delivers breaths at higher rates (usually 120-900 breaths per minute) and smaller tidal volumes (1-3 mL/kg) compared to conventional ventilation. This technique aims to reduce lung injury caused by overdistension and atelectasis, which can occur with traditional ventilator settings. It is often used in neonatal and pediatric intensive care units for the management of severe respiratory distress syndrome, meconium aspiration syndrome, and other conditions where conventional ventilation may be harmful.

There are two main types of high-frequency ventilation: high-frequency oscillatory ventilation (HFOV) and high-frequency jet ventilation (HFJV). Both techniques use different methods to generate the high-frequency breaths but share similar principles in delivering small tidal volumes at rapid rates.

In summary, high-frequency ventilation is a medical intervention that utilizes specialized ventilators to deliver faster and smaller breaths, minimizing lung injury and improving oxygenation for critically ill patients with severe respiratory distress.

Inhalation is the act or process of breathing in where air or other gases are drawn into the lungs. It's also known as inspiration. This process involves several muscles, including the diaphragm and intercostal muscles between the ribs, working together to expand the chest cavity and decrease the pressure within the thorax, which then causes air to flow into the lungs.

In a medical context, inhalation can also refer to the administration of medications or therapeutic gases through the respiratory tract, typically using an inhaler or nebulizer. This route of administration allows for direct delivery of the medication to the lungs, where it can be quickly absorbed into the bloodstream and exert its effects.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

Idiopathic interstitial pneumonias (IIPs) are a group of rare lung diseases with no known cause, characterized by inflammation and scarring (fibrosis) of the lung tissue. The term "idiopathic" means that the cause is unknown, and "interstitial" refers to the spaces between the air sacs in the lungs where the inflammation and scarring occur.

IIPs are classified into several subtypes based on their clinical, radiological, and pathological features. These include:

1. Idiopathic Pulmonary Fibrosis (IPF): This is the most common and aggressive form of IIP, characterized by progressive scarring of the lung tissue, which leads to difficulty breathing and decreased lung function over time.
2. Nonspecific Interstitial Pneumonia (NSIP): This subtype is characterized by varying degrees of inflammation and fibrosis in the lung tissue. NSIP can be idiopathic or associated with connective tissue diseases.
3. Respiratory Bronchiolitis-Interstitial Lung Disease (RB-ILD): This subtype primarily affects smokers and is characterized by inflammation of the small airways and surrounding lung tissue.
4. Desquamative Interstitial Pneumonia (DIP): This subtype is also more common in smokers and is characterized by accumulation of pigmented macrophages in the lung tissue.
5. Cryptogenic Organizing Pneumonia (COP): This subtype is characterized by the formation of fibrous masses in the small airways and alveoli, leading to cough and shortness of breath.
6. Acute Interstitial Pneumonia (AIP)/Acute Respiratory Distress Syndrome (ARDS): This subtype is a severe form of IIP that can rapidly progress to respiratory failure and requires immediate medical attention.

The diagnosis of IIPs typically involves a combination of clinical evaluation, imaging studies, and lung biopsy. Treatment options may include corticosteroids, immunosuppressive medications, and oxygen therapy, depending on the severity and subtype of the disease.

I couldn't find a medical definition specific to "data display," but I can provide some information related to the visual representation of medical data.

In healthcare and research, data displays are graphical representations of data designed to facilitate understanding, communication, and interpretation of complex information. These visualizations can include various types of charts, graphs, tables, and infographics that present medical data in a more accessible and easily digestible format. Examples of data displays in a medical context may include:

1. Line graphs: Used to show trends over time, such as changes in a patient's vital signs or the progression of a disease.
2. Bar charts: Employed to compare categorical data, like the frequency of different symptoms across various patient groups.
3. Pie charts: Utilized to illustrate proportions or percentages of different categories within a whole, such as the distribution of causes of death in a population.
4. Scatter plots: Applied to display relationships between two continuous variables, like the correlation between age and blood pressure.
5. Heat maps: Used to represent density or intensity of data points across a two-dimensional space, often used for geographical data or large datasets with spatial components.
6. Forest plots: Commonly employed in systematic reviews and meta-analyses to display the effect sizes and confidence intervals of individual studies and overall estimates.
7. Flow diagrams: Used to illustrate diagnostic algorithms, treatment pathways, or patient flow through a healthcare system.
8. Icon arrays: Employed to represent risks or probabilities visually, often used in informed consent processes or shared decision-making tools.

These visual representations of medical data can aid in clinical decision-making, research, education, and communication between healthcare professionals, patients, and policymakers.

Ventilator-Induced Lung Injury (VILI) is a type of lung injury that can occur in patients who require mechanical ventilation to assist their breathing. It's caused by the application of excessive pressure or volume to the lungs during the process of mechanical ventilation, which can lead to damage of the alveoli (tiny air sacs in the lungs). This can result in inflammation, increased permeability of the alveolar-capillary membrane, and potentially even progressive lung dysfunction.

The risk factors for VILI include high tidal volumes (the amount of air moved into and out of the lungs during each breath), high inspiratory pressures, and high levels of positive end-expiratory pressure (PEEP). To minimize the risk of VILI, clinicians often use a lung protective ventilation strategy that involves using lower tidal volumes and limiting inspiratory pressures.

It's important to note that while mechanical ventilation is a lifesaving intervention for many critically ill patients, it is not without risks. VILI is one of the potential complications of this therapy, and clinicians must be mindful of this risk when managing mechanically ventilated patients.

In medical terms, suction refers to the process of creating and maintaining a partial vacuum in order to remove fluids or gases from a body cavity or wound. This is typically accomplished using specialized medical equipment such as a suction machine, which uses a pump to create the vacuum, and a variety of different suction tips or catheters that can be inserted into the area being treated.

Suction is used in a wide range of medical procedures and treatments, including wound care, surgical procedures, respiratory therapy, and diagnostic tests. It can help to remove excess fluids such as blood or pus from a wound, clear secretions from the airways during mechanical ventilation, or provide a means of visualizing internal structures during endoscopic procedures.

It is important to use proper technique when performing suctioning, as excessive or improperly applied suction can cause tissue damage or bleeding. Medical professionals are trained in the safe and effective use of suction equipment and techniques to minimize risks and ensure optimal patient outcomes.

Bronchoalveolar lavage (BAL) fluid is a type of clinical specimen obtained through a procedure called bronchoalveolar lavage. This procedure involves inserting a bronchoscope into the lungs and instilling a small amount of saline solution into a specific area of the lung, then gently aspirating the fluid back out. The fluid that is recovered is called bronchoalveolar lavage fluid.

BAL fluid contains cells and other substances that are present in the lower respiratory tract, including the alveoli (the tiny air sacs where gas exchange occurs). By analyzing BAL fluid, doctors can diagnose various lung conditions, such as pneumonia, interstitial lung disease, and lung cancer. They can also monitor the effectiveness of treatments for these conditions by comparing the composition of BAL fluid before and after treatment.

BAL fluid is typically analyzed for its cellular content, including the number and type of white blood cells present, as well as for the presence of bacteria, viruses, or other microorganisms. The fluid may also be tested for various proteins, enzymes, and other biomarkers that can provide additional information about lung health and disease.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

Bronchoalveolar lavage (BAL) is a medical procedure in which a small amount of fluid is introduced into a segment of the lung and then gently suctioned back out. The fluid contains cells and other materials that can be analyzed to help diagnose various lung conditions, such as inflammation, infection, or cancer.

The procedure is typically performed during bronchoscopy, which involves inserting a thin, flexible tube with a light and camera on the end through the nose or mouth and into the lungs. Once the bronchoscope is in place, a small catheter is passed through the bronchoscope and into the desired lung segment. The fluid is then introduced and suctioned back out, and the sample is sent to a laboratory for analysis.

BAL can be helpful in diagnosing various conditions such as pneumonia, interstitial lung diseases, alveolar proteinosis, and some types of cancer. It can also be used to monitor the effectiveness of treatment for certain lung conditions. However, like any medical procedure, it carries some risks, including bleeding, infection, and respiratory distress. Therefore, it is important that the procedure is performed by a qualified healthcare professional in a controlled setting.

Air pressure, also known as atmospheric pressure, is the force exerted by the weight of air in the atmosphere on a surface. It is measured in units such as pounds per square inch (psi), hectopascals (hPa), or inches of mercury (inHg). The standard atmospheric pressure at sea level is defined as 101,325 Pa (14.7 psi/1013 hPa/29.92 inHg). Changes in air pressure can be used to predict weather patterns and are an important factor in the study of aerodynamics and respiratory physiology.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

I'm sorry for any confusion, but "Man-Machine Systems" is not a commonly used medical term or concept in the field of medicine or healthcare. It is more commonly associated with fields such as engineering, human factors, and ergonomics.

In those contexts, "Man-Machine Systems" typically refers to systems where humans and machines work together to achieve a common goal. The human operator provides intelligence, decision-making capabilities, and the ability to adapt to new situations, while the machine provides strength, precision, and the ability to process large amounts of data quickly.

Examples of Man-Machine Systems in healthcare might include robotic surgical systems, where a surgeon uses a robot to perform precise movements during surgery, or computerized decision support systems that help healthcare providers make informed decisions based on patient data.

Streptococcus pneumoniae, also known as the pneumococcus, is a gram-positive, alpha-hemolytic bacterium frequently found in the upper respiratory tract of healthy individuals. It is a leading cause of community-acquired pneumonia and can also cause other infectious diseases such as otitis media (ear infection), sinusitis, meningitis, and bacteremia (bloodstream infection). The bacteria are encapsulated, and there are over 90 serotypes based on variations in the capsular polysaccharide. Some serotypes are more virulent or invasive than others, and the polysaccharide composition is crucial for vaccine development. S. pneumoniae infection can be treated with antibiotics, but the emergence of drug-resistant strains has become a significant global health concern.

Physiological monitoring is the continuous or intermittent observation and measurement of various body functions or parameters in a patient, with the aim of evaluating their health status, identifying any abnormalities or changes, and guiding clinical decision-making and treatment. This may involve the use of specialized medical equipment, such as cardiac monitors, pulse oximeters, blood pressure monitors, and capnographs, among others. The data collected through physiological monitoring can help healthcare professionals assess the effectiveness of treatments, detect complications early, and make timely adjustments to patient care plans.

Respiratory therapy is a healthcare profession that specializes in the diagnosis, treatment, and management of respiratory disorders and diseases. Respiratory therapists (RTs) work under the direction of physicians to provide care for patients with conditions such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, sleep apnea, and neuromuscular diseases that affect breathing.

RTs use a variety of techniques and treatments to help patients breathe more easily, including oxygen therapy, aerosol medication delivery, chest physiotherapy, mechanical ventilation, and patient education. They also perform diagnostic tests such as pulmonary function studies to assess lung function and help diagnose respiratory conditions.

RTs work in a variety of healthcare settings, including hospitals, clinics, long-term care facilities, and home health agencies. They may provide care for patients of all ages, from premature infants to the elderly. The overall goal of respiratory therapy is to help patients achieve and maintain optimal lung function and quality of life.

Critical care, also known as intensive care, is a medical specialty that deals with the diagnosis and management of life-threatening conditions that require close monitoring and organ support. Critical care medicine is practiced in critical care units (ICUs) or intensive care units of hospitals. The goal of critical care is to prevent further deterioration of the patient's condition, to support failing organs, and to treat any underlying conditions that may have caused the patient to become critically ill.

Critical care involves a multidisciplinary team approach, including intensivists (specialist doctors trained in critical care), nurses, respiratory therapists, pharmacists, and other healthcare professionals. The care provided in the ICU is highly specialized and often involves advanced medical technology such as mechanical ventilation, dialysis, and continuous renal replacement therapy.

Patients who require critical care may have a wide range of conditions, including severe infections, respiratory failure, cardiovascular instability, neurological emergencies, and multi-organ dysfunction syndrome (MODS). Critical care is an essential component of modern healthcare and has significantly improved the outcomes of critically ill patients.

Equipment contamination in a medical context refers to the presence of harmful microorganisms, such as bacteria, viruses, or fungi, on the surfaces of medical equipment or devices. This can occur during use, storage, or transportation of the equipment and can lead to the transmission of infections to patients, healthcare workers, or other individuals who come into contact with the contaminated equipment.

Equipment contamination can occur through various routes, including contact with contaminated body fluids, airborne particles, or environmental surfaces. To prevent equipment contamination and the resulting infection transmission, it is essential to follow strict infection control practices, such as regular cleaning and disinfection of equipment, use of personal protective equipment (PPE), and proper handling and storage of medical devices.

In medical terms, pressure is defined as the force applied per unit area on an object or body surface. It is often measured in millimeters of mercury (mmHg) in clinical settings. For example, blood pressure is the force exerted by circulating blood on the walls of the arteries and is recorded as two numbers: systolic pressure (when the heart beats and pushes blood out) and diastolic pressure (when the heart rests between beats).

Pressure can also refer to the pressure exerted on a wound or incision to help control bleeding, or the pressure inside the skull or spinal canal. High or low pressure in different body systems can indicate various medical conditions and require appropriate treatment.

A tracheotomy is a surgical procedure that involves creating an opening in the neck and through the front (anterior) wall of the trachea (windpipe). This is performed to provide a new airway for the patient, bypassing any obstruction or damage in the upper airways. A tube is then inserted into this opening to maintain it and allow breathing.

This procedure is often conducted in emergency situations when there is an upper airway obstruction that cannot be easily removed or in critically ill patients who require long-term ventilation support. Complications can include infection, bleeding, damage to surrounding structures, and difficulties with speaking, swallowing, or coughing.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Murine pneumonia virus (MPV) is not a widely recognized or officially established medical term. However, it may refer to the Pneumonia Virus of Mice (PVM), which is a pathogen that affects mice and can cause interstitial pneumonia.

PVM is an enveloped, single-stranded, negative-sense RNA virus belonging to the family Paramyxoviridae and the genus Pneumovirus. It primarily infects laboratory mice but has also been found in wild mouse populations. The virus replicates in the respiratory epithelium, leading to interstitial pneumonia and inflammation of the airways.

It is essential to note that Murine Pneumonia Virus should not be confused with Hantavirus Pulmonary Syndrome (HPS), which is also known as "mouse-related pulmonary syndrome." HPS is a severe, sometimes fatal, respiratory disease in humans caused by exposure to hantaviruses, which are found in rodents.

Obesity Hypoventilation Syndrome (OHS) is a medical condition characterized by the presence of obesity (generally defined as a body mass index of 30 or higher) and chronic hypoventilation, which means that the person is not breathing adequately, resulting in low levels of oxygen and high levels of carbon dioxide in the blood.

In OHS, the excess weight of the chest walls makes it difficult for the respiratory muscles to work effectively, leading to reduced lung volumes and impaired gas exchange. This results in chronic hypoxemia (low oxygen levels) and hypercapnia (high carbon dioxide levels) during wakefulness and sleep.

OHS is often associated with obstructive sleep apnea (OSA), a condition characterized by repeated episodes of upper airway obstruction during sleep, which can further exacerbate hypoventilation. However, not all patients with OHS have OSA, and vice versa.

The diagnosis of OHS is typically made based on the presence of obesity, chronic hypoventilation (as evidenced by elevated arterial carbon dioxide levels), and the absence of other causes of hypoventilation. Treatment usually involves the use of non-invasive ventilation to support breathing and improve gas exchange, as well as weight loss interventions to address the underlying obesity.

"Pneumocystis jirovecii" is a species of fungus that commonly infects the lungs of humans, leading to a serious respiratory infection known as Pneumocystis pneumonia (PCP). This fungal infection primarily affects individuals with weakened immune systems, such as those with HIV/AIDS, cancer, or organ transplant recipients. The organism was previously classified as a protozoan but has since been reclassified as a fungus based on genetic analysis. It is typically acquired through inhalation of airborne spores and can cause severe illness if left untreated.

Dimensional measurement accuracy refers to the degree of closeness with which the measured dimension of a object or feature corresponds to its true value. It is usually expressed as a tolerance, which indicates the maximum allowable deviation from the true value. This measurement accuracy can be affected by various factors such as the precision and calibration of the measuring instrument, the skill and experience of the person taking the measurement, and environmental conditions such as temperature and humidity. High dimensional measurement accuracy is essential in many fields, including manufacturing, engineering, and scientific research, to ensure that parts and products meet specified dimensions and function properly.

"Nursing, Team" in a medical context refers to a group of healthcare professionals, including but not limited to registered nurses, nurse practitioners, licensed practical nurses, nursing assistants, and other support staff, who work collaboratively to provide comprehensive nursing care to patients. The team members bring their unique skills, knowledge, and expertise to the table to achieve optimal patient outcomes through coordinated efforts, open communication, and evidence-based practice. The goal of a nursing team is to ensure continuity of care, promote patient safety, and enhance the overall quality of care by working together in a cohesive and interdisciplinary manner.

Transportation of patients, in a medical context, refers to the process of moving patients safely and comfortably from one location to another. This can include the movement of patients within a healthcare facility (such as from their hospital room to the radiology department for testing) or between facilities (such as from a hospital to a rehabilitation center). Patient transportation may be required for various reasons, including receiving medical treatment, undergoing diagnostic tests, attending appointments, or being discharged from the hospital.

The process of patient transportation involves careful planning and coordination to ensure the safety, comfort, and well-being of the patient during transit. It may involve the use of specialized equipment, such as stretchers, wheelchairs, or ambulances, depending on the patient's medical needs and mobility status. Trained personnel, such as paramedics, nurses, or patient care technicians, are often involved in the transportation process to monitor the patient's condition, provide medical assistance if needed, and ensure a smooth and uneventful transfer.

It is essential to follow established protocols and guidelines for patient transportation to minimize risks and ensure the best possible outcomes for patients. This includes assessing the patient's medical status, determining the appropriate mode of transportation, providing necessary care and support during transit, and communicating effectively with all parties involved in the process.

A critical illness is a serious condition that has the potential to cause long-term or permanent disability, or even death. It often requires intensive care and life support from medical professionals. Critical illnesses can include conditions such as:

1. Heart attack
2. Stroke
3. Organ failure (such as kidney, liver, or lung)
4. Severe infections (such as sepsis)
5. Coma or brain injury
6. Major trauma
7. Cancer that has spread to other parts of the body

These conditions can cause significant physical and emotional stress on patients and their families, and often require extensive medical treatment, rehabilitation, and long-term care. Critical illness insurance is a type of insurance policy that provides financial benefits to help cover the costs associated with treating these serious medical conditions.

Inspiratory Capacity (IC) is the maximum volume of air that can be breathed in after a normal expiration. It is the sum of the tidal volume (the amount of air displaced between normal inspiration and expiration during quiet breathing) and the inspiratory reserve volume (the additional amount of air that can be inspired over and above the tidal volume). IC is an important parameter used in pulmonary function testing to assess lung volumes and capacities in patients with respiratory disorders.

Medical Definition of Respiration:

Respiration, in physiology, is the process by which an organism takes in oxygen and gives out carbon dioxide. It's also known as breathing. This process is essential for most forms of life because it provides the necessary oxygen for cellular respiration, where the cells convert biochemical energy from nutrients into adenosine triphosphate (ATP), and releases waste products, primarily carbon dioxide.

In humans and other mammals, respiration is a two-stage process:

1. Breathing (or external respiration): This involves the exchange of gases with the environment. Air enters the lungs through the mouth or nose, then passes through the pharynx, larynx, trachea, and bronchi, finally reaching the alveoli where the actual gas exchange occurs. Oxygen from the inhaled air diffuses into the blood, while carbon dioxide, a waste product of metabolism, diffuses from the blood into the alveoli to be exhaled.

2. Cellular respiration (or internal respiration): This is the process by which cells convert glucose and other nutrients into ATP, water, and carbon dioxide in the presence of oxygen. The carbon dioxide produced during this process then diffuses out of the cells and into the bloodstream to be exhaled during breathing.

In summary, respiration is a vital physiological function that enables organisms to obtain the necessary oxygen for cellular metabolism while eliminating waste products like carbon dioxide.

"Pneumocystis" is a genus of fungi that are commonly found in the lungs of many mammals, including humans. The most well-known and studied species within this genus is "Pneumocystis jirovecii," which was previously known as "Pneumocystis carinii." This organism can cause a serious lung infection known as Pneumocystis pneumonia (PCP) in individuals with weakened immune systems, such as those with HIV/AIDS or who are undergoing immunosuppressive therapy.

It's worth noting that while "Pneumocystis" was once classified as a protozoan, it is now considered to be a fungus based on its genetic and biochemical characteristics.

Exhalation is the act of breathing out or exhaling, which is the reverse process of inhalation. During exhalation, the diaphragm relaxes and moves upwards, while the chest muscles also relax, causing the chest cavity to decrease in size. This decrease in size puts pressure on the lungs, causing them to deflate and expel air.

Exhalation is a passive process that occurs naturally after inhalation, but it can also be actively controlled during activities such as speaking, singing, or playing a wind instrument. In medical terms, exhalation may also be referred to as expiration.

Humidity, in a medical context, is not typically defined on its own but is related to environmental conditions that can affect health. Humidity refers to the amount of water vapor present in the air. It is often discussed in terms of absolute humidity (the mass of water per unit volume of air) or relative humidity (the ratio of the current absolute humidity to the maximum possible absolute humidity, expressed as a percentage). High humidity can contribute to feelings of discomfort, difficulty sleeping, and exacerbation of respiratory conditions such as asthma.

Oxygen is a colorless, odorless, tasteless gas that constitutes about 21% of the earth's atmosphere. It is a crucial element for human and most living organisms as it is vital for respiration. Inhaled oxygen enters the lungs and binds to hemoglobin in red blood cells, which carries it to tissues throughout the body where it is used to convert nutrients into energy and carbon dioxide, a waste product that is exhaled.

Medically, supplemental oxygen therapy may be provided to patients with conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, heart failure, or other medical conditions that impair the body's ability to extract sufficient oxygen from the air. Oxygen can be administered through various devices, including nasal cannulas, face masks, and ventilators.

Equipment safety in a medical context refers to the measures taken to ensure that medical equipment is free from potential harm or risks to patients, healthcare providers, and others who may come into contact with the equipment. This includes:

1. Designing and manufacturing the equipment to meet safety standards and regulations.
2. Properly maintaining and inspecting the equipment to ensure it remains safe over time.
3. Providing proper training for healthcare providers on how to use the equipment safely.
4. Implementing safeguards, such as alarms and warnings, to alert users of potential hazards.
5. Conducting regular risk assessments to identify and address any potential safety concerns.
6. Reporting and investigating any incidents or accidents involving the equipment to determine their cause and prevent future occurrences.

Respiratory paralysis is a condition characterized by the inability to breathe effectively due to the failure or weakness of the muscles involved in respiration. This can include the diaphragm, intercostal muscles, and other accessory muscles.

In medical terms, it's often associated with conditions that affect the neuromuscular junction, such as botulism, myasthenia gravis, or spinal cord injuries. It can also occur as a complication of general anesthesia, sedative drugs, or certain types of poisoning.

Respiratory paralysis is a serious condition that requires immediate medical attention, as it can lead to lack of oxygen (hypoxia) and buildup of carbon dioxide (hypercapnia) in the body, which can be life-threatening if not treated promptly.

Helium is not a medical term, but it's a chemical element with symbol He and atomic number 2. It's a colorless, odorless, tasteless, non-toxic, inert, monatomic gas that heads the noble gases section of the periodic table. In medicine, helium is sometimes used in medical settings for its unique properties, such as being less dense than air, which can help improve the delivery of oxygen to patients with respiratory conditions. For example, heliox, a mixture of helium and oxygen, may be used to reduce the work of breathing in patients with conditions like chronic obstructive pulmonary disease (COPD) or asthma. Additionally, helium is also used in cryogenic medical equipment and in magnetic resonance imaging (MRI) machines to cool the superconducting magnets.

Capnography is the non-invasive measurement and monitoring of carbon dioxide (CO2) in exhaled breath, also known as end-tidal CO2 (EtCO2). It is typically displayed as a waveform graph that shows the concentration of CO2 over time. Capnography provides important information about respiratory function, metabolic rate, and the effectiveness of ventilation during medical procedures such as anesthesia, mechanical ventilation, and resuscitation. Changes in capnograph patterns can help detect conditions such as hypoventilation, hyperventilation, esophageal intubation, and pulmonary embolism.

Neuromuscular diseases are a group of disorders that involve the peripheral nervous system, which includes the nerves and muscles outside of the brain and spinal cord. These conditions can affect both children and adults, and they can be inherited or acquired. Neuromuscular diseases can cause a wide range of symptoms, including muscle weakness, numbness, tingling, pain, cramping, and twitching. Some common examples of neuromuscular diseases include muscular dystrophy, amyotrophic lateral sclerosis (ALS), peripheral neuropathy, and myasthenia gravis. The specific symptoms and severity of these conditions can vary widely depending on the underlying cause and the specific muscles and nerves that are affected. Treatment for neuromuscular diseases may include medications, physical therapy, assistive devices, or surgery, depending on the individual case.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Legionnaires' disease is a severe and often lethal form of pneumonia, a lung infection, caused by the bacterium Legionella pneumophila. It's typically contracted by inhaling microscopic water droplets containing the bacteria, which can be found in various environmental sources like cooling towers, hot tubs, whirlpools, decorative fountains, and large plumbing systems. The disease is not transmitted through person-to-person contact. Symptoms usually appear within 2-10 days after exposure and may include cough, fever, chills, muscle aches, headache, and shortness of breath. Some individuals, particularly those with weakened immune systems, elderly people, and smokers, are at higher risk for developing Legionnaires' disease. Early diagnosis and appropriate antibiotic treatment can improve the chances of recovery. Preventive measures include regular testing and maintenance of potential sources of Legionella bacteria in buildings and other facilities.

Carbon dioxide (CO2) is a colorless, odorless gas that is naturally present in the Earth's atmosphere. It is a normal byproduct of cellular respiration in humans, animals, and plants, and is also produced through the combustion of fossil fuels such as coal, oil, and natural gas.

In medical terms, carbon dioxide is often used as a respiratory stimulant and to maintain the pH balance of blood. It is also used during certain medical procedures, such as laparoscopic surgery, to insufflate (inflate) the abdominal cavity and create a working space for the surgeon.

Elevated levels of carbon dioxide in the body can lead to respiratory acidosis, a condition characterized by an increased concentration of carbon dioxide in the blood and a decrease in pH. This can occur in conditions such as chronic obstructive pulmonary disease (COPD), asthma, or other lung diseases that impair breathing and gas exchange. Symptoms of respiratory acidosis may include shortness of breath, confusion, headache, and in severe cases, coma or death.

Nebulizer: A nebulizer is a medical device that delivers medication in the form of a mist to the respiratory system. It is often used for people who have difficulty inhaling medication through traditional inhalers, such as young children or individuals with severe respiratory conditions. The medication is placed in the nebulizer cup and then converted into a fine mist by the machine. This allows the user to breathe in the medication directly through a mouthpiece or mask.

Vaporizer: A vaporizer, on the other hand, is a device that heats up a liquid, often water or essential oils, to produce steam or vapor. While some people use vaporizers for therapeutic purposes, such as to help relieve congestion or cough, it is important to note that vaporizers are not considered medical devices and their effectiveness for these purposes is not well-established.

It's worth noting that nebulizers and vaporizers are different from each other in terms of their purpose and usage. Nebulizers are used specifically for delivering medication, while vaporizers are used to produce steam or vapor, often for non-medical purposes.

Computer-assisted therapy, also known as computerized cognitive behavioral therapy (CCBT), refers to the use of computer programs or digital platforms to deliver therapeutic interventions that are typically guided by a trained professional. This approach often involves interactive activities and exercises designed to help individuals develop skills and strategies for managing various psychological, emotional, or behavioral issues.

The goal of computer-assisted therapy is to increase accessibility, affordability, and convenience of mental health services while maintaining the effectiveness of traditional face-to-face therapy. It can be used as a standalone treatment or as an adjunct to traditional therapy, depending on the individual's needs and preferences. Common applications of computer-assisted therapy include treating anxiety disorders, depression, post-traumatic stress disorder (PTSD), insomnia, and substance use disorders.

Blood gas analysis is a medical test that measures the levels of oxygen and carbon dioxide in the blood, as well as the pH level, which indicates the acidity or alkalinity of the blood. This test is often used to evaluate lung function, respiratory disorders, and acid-base balance in the body. It can also be used to monitor the effectiveness of treatments for conditions such as chronic obstructive pulmonary disease (COPD), asthma, and other respiratory illnesses. The analysis is typically performed on a sample of arterial blood, although venous blood may also be used in some cases.

Intermittent Positive-Pressure Breathing (IPPB) is a type of ventilatory support that involves the intermittent delivery of positive pressure to the airways and alveoli during inspiration, while allowing for expiration to occur passively. This technique is often used in medical settings to assist patients with respiratory insufficiency or failure, such as those with chronic obstructive pulmonary disease (COPD), neuromuscular disorders, or following surgery.

During IPPB, the patient breathes in through a mouthpiece or mask that is connected to a ventilator or breathing machine. The machine delivers positive pressure to the airways, which helps to inflate the lungs and improve oxygenation. The pressure can be adjusted to meet the needs of each individual patient, and the frequency and duration of breaths can also be controlled by the healthcare provider.

IPPB is typically used on a short-term basis, as a means of providing respiratory support while a patient's underlying condition improves. It may be used in conjunction with other therapies, such as bronchodilators or corticosteroids, to help improve lung function and reduce symptoms. While IPPB can be an effective tool for managing respiratory insufficiency, it is not without risks, and careful monitoring is required to ensure that it is used safely and effectively.

Equipment Failure Analysis is a process of identifying the cause of failure in medical equipment or devices. This involves a systematic examination and evaluation of the equipment, its components, and operational history to determine why it failed. The analysis may include physical inspection, chemical testing, and review of maintenance records, as well as assessment of design, manufacturing, and usage factors that may have contributed to the failure.

The goal of Equipment Failure Analysis is to identify the root cause of the failure, so that corrective actions can be taken to prevent similar failures in the future. This is important in medical settings to ensure patient safety and maintain the reliability and effectiveness of medical equipment.

Thoracic radiography is a type of diagnostic imaging that involves using X-rays to produce images of the chest, including the lungs, heart, bronchi, great vessels, and the bones of the spine and chest wall. It is a commonly used tool in the diagnosis and management of various respiratory, cardiovascular, and thoracic disorders such as pneumonia, lung cancer, heart failure, and rib fractures.

During the procedure, the patient is positioned between an X-ray machine and a cassette containing a film or digital detector. The X-ray beam is directed at the chest, and the resulting image is captured on the film or detector. The images produced can help identify any abnormalities in the structure or function of the organs within the chest.

Thoracic radiography may be performed as a routine screening test for certain conditions, such as lung cancer, or it may be ordered when a patient presents with symptoms suggestive of a respiratory or cardiovascular disorder. It is a safe and non-invasive procedure that can provide valuable information to help guide clinical decision making and improve patient outcomes.

Lung diseases refer to a broad category of disorders that affect the lungs and other structures within the respiratory system. These diseases can impair lung function, leading to symptoms such as coughing, shortness of breath, chest pain, and wheezing. They can be categorized into several types based on the underlying cause and nature of the disease process. Some common examples include:

1. Obstructive lung diseases: These are characterized by narrowing or blockage of the airways, making it difficult to breathe out. Examples include chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, and cystic fibrosis.
2. Restrictive lung diseases: These involve stiffening or scarring of the lungs, which reduces their ability to expand and take in air. Examples include idiopathic pulmonary fibrosis, sarcoidosis, and asbestosis.
3. Infectious lung diseases: These are caused by bacteria, viruses, fungi, or parasites that infect the lungs. Examples include pneumonia, tuberculosis, and influenza.
4. Vascular lung diseases: These affect the blood vessels in the lungs, impairing oxygen exchange. Examples include pulmonary embolism, pulmonary hypertension, and chronic thromboembolic pulmonary hypertension (CTEPH).
5. Neoplastic lung diseases: These involve abnormal growth of cells within the lungs, leading to cancer. Examples include small cell lung cancer, non-small cell lung cancer, and mesothelioma.
6. Other lung diseases: These include interstitial lung diseases, pleural effusions, and rare disorders such as pulmonary alveolar proteinosis and lymphangioleiomyomatosis (LAM).

It is important to note that this list is not exhaustive, and there are many other conditions that can affect the lungs. Proper diagnosis and treatment of lung diseases require consultation with a healthcare professional, such as a pulmonologist or respiratory therapist.

A Pediatric Intensive Care Unit (PICU) is a specialized hospital unit that provides intensive care to critically ill or injured infants, children, and adolescents. The PICU is equipped with advanced medical technology and staffed by healthcare professionals trained in pediatrics, including pediatric intensivists, pediatric nurses, respiratory therapists, and other specialists as needed.

The primary goal of the PICU is to closely monitor and manage the most critical patients, providing around-the-clock care and interventions to support organ function, treat life-threatening conditions, and prevent complications. The PICU team works together to provide family-centered care, keeping parents informed about their child's condition and involving them in decision-making processes.

Common reasons for admission to the PICU include respiratory failure, shock, sepsis, severe trauma, congenital heart disease, neurological emergencies, and post-operative monitoring after complex surgeries. The length of stay in the PICU can vary widely depending on the severity of the child's illness or injury and their response to treatment.

"Length of Stay" (LOS) is a term commonly used in healthcare to refer to the amount of time a patient spends receiving care in a hospital, clinic, or other healthcare facility. It is typically measured in hours, days, or weeks and can be used as a metric for various purposes such as resource planning, quality assessment, and reimbursement. The length of stay can vary depending on the type of illness or injury, the severity of the condition, the patient's response to treatment, and other factors. It is an important consideration in healthcare management and can have significant implications for both patients and providers.

"Mycoplasma pneumoniae" is a type of bacteria that lacks a cell wall and can cause respiratory infections, particularly bronchitis and atypical pneumonia. It is one of the most common causes of community-acquired pneumonia. Infection with "M. pneumoniae" typically results in mild symptoms, such as cough, fever, and fatigue, although more severe complications can occur in some cases. The bacteria can also cause various extrapulmonary manifestations, including skin rashes, joint pain, and neurological symptoms. Diagnosis of "M. pneumoniae" infection is typically made through serological tests or PCR assays. Treatment usually involves antibiotics such as macrolides or tetracyclines.

Oxygen inhalation therapy is a medical treatment that involves the administration of oxygen to a patient through a nasal tube or mask, with the purpose of increasing oxygen concentration in the body. This therapy is used to treat various medical conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, heart failure, and other conditions that cause low levels of oxygen in the blood. The additional oxygen helps to improve tissue oxygenation, reduce work of breathing, and promote overall patient comfort and well-being. Oxygen therapy may be delivered continuously or intermittently, depending on the patient's needs and medical condition.

Aerosols are defined in the medical field as suspensions of fine solid or liquid particles in a gas. In the context of public health and medicine, aerosols often refer to particles that can remain suspended in air for long periods of time and can be inhaled. They can contain various substances, such as viruses, bacteria, fungi, or chemicals, and can play a role in the transmission of respiratory infections or other health effects.

For example, when an infected person coughs or sneezes, they may produce respiratory droplets that can contain viruses like influenza or SARS-CoV-2 (the virus that causes COVID-19). Some of these droplets can evaporate quickly and leave behind smaller particles called aerosols, which can remain suspended in the air for hours and potentially be inhaled by others. This is one way that respiratory viruses can spread between people in close proximity to each other.

Aerosols can also be generated through medical procedures such as bronchoscopy, suctioning, or nebulizer treatments, which can produce aerosols containing bacteria, viruses, or other particles that may pose an infection risk to healthcare workers or other patients. Therefore, appropriate personal protective equipment (PPE) and airborne precautions are often necessary to reduce the risk of transmission in these settings.

Bronchoscopy is a medical procedure that involves the examination of the inside of the airways and lungs with a flexible or rigid tube called a bronchoscope. This procedure allows healthcare professionals to directly visualize the airways, take tissue samples for biopsy, and remove foreign objects or secretions. Bronchoscopy can be used to diagnose and manage various respiratory conditions such as lung infections, inflammation, cancer, and bleeding. It is usually performed under local or general anesthesia to minimize discomfort and risks associated with the procedure.

Respiratory Function Tests (RFTs) are a group of medical tests that measure how well your lungs take in and exhale air, and how well they transfer oxygen and carbon dioxide into and out of your blood. They can help diagnose certain lung disorders, measure the severity of lung disease, and monitor response to treatment.

RFTs include several types of tests, such as:

1. Spirometry: This test measures how much air you can exhale and how quickly you can do it. It's often used to diagnose and monitor conditions like asthma, chronic obstructive pulmonary disease (COPD), and other lung diseases.
2. Lung volume testing: This test measures the total amount of air in your lungs. It can help diagnose restrictive lung diseases, such as pulmonary fibrosis or sarcoidosis.
3. Diffusion capacity testing: This test measures how well oxygen moves from your lungs into your bloodstream. It's often used to diagnose and monitor conditions like pulmonary fibrosis, interstitial lung disease, and other lung diseases that affect the ability of the lungs to transfer oxygen to the blood.
4. Bronchoprovocation testing: This test involves inhaling a substance that can cause your airways to narrow, such as methacholine or histamine. It's often used to diagnose and monitor asthma.
5. Exercise stress testing: This test measures how well your lungs and heart work together during exercise. It's often used to diagnose lung or heart disease.

Overall, Respiratory Function Tests are an important tool for diagnosing and managing a wide range of lung conditions.

Anatomic models are three-dimensional representations of body structures used for educational, training, or demonstration purposes. They can be made from various materials such as plastic, wax, or rubber and may depict the entire body or specific regions, organs, or systems. These models can be used to provide a visual aid for understanding anatomy, physiology, and pathology, and can be particularly useful in situations where actual human specimens are not available or practical to use. They may also be used for surgical planning and rehearsal, as well as in medical research and product development.

Home care services, also known as home health care, refer to a wide range of health and social services delivered at an individual's residence. These services are designed to help people who have special needs or disabilities, those recovering from illness or surgery, and the elderly or frail who require assistance with activities of daily living (ADLs) or skilled nursing care.

Home care services can include:

1. Skilled Nursing Care: Provided by registered nurses (RNs), licensed practical nurses (LPNs), or licensed vocational nurses (LVNs) to administer medications, wound care, injections, and other medical treatments. They also monitor the patient's health status, provide education on disease management, and coordinate with other healthcare professionals.
2. Therapy Services: Occupational therapists, physical therapists, and speech-language pathologists help patients regain strength, mobility, coordination, balance, and communication skills after an illness or injury. They develop personalized treatment plans to improve the patient's ability to perform daily activities independently.
3. Personal Care/Assistance with Activities of Daily Living (ADLs): Home health aides and personal care assistants provide assistance with bathing, dressing, grooming, toileting, and other personal care tasks. They may also help with light housekeeping, meal preparation, and shopping.
4. Social Work Services: Provided by licensed social workers who assess the patient's psychosocial needs, connect them to community resources, and provide counseling and support for patients and their families.
5. Nutritional Support: Registered dietitians evaluate the patient's nutritional status, develop meal plans, and provide education on special diets or feeding techniques as needed.
6. Telehealth Monitoring: Remote monitoring of a patient's health status using technology such as video conferencing, wearable devices, or mobile apps to track vital signs, medication adherence, and symptoms. This allows healthcare providers to monitor patients closely and adjust treatment plans as necessary without requiring in-person visits.
7. Hospice Care: End-of-life care provided in the patient's home to manage pain, provide emotional support, and address spiritual needs. The goal is to help the patient maintain dignity and quality of life during their final days.
8. Respite Care: Temporary relief for family caregivers who need a break from caring for their loved ones. This can include short-term stays in assisted living facilities or hiring professional caregivers to provide in-home support.

Lung injury, also known as pulmonary injury, refers to damage or harm caused to the lung tissue, blood vessels, or air sacs (alveoli) in the lungs. This can result from various causes such as infection, trauma, exposure to harmful substances, or systemic diseases. Common types of lung injuries include acute respiratory distress syndrome (ARDS), pneumonia, and chemical pneumonitis. Symptoms may include difficulty breathing, cough, chest pain, and decreased oxygen levels in the blood. Treatment depends on the underlying cause and may include medications, oxygen therapy, or mechanical ventilation.

Interactive Ventilatory Support (IVS) is not a widely recognized or established medical term with a universally accepted definition. However, in the context of mechanical ventilation, it generally refers to a mode of support that allows for some level of interaction between the patient's own breathing efforts and the ventilator's assistance.

One example of IVS is called "Pressure Regulated Volume Control with Automatic Tube Compensation" (PRVC-ATC). In this mode, the ventilator delivers a preset volume while adjusting the pressure to maintain a constant flow, and it compensates for the resistance of the endotracheal tube. The patient's spontaneous breaths are assisted by a lower level of pressure, allowing for some interaction between the patient's efforts and the ventilator's support.

It is important to note that different manufacturers may use the term "Interactive Ventilatory Support" or similar terms to describe various modes or functions of their mechanical ventilators. Therefore, it is always recommended to refer to the specific definitions provided by the manufacturer's user manual or clinical literature.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

Barotrauma is a type of injury that occurs when there is a difference in pressure between the external environment and the internal body, leading to damage to body tissues. It commonly affects gas-filled spaces in the body, such as the lungs, middle ear, or sinuses.

In medical terms, barotrauma refers to the damage caused by changes in pressure that occur rapidly, such as during scuba diving, flying in an airplane, or receiving treatment in a hyperbaric chamber. These rapid changes in pressure can cause the gas-filled spaces in the body to expand or contract, leading to injury.

For example, during descent while scuba diving, the pressure outside the body increases, and if the diver does not equalize the pressure in their middle ear by swallowing or yawning, the increased pressure can cause the eardrum to rupture, resulting in barotrauma. Similarly, rapid ascent while flying can cause the air in the lungs to expand, leading to lung overexpansion injuries such as pneumothorax or arterial gas embolism.

Prevention of barotrauma involves equalizing pressure in the affected body spaces during changes in pressure and avoiding diving or flying with respiratory infections or other conditions that may increase the risk of injury. Treatment of barotrauma depends on the severity and location of the injury and may include pain management, antibiotics, surgery, or hyperbaric oxygen therapy.

Pulmonary eosinophilia is a condition characterized by an increased number of eosinophils, a type of white blood cell, in the lungs or pulmonary tissues. Eosinophils play a role in the body's immune response to parasites and allergens, but an overabundance can contribute to inflammation and damage in the lungs.

The condition may be associated with various underlying causes, such as:

1. Asthma or allergic bronchopulmonary aspergillosis (ABPA)
2. Eosinophilic lung diseases, like eosinophilic pneumonia or idiopathic hypereosinophilic syndrome
3. Parasitic infections, such as ascariasis or strongyloidiasis
4. Drug reactions, including certain antibiotics and anti-inflammatory drugs
5. Connective tissue disorders, like rheumatoid arthritis or Churg-Strauss syndrome
6. Malignancies, such as lymphoma or leukemia
7. Other less common conditions, like tropical pulmonary eosinophilia or cryptogenic organizing pneumonia

Symptoms of pulmonary eosinophilia can vary but often include cough, shortness of breath, wheezing, and chest discomfort. Diagnosis typically involves a combination of clinical evaluation, imaging studies, and laboratory tests, such as complete blood count (CBC) with differential, bronchoalveolar lavage (BAL), or lung biopsy. Treatment depends on the underlying cause and may include corticosteroids, antibiotics, or antiparasitic medications.

Pasteurization is a process that involves heating a liquid, such as milk or fruit juice, to a specific temperature for a certain amount of time in order to kill harmful bacteria and reduce the risk of foodborne illness. The process was named after Louis Pasteur, who developed it in the 19th century.

In pasteurization, the liquid is typically heated to a temperature between 63°C (145°F) and 75°C (167°F) for at least 15 seconds to 30 minutes, depending on the type of product being pasteurized. This heat treatment destroys pathogens such as Listeria monocytogenes, Salmonella, Escherichia coli, and Staphylococcus aureus, which can cause serious illness if consumed.

Pasteurization does not sterilize the product completely, but it significantly reduces the number of bacteria present, making it safer for consumption. It is important to note that pasteurized products still have a shelf life and should be stored properly to prevent contamination and spoilage.

Trimethoprim-sulfamethoxazole combination is an antibiotic medication used to treat various bacterial infections. It contains two active ingredients: trimethoprim and sulfamethoxazole, which work together to inhibit the growth of bacteria by interfering with their ability to synthesize folic acid, a vital component for their survival.

Trimethoprim is a bacteriostatic agent that inhibits dihydrofolate reductase, an enzyme needed for bacterial growth, while sulfamethoxazole is a bacteriostatic sulfonamide that inhibits the synthesis of tetrahydrofolate by blocking the action of the enzyme bacterial dihydropteroate synthase. The combination of these two agents produces a synergistic effect, increasing the overall antibacterial activity of the medication.

Trimethoprim-sulfamethoxazole is commonly used to treat urinary tract infections, middle ear infections, bronchitis, traveler's diarrhea, and pneumocystis pneumonia (PCP), a severe lung infection that can occur in people with weakened immune systems. It is also used as a prophylactic treatment to prevent PCP in individuals with HIV/AIDS or other conditions that compromise the immune system.

As with any medication, trimethoprim-sulfamethoxazole combination can have side effects and potential risks, including allergic reactions, skin rashes, gastrointestinal symptoms, and blood disorders. It is essential to follow the prescribing physician's instructions carefully and report any adverse reactions promptly.

Respiratory muscles are a group of muscles involved in the process of breathing. They include the diaphragm, intercostal muscles (located between the ribs), scalene muscles (located in the neck), and abdominal muscles. These muscles work together to allow the chest cavity to expand or contract, which draws air into or pushes it out of the lungs. The diaphragm is the primary muscle responsible for breathing, contracting to increase the volume of the chest cavity and draw air into the lungs during inhalation. The intercostal muscles help to further expand the ribcage, while the abdominal muscles assist in exhaling by compressing the abdomen and pushing up on the diaphragm.

Bronchopneumonia is a type of pneumonia that involves inflammation and infection of the bronchioles (small airways in the lungs) and alveoli (tiny air sacs in the lungs). It can be caused by various bacteria, viruses, or fungi and often occurs as a complication of a respiratory tract infection.

The symptoms of bronchopneumonia may include cough, chest pain, fever, chills, shortness of breath, and fatigue. In severe cases, it can lead to complications such as respiratory failure or sepsis. Treatment typically involves antibiotics for bacterial infections, antiviral medications for viral infections, and supportive care such as oxygen therapy and hydration.

A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.

Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.

It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.

Electric power supplies are devices that convert electrical energy from a source into a form suitable for powering various types of equipment or devices. They can include a wide range of products such as batteries, generators, transformers, and rectifiers. The main function of an electric power supply is to maintain a stable voltage and current to the load, despite variations in the input voltage or changes in the load's electrical characteristics.

In medical terminology, electric power supplies are used in various medical devices such as diagnostic equipment, therapeutic machines, and monitoring systems. They provide a reliable source of power to these devices, ensuring their proper functioning and enabling accurate measurements and treatments. In some cases, medical power supplies may also include features such as uninterruptible power supply (UPS) systems or emergency power-off functions to ensure patient safety in the event of a power failure or other electrical issues.

Hospitalization is the process of admitting a patient to a hospital for the purpose of receiving medical treatment, surgery, or other health care services. It involves staying in the hospital as an inpatient, typically under the care of doctors, nurses, and other healthcare professionals. The length of stay can vary depending on the individual's medical condition and the type of treatment required. Hospitalization may be necessary for a variety of reasons, such as to receive intensive care, to undergo diagnostic tests or procedures, to recover from surgery, or to manage chronic illnesses or injuries.

Hypercapnia is a state of increased carbon dioxide (CO2) concentration in the blood, typically defined as an arterial CO2 tension (PaCO2) above 45 mmHg. It is often associated with conditions that impair gas exchange or eliminate CO2 from the body, such as chronic obstructive pulmonary disease (COPD), severe asthma, respiratory failure, or certain neuromuscular disorders. Hypercapnia can cause symptoms such as headache, confusion, shortness of breath, and in severe cases, it can lead to life-threatening complications such as respiratory acidosis, coma, and even death if not promptly treated.

Airway obstruction is a medical condition that occurs when the normal flow of air into and out of the lungs is partially or completely blocked. This blockage can be caused by a variety of factors, including swelling of the tissues in the airway, the presence of foreign objects or substances, or abnormal growths such as tumors.

When the airway becomes obstructed, it can make it difficult for a person to breathe normally. They may experience symptoms such as shortness of breath, wheezing, coughing, and chest tightness. In severe cases, airway obstruction can lead to respiratory failure and other life-threatening complications.

There are several types of airway obstruction, including:

1. Upper airway obstruction: This occurs when the blockage is located in the upper part of the airway, such as the nose, throat, or voice box.
2. Lower airway obstruction: This occurs when the blockage is located in the lower part of the airway, such as the trachea or bronchi.
3. Partial airway obstruction: This occurs when the airway is partially blocked, allowing some air to flow in and out of the lungs.
4. Complete airway obstruction: This occurs when the airway is completely blocked, preventing any air from flowing into or out of the lungs.

Treatment for airway obstruction depends on the underlying cause of the condition. In some cases, removing the obstruction may be as simple as clearing the airway of foreign objects or mucus. In other cases, more invasive treatments such as surgery may be necessary.

Progressive interstitial pneumonia of sheep, also known as ovine progressive pneumonic dyspnea (OPPD), is a contagious and fatal disease that affects the respiratory system of sheep. It is caused by the bacterium Mycoplasma ovipneumoniae.

The disease is characterized by inflammation and fibrosis of the interstitial tissue of the lungs, which leads to progressive difficulty in breathing, coughing, and weight loss. The infection can also spread to the air sacs (alveoli) of the lungs, causing pus-filled lesions and further compromising lung function.

OPPD is a chronic disease that can take several months to progress from initial infection to death. It is highly contagious and can be spread through direct contact with infected animals or contaminated equipment. The disease is most commonly seen in sheep that are under stress, such as those that have been transported or housed in close quarters.

Prevention and control measures for OPPD include good biosecurity practices, such as quarantine and testing of new animals before introducing them to a flock, as well as vaccination of susceptible animals. Treatment is generally not effective once clinical signs appear, and affected animals usually need to be euthanized to prevent further spread of the disease.

Apnea is a medical condition defined as the cessation of breathing for 10 seconds or more. It can occur during sleep (sleep apnea) or while awake (wakeful apnea). There are different types of sleep apnea, including obstructive sleep apnea, central sleep apnea, and complex sleep apnea syndrome. Obstructive sleep apnea occurs when the airway becomes blocked during sleep, while central sleep apnea occurs when the brain fails to signal the muscles to breathe. Complex sleep apnea syndrome, also known as treatment-emergent central sleep apnea, is a combination of obstructive and central sleep apneas. Sleep apnea can lead to various complications, such as fatigue, difficulty concentrating, high blood pressure, heart disease, and stroke.

The pleural cavity is the potential space between the visceral and parietal pleura, which are the two membranes that surround the lungs. The visceral pleura covers the outside of the lungs, while the parietal pleura lines the inside of the chest wall. Under normal conditions, these two layers are in contact with each other, and the space between them is virtually nonexistent. However, when air, fluid or inflammation accumulates within this space, it results in the formation of a pleural effusion, which can cause discomfort and difficulty breathing.

Quadriplegia, also known as tetraplegia, is a medical condition characterized by paralysis affecting all four limbs and the trunk of the body. It results from damage to the cervical spinal cord, typically at levels C1-C8, which controls signals to the muscles in the arms, hands, trunk, legs, and pelvic organs. The extent of quadriplegia can vary widely, ranging from weakness to complete loss of movement and sensation below the level of injury. Other symptoms may include difficulty breathing, bowel and bladder dysfunction, and sexual dysfunction. The severity and prognosis depend on the location and extent of the spinal cord injury.

A premature infant is a baby born before 37 weeks of gestation. They may face various health challenges because their organs are not fully developed. The earlier a baby is born, the higher the risk of complications. Prematurity can lead to short-term and long-term health issues, such as respiratory distress syndrome, jaundice, anemia, infections, hearing problems, vision problems, developmental delays, and cerebral palsy. Intensive medical care and support are often necessary for premature infants to ensure their survival and optimal growth and development.

Chest wall oscillation is a technique used in physical therapy to help clear secretions from the airways in individuals with respiratory conditions such as cystic fibrosis, bronchiectasis, or chronic obstructive pulmonary disease (COPD). It involves the use of an inflatable vest or wrap that is connected to a machine that delivers rapid, small bursts of air. These bursts cause the chest wall to oscillate or vibrate, which helps to loosen and mobilize secretions in the airways.

The therapy can be administered in different ways, including high-frequency chest wall oscillation (HFCWO), intrapulmonary percussive ventilation (IPV), and mechanical insufflation-exsufflation (MI-E). The goal of chest wall oscillation is to improve lung function, reduce the risk of respiratory infections, and enhance overall quality of life.

It's important to note that chest wall oscillation should only be performed under the guidance and supervision of a trained healthcare professional, as improper use can lead to discomfort or injury.

Tracheitis is a medical condition that involves inflammation of the trachea, or windpipe. It can cause symptoms such as cough, sore throat, difficulty swallowing, and fever. Tracheitis can be caused by viral or bacterial infections, and it may also occur as a complication of other respiratory conditions. In some cases, tracheitis may require medical treatment, including antibiotics for bacterial infections or corticosteroids to reduce inflammation. It is important to seek medical attention if you experience symptoms of tracheitis, especially if they are severe or persistent.

Extracorporeal Membrane Oxygenation (ECMO) is a medical procedure that uses a machine to take over the function of the lungs and sometimes also the heart, by pumping and oxygenating the patient's blood outside of their body. This technique is used when a patient's lungs or heart are unable to provide adequate gas exchange or circulation, despite other forms of treatment.

During ECMO, blood is removed from the body through a large catheter or cannula, passed through a membrane oxygenator that adds oxygen and removes carbon dioxide, and then returned to the body through another catheter. This process helps to rest and heal the lungs and/or heart while maintaining adequate oxygenation and circulation to the rest of the body.

ECMO is typically used as a last resort in patients with severe respiratory or cardiac failure who have not responded to other treatments, such as mechanical ventilation or medication. It can be a life-saving procedure, but it also carries risks, including bleeding, infection, and damage to blood vessels or organs.

A "premature infant" is a newborn delivered before 37 weeks of gestation. They are at greater risk for various health complications and medical conditions compared to full-term infants, due to their immature organ systems and lower birth weight. Some common diseases and health issues that premature infants may face include:

1. Respiratory Distress Syndrome (RDS): A lung disorder caused by the lack of surfactant, a substance that helps keep the lungs inflated. Premature infants, especially those born before 34 weeks, are at higher risk for RDS.
2. Intraventricular Hemorrhage (IVH): Bleeding in the brain's ventricles, which can lead to developmental delays or neurological issues. The risk of IVH is inversely proportional to gestational age, meaning that the earlier the infant is born, the higher the risk.
3. Necrotizing Enterocolitis (NEC): A gastrointestinal disease where the intestinal tissue becomes inflamed and can die. Premature infants are at greater risk for NEC due to their immature digestive systems.
4. Jaundice: A yellowing of the skin and eyes caused by an accumulation of bilirubin, a waste product from broken-down red blood cells. Premature infants may have higher rates of jaundice due to their liver's immaturity.
5. Infections: Premature infants are more susceptible to infections because of their underdeveloped immune systems. Common sources of infection include the mother's genital tract, bloodstream, or hospital environment.
6. Anemia: A condition characterized by a low red blood cell count or insufficient hemoglobin. Premature infants may develop anemia due to frequent blood sampling, rapid growth, or inadequate erythropoietin production.
7. Retinopathy of Prematurity (ROP): An eye disorder affecting premature infants, where abnormal blood vessel growth occurs in the retina. Severe ROP can lead to vision loss or blindness if not treated promptly.
8. Developmental Delays: Premature infants are at risk for developmental delays due to their immature nervous systems and environmental factors such as sensory deprivation or separation from parents.
9. Patent Ductus Arteriosus (PDA): A congenital heart defect where the ductus arteriosus, a blood vessel that connects two major arteries in the fetal heart, fails to close after birth. Premature infants are at higher risk for PDA due to their immature cardiovascular systems.
10. Hypothermia: Premature infants have difficulty maintaining body temperature and are at risk for hypothermia, which can lead to increased metabolic demands, poor feeding, and infection.

A Neonatal Intensive Care Unit (NICU) is a specialized hospital unit that provides advanced, intensive care for newborn babies who are born prematurely, critically ill, or have complex medical conditions. The NICU staff includes neonatologists, neonatal nurses, respiratory therapists, and other healthcare professionals trained to provide specialized care for these vulnerable infants.

The NICU is equipped with advanced technology and monitoring systems to support the babies' breathing, heart function, temperature regulation, and nutrition. The unit may include incubators or radiant warmers to maintain the baby's body temperature, ventilators to assist with breathing, and intravenous lines to provide fluids and medications.

NICUs are typically classified into levels based on the complexity of care provided, ranging from Level I (basic care for healthy newborns) to Level IV (the highest level of care for critically ill newborns). The specific services and level of care provided in a NICU may vary depending on the hospital and geographic location.

Influenza, also known as the flu, is a highly contagious viral infection that attacks the respiratory system of humans. It is caused by influenza viruses A, B, or C and is characterized by the sudden onset of fever, chills, headache, muscle pain, sore throat, cough, runny nose, and fatigue. Influenza can lead to complications such as pneumonia, bronchitis, and ear infections, and can be particularly dangerous for young children, older adults, pregnant women, and people with weakened immune systems or chronic medical conditions. The virus is spread through respiratory droplets produced when an infected person coughs, sneezes, or talks, and can also survive on surfaces for a period of time. Influenza viruses are constantly changing, which makes it necessary to get vaccinated annually to protect against the most recent and prevalent strains.

Pneumothorax is a medical condition that refers to the presence of air in the pleural space, which is the potential space between the lungs and the chest wall. This collection of air can result in a partial or complete collapse of the lung. The symptoms of pneumothorax may include sudden chest pain, shortness of breath, cough, and rapid heartbeat.

The two main types of pneumothorax are spontaneous pneumothorax, which occurs without any apparent cause or underlying lung disease, and secondary pneumothorax, which is caused by an underlying lung condition such as chronic obstructive pulmonary disease (COPD), asthma, or lung cancer.

Treatment for pneumothorax may include observation, oxygen therapy, needle aspiration, or chest tube insertion to remove the excess air from the pleural space and allow the lung to re-expand. In severe cases, surgery may be required to prevent recurrence.

An acute disease is a medical condition that has a rapid onset, develops quickly, and tends to be short in duration. Acute diseases can range from minor illnesses such as a common cold or flu, to more severe conditions such as pneumonia, meningitis, or a heart attack. These types of diseases often have clear symptoms that are easy to identify, and they may require immediate medical attention or treatment.

Acute diseases are typically caused by an external agent or factor, such as a bacterial or viral infection, a toxin, or an injury. They can also be the result of a sudden worsening of an existing chronic condition. In general, acute diseases are distinct from chronic diseases, which are long-term medical conditions that develop slowly over time and may require ongoing management and treatment.

Examples of acute diseases include:

* Acute bronchitis: a sudden inflammation of the airways in the lungs, often caused by a viral infection.
* Appendicitis: an inflammation of the appendix that can cause severe pain and requires surgical removal.
* Gastroenteritis: an inflammation of the stomach and intestines, often caused by a viral or bacterial infection.
* Migraine headaches: intense headaches that can last for hours or days, and are often accompanied by nausea, vomiting, and sensitivity to light and sound.
* Myocardial infarction (heart attack): a sudden blockage of blood flow to the heart muscle, often caused by a buildup of plaque in the coronary arteries.
* Pneumonia: an infection of the lungs that can cause coughing, chest pain, and difficulty breathing.
* Sinusitis: an inflammation of the sinuses, often caused by a viral or bacterial infection.

It's important to note that while some acute diseases may resolve on their own with rest and supportive care, others may require medical intervention or treatment to prevent complications and promote recovery. If you are experiencing symptoms of an acute disease, it is always best to seek medical attention to ensure proper diagnosis and treatment.

"Inhalation administration" is a medical term that refers to the method of delivering medications or therapeutic agents directly into the lungs by inhaling them through the airways. This route of administration is commonly used for treating respiratory conditions such as asthma, COPD (chronic obstructive pulmonary disease), and cystic fibrosis.

Inhalation administration can be achieved using various devices, including metered-dose inhalers (MDIs), dry powder inhalers (DPIs), nebulizers, and soft-mist inhalers. Each device has its unique mechanism of delivering the medication into the lungs, but they all aim to provide a high concentration of the drug directly to the site of action while minimizing systemic exposure and side effects.

The advantages of inhalation administration include rapid onset of action, increased local drug concentration, reduced systemic side effects, and improved patient compliance due to the ease of use and non-invasive nature of the delivery method. However, proper technique and device usage are crucial for effective therapy, as incorrect usage may result in suboptimal drug deposition and therapeutic outcomes.

Air filters are devices used to remove contaminants and impurities from the air. They work by trapping particles that flow through them, such as dust, pollen, mold spores, and bacteria. Air filters are often used in heating, ventilation, and air conditioning (HVAC) systems to improve indoor air quality. They can also be found in portable air cleaners and vacuum cleaners.

Air filters are typically made of a porous material such as fiberglass, cotton, or paper, which is designed to trap particles of different sizes. The efficiency of an air filter is measured by its Minimum Efficiency Reporting Value (MERV) rating, which ranges from 1 to 16, with higher ratings indicating better filtration performance.

Medical-grade air filters, such as High Efficiency Particulate Air (HEPA) filters, are designed to remove at least 99.97% of particles that are 0.3 microns or larger in diameter. These filters are commonly used in hospitals and medical facilities to help prevent the spread of infectious diseases.

The thoracic wall refers to the anatomical structure that surrounds and protects the chest cavity or thorax, which contains the lungs, heart, and other vital organs. It is composed of several components:

1. Skeletal framework: This includes the 12 pairs of ribs, the sternum (breastbone) in the front, and the thoracic vertebrae in the back. The upper seven pairs of ribs are directly attached to the sternum in the front through costal cartilages. The lower five pairs of ribs are not directly connected to the sternum but are joined to the ribs above them.
2. Muscles: The thoracic wall contains several muscles, including the intercostal muscles (located between the ribs), the scalene muscles (at the side and back of the neck), and the serratus anterior muscle (on the sides of the chest). These muscles help in breathing by expanding and contracting the ribcage.
3. Soft tissues: The thoracic wall also contains various soft tissues, such as fascia, nerves, blood vessels, and fat. These structures support the functioning of the thoracic organs and contribute to the overall stability and protection of the chest cavity.

The primary function of the thoracic wall is to protect the vital organs within the chest cavity while allowing for adequate movement during respiration. Additionally, it provides a stable base for the attachment of various muscles involved in upper limb movement and posture.

A manikin is commonly referred to as a full-size model of the human body used for training in various medical and healthcare fields. Medical manikins are often made from materials that simulate human skin and tissues, allowing for realistic practice in procedures such as physical examinations, resuscitation, and surgical techniques.

These manikins can be highly advanced, with built-in mechanisms to simulate physiological responses, such as breathing, heartbeats, and pupil dilation. They may also have interchangeable parts, allowing for the simulation of various medical conditions and scenarios. Medical manikins are essential tools in healthcare education, enabling learners to develop their skills and confidence in a controlled, safe environment before working with real patients.

Respiratory tract infections (RTIs) are infections that affect the respiratory system, which includes the nose, throat (pharynx), voice box (larynx), windpipe (trachea), bronchi, and lungs. These infections can be caused by viruses, bacteria, or, less commonly, fungi.

RTIs are classified into two categories based on their location: upper respiratory tract infections (URTIs) and lower respiratory tract infections (LRTIs). URTIs include infections of the nose, sinuses, throat, and larynx, such as the common cold, flu, laryngitis, and sinusitis. LRTIs involve the lower airways, including the bronchi and lungs, and can be more severe. Examples of LRTIs are pneumonia, bronchitis, and bronchiolitis.

Symptoms of RTIs depend on the location and cause of the infection but may include cough, congestion, runny nose, sore throat, difficulty breathing, wheezing, fever, fatigue, and chest pain. Treatment for RTIs varies depending on the severity and underlying cause of the infection. For viral infections, treatment typically involves supportive care to manage symptoms, while antibiotics may be prescribed for bacterial infections.

Inhalation burns, also known as respiratory or pulmonary burns, refer to damage to the airways and lungs caused by inhaling hot gases, smoke, steam, or toxic fumes. This type of injury can occur during a fire or other thermal incidents and can result in significant morbidity and mortality.

Inhalation burns are classified into three categories based on the location and severity of the injury:

1. Upper airway burns: These involve the nose, throat, and voice box (larynx) and are usually caused by inhaling hot gases or steam. Symptoms may include singed nasal hairs, soot in the nose or mouth, coughing, wheezing, and difficulty speaking or swallowing.
2. Lower airway burns: These involve the trachea, bronchi, and bronchioles and are usually caused by inhaling smoke or toxic fumes. Symptoms may include coughing, chest pain, shortness of breath, and wheezing.
3. Systemic burns: These occur when toxic substances are absorbed into the bloodstream and can affect multiple organs. Symptoms may include nausea, vomiting, confusion, and organ failure.

Inhalation burns can lead to complications such as pneumonia, respiratory failure, and acute respiratory distress syndrome (ARDS). Treatment typically involves providing oxygen therapy, removing secretions from the airways, and administering bronchodilators and corticosteroids to reduce inflammation. Severe cases may require intubation and mechanical ventilation.

Prevention of inhalation burns includes avoiding smoke-filled areas during a fire, staying close to the ground where the air is cooler and cleaner, and using appropriate respiratory protection devices when exposed to toxic fumes or gases.

Sepsis is a life-threatening condition that arises when the body's response to an infection injures its own tissues and organs. It is characterized by a whole-body inflammatory state (systemic inflammation) that can lead to blood clotting issues, tissue damage, and multiple organ failure.

Sepsis happens when an infection you already have triggers a chain reaction throughout your body. Infections that lead to sepsis most often start in the lungs, urinary tract, skin, or gastrointestinal tract.

Sepsis is a medical emergency. If you suspect sepsis, seek immediate medical attention. Early recognition and treatment of sepsis are crucial to improve outcomes. Treatment usually involves antibiotics, intravenous fluids, and may require oxygen, medication to raise blood pressure, and corticosteroids. In severe cases, surgery may be required to clear the infection.

A diaphragm is a thin, dome-shaped muscle that separates the chest cavity from the abdominal cavity. It plays a vital role in the process of breathing as it contracts and flattens to draw air into the lungs (inhalation) and relaxes and returns to its domed shape to expel air out of the lungs (exhalation).

In addition, a diaphragm is also a type of barrier method of birth control. It is a flexible dome-shaped device made of silicone that fits over the cervix inside the vagina. When used correctly and consistently, it prevents sperm from entering the uterus and fertilizing an egg, thereby preventing pregnancy.

A fatal outcome is a term used in medical context to describe a situation where a disease, injury, or illness results in the death of an individual. It is the most severe and unfortunate possible outcome of any medical condition, and is often used as a measure of the severity and prognosis of various diseases and injuries. In clinical trials and research, fatal outcome may be used as an endpoint to evaluate the effectiveness and safety of different treatments or interventions.

Smoke inhalation injury is a type of damage that occurs to the respiratory system when an individual breathes in smoke, most commonly during a fire. This injury can affect both the upper and lower airways and can cause a range of symptoms, including coughing, wheezing, shortness of breath, and chest pain.

Smoke inhalation injury can also lead to more severe complications, such as chemical irritation of the airways, swelling of the throat and lungs, and respiratory failure. In some cases, it can even be fatal. The severity of the injury depends on several factors, including the duration and intensity of the exposure, the individual's underlying health status, and the presence of any pre-existing lung conditions.

Smoke inhalation injury is caused by a combination of thermal injury (heat damage) and chemical injury (damage from toxic substances present in the smoke). The heat from the smoke can cause direct damage to the airways, leading to inflammation and swelling. At the same time, the chemicals in the smoke can irritate and corrode the lining of the airways, causing further damage.

Some of the toxic substances found in smoke include carbon monoxide, cyanide, and various other chemicals released by burning materials. These substances can interfere with the body's ability to transport oxygen and can cause metabolic acidosis, a condition characterized by an excessively acidic environment in the body.

Treatment for smoke inhalation injury typically involves providing supportive care to help the individual breathe more easily, such as administering oxygen or using mechanical ventilation. In some cases, medications may be used to reduce inflammation and swelling in the airways. Severe cases of smoke inhalation injury may require hospitalization and intensive care.

Medical Definition:

Mycoplasmal Pneumonia of Swine, also known as Enzootic Pneumonia, is a respiratory disease in pigs caused by the bacterium Mycoplasma hyopneumoniae. It primarily affects the lungs and is characterized by coughing, difficulty breathing, and reduced growth rates in affected animals. The disease is called "enzootic" because it is widespread among swine populations in many parts of the world.

The bacteria responsible for this condition are highly contagious and can spread rapidly among pigs through direct contact with infected animals or contaminated surfaces. Infection can also occur through aerosolized droplets expelled by coughing pigs. The disease is often associated with other respiratory pathogens, such as Pasteurella multocida and Haemophilus parasuis, which can exacerbate the severity of the symptoms.

Mycoplasmal Pneumonia of Swine is a significant economic concern for the swine industry due to its impact on growth rates, feed conversion efficiency, and increased mortality. Control measures typically involve a combination of management practices, vaccination, and biosecurity protocols to minimize the spread of the disease within herds.

Hyaline Membrane Disease (HMD) is a medical condition primarily seen in newborns, also known as Infant Respiratory Distress Syndrome (IRDS). It's characterized by the presence of hyaline membranes, which are made up of proteins and cellular debris, on the inside surfaces of the alveoli (air sacs) in the lungs.

These membranes can interfere with the normal gas exchange process, making it difficult for the newborn to breathe effectively. The condition is often associated with premature birth, as the surfactant that coats the inside of the lungs and keeps them inflated isn't fully produced until around the 35th week of gestation.

The lack of sufficient surfactant can lead to collapse of the alveoli (atelectasis), inflammation, and the formation of hyaline membranes. HMD is a significant cause of morbidity and mortality in premature infants, but with early detection and proper medical care, including the use of artificial surfactant, oxygen therapy, and mechanical ventilation, many babies can recover.

Pseudomonas infections are infections caused by the bacterium Pseudomonas aeruginosa or other species of the Pseudomonas genus. These bacteria are gram-negative, opportunistic pathogens that can cause various types of infections, including respiratory, urinary tract, gastrointestinal, dermatological, and bloodstream infections.

Pseudomonas aeruginosa is a common cause of healthcare-associated infections, particularly in patients with weakened immune systems, chronic lung diseases, or those who are hospitalized for extended periods. The bacteria can also infect wounds, burns, and medical devices such as catheters and ventilators.

Pseudomonas infections can be difficult to treat due to the bacteria's resistance to many antibiotics. Treatment typically involves the use of multiple antibiotics that are effective against Pseudomonas aeruginosa. In severe cases, intravenous antibiotics or even hospitalization may be necessary.

Prevention measures include good hand hygiene, contact precautions for patients with known Pseudomonas infections, and proper cleaning and maintenance of medical equipment.

Pneumococcal vaccines are immunizing agents that protect against infections caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. These vaccines help to prevent several types of diseases, including pneumonia, meningitis, and bacteremia (bloodstream infection).

There are two main types of pneumococcal vaccines available:

1. Pneumococcal Conjugate Vaccine (PCV): This vaccine is recommended for children under 2 years old, adults aged 65 and older, and people with certain medical conditions that increase their risk of pneumococcal infections. PCV protects against 13 or 20 serotypes (strains) of Streptococcus pneumoniae, depending on the formulation (PCV13 or PCV20).
2. Pneumococcal Polysaccharide Vaccine (PPSV): This vaccine is recommended for adults aged 65 and older, children and adults with specific medical conditions, and smokers. PPSV protects against 23 serotypes of Streptococcus pneumoniae.

These vaccines work by stimulating the immune system to produce antibodies that recognize and fight off the bacteria if an individual comes into contact with it in the future. Both types of pneumococcal vaccines have been proven to be safe and effective in preventing severe pneumococcal diseases.

Hospital mortality is a term used to describe the number or rate of deaths that occur in a hospital setting during a specific period. It is often used as a measure of the quality of healthcare provided by a hospital, as a higher hospital mortality rate may indicate poorer care or more complex cases being treated. However, it's important to note that hospital mortality rates can be influenced by many factors, including the severity of illness of the patients being treated, patient demographics, and the availability of resources and specialized care. Therefore, hospital mortality rates should be interpreted with caution and in the context of other quality metrics.

The trachea, also known as the windpipe, is a tube-like structure in the respiratory system that connects the larynx (voice box) to the bronchi (the two branches leading to each lung). It is composed of several incomplete rings of cartilage and smooth muscle, which provide support and flexibility. The trachea plays a crucial role in directing incoming air to the lungs during inspiration and outgoing air to the larynx during expiration.

In epidemiology, the incidence of a disease is defined as the number of new cases of that disease within a specific population over a certain period of time. It is typically expressed as a rate, with the number of new cases in the numerator and the size of the population at risk in the denominator. Incidence provides information about the risk of developing a disease during a given time period and can be used to compare disease rates between different populations or to monitor trends in disease occurrence over time.

Lung volume measurements are clinical tests that determine the amount of air inhaled, exhaled, and present in the lungs at different times during the breathing cycle. These measurements include:

1. Tidal Volume (TV): The amount of air inhaled or exhaled during normal breathing, usually around 500 mL in resting adults.
2. Inspiratory Reserve Volume (IRV): The additional air that can be inhaled after a normal inspiration, approximately 3,000 mL in adults.
3. Expiratory Reserve Volume (ERV): The extra air that can be exhaled after a normal expiration, about 1,000-1,200 mL in adults.
4. Residual Volume (RV): The air remaining in the lungs after a maximal exhalation, approximately 1,100-1,500 mL in adults.
5. Total Lung Capacity (TLC): The total amount of air the lungs can hold at full inflation, calculated as TV + IRV + ERV + RV, around 6,000 mL in adults.
6. Functional Residual Capacity (FRC): The volume of air remaining in the lungs after a normal expiration, equal to ERV + RV, about 2,100-2,700 mL in adults.
7. Inspiratory Capacity (IC): The maximum amount of air that can be inhaled after a normal expiration, equal to TV + IRV, around 3,500 mL in adults.
8. Vital Capacity (VC): The total volume of air that can be exhaled after a maximal inspiration, calculated as IC + ERV, approximately 4,200-5,600 mL in adults.

These measurements help assess lung function and identify various respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and restrictive lung diseases.

Anti-infective agents are a class of medications that are used to treat infections caused by various microorganisms such as bacteria, viruses, fungi, and parasites. These agents work by either killing the microorganism or inhibiting its growth, thereby helping to control the infection and alleviate symptoms.

There are several types of anti-infective agents, including:

1. Antibiotics: These are medications that are used to treat bacterial infections. They work by either killing bacteria (bactericidal) or inhibiting their growth (bacteriostatic).
2. Antivirals: These are medications that are used to treat viral infections. They work by interfering with the replication of the virus, preventing it from spreading and causing further damage.
3. Antifungals: These are medications that are used to treat fungal infections. They work by disrupting the cell membrane of the fungus, killing it or inhibiting its growth.
4. Antiparasitics: These are medications that are used to treat parasitic infections. They work by either killing the parasite or inhibiting its growth and reproduction.

It is important to note that anti-infective agents are not effective against all types of infections, and it is essential to use them appropriately to avoid the development of drug-resistant strains of microorganisms.

"Pneumocystis carinii" is an outdated term. The organism it refers to is now known as "Pneumocystis jirovecii" and it's a type of fungus that can cause a serious lung infection called pneumocystis pneumonia (PCP). This infection mainly affects people with weakened immune systems, such as those with HIV/AIDS, cancer, or who have had organ transplants. It's important to note that "Pneumocystis jirovecii" is not the same as the bacterium "Legionella pneumophila" which causes Legionnaires' disease.

Empyema is a medical condition characterized by the accumulation of pus in a body cavity, most commonly in the pleural space surrounding the lungs. It is usually caused by a bacterial infection that spreads from the lung tissue to the pleural space. The buildup of pus can cause chest pain, cough, fever, and difficulty breathing. Empyema can be a complication of pneumonia or other respiratory infections, and it may require treatment with antibiotics, drainage of the pus, and sometimes surgery.

Pulmonary alveoli, also known as air sacs, are tiny clusters of air-filled pouches located at the end of the bronchioles in the lungs. They play a crucial role in the process of gas exchange during respiration. The thin walls of the alveoli, called alveolar membranes, allow oxygen from inhaled air to pass into the bloodstream and carbon dioxide from the bloodstream to pass into the alveoli to be exhaled out of the body. This vital function enables the lungs to supply oxygen-rich blood to the rest of the body and remove waste products like carbon dioxide.

Pulmonary atelectasis is a medical condition characterized by the collapse or closure of the alveoli (tiny air sacs) in the lungs, leading to reduced or absent gas exchange in the affected area. This results in decreased lung volume and can cause hypoxemia (low oxygen levels in the blood). Atelectasis can be caused by various factors such as obstruction of the airways, surfactant deficiency, pneumothorax, or compression from outside the lung. It can also occur after surgical procedures, particularly when the patient is lying in one position for a long time. Symptoms may include shortness of breath, cough, and chest discomfort, but sometimes it may not cause any symptoms, especially if only a small area of the lung is affected. Treatment depends on the underlying cause and may include bronchodilators, chest physiotherapy, or even surgery in severe cases.

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by the persistent obstruction of airflow in and out of the lungs. This obstruction is usually caused by two primary conditions: chronic bronchitis and emphysema. Chronic bronchitis involves inflammation and narrowing of the airways, leading to excessive mucus production and coughing. Emphysema is a condition where the alveoli (air sacs) in the lungs are damaged, resulting in decreased gas exchange and shortness of breath.

The main symptoms of COPD include progressive shortness of breath, chronic cough, chest tightness, wheezing, and excessive mucus production. The disease is often associated with exposure to harmful particles or gases, such as cigarette smoke, air pollution, or occupational dusts and chemicals. While there is no cure for COPD, treatments can help alleviate symptoms, improve quality of life, and slow the progression of the disease. These treatments may include bronchodilators, corticosteroids, combination inhalers, pulmonary rehabilitation, and, in severe cases, oxygen therapy or lung transplantation.

Nonparametric statistics is a branch of statistics that does not rely on assumptions about the distribution of variables in the population from which the sample is drawn. In contrast to parametric methods, nonparametric techniques make fewer assumptions about the data and are therefore more flexible in their application. Nonparametric tests are often used when the data do not meet the assumptions required for parametric tests, such as normality or equal variances.

Nonparametric statistical methods include tests such as the Wilcoxon rank-sum test (also known as the Mann-Whitney U test) for comparing two independent groups, the Wilcoxon signed-rank test for comparing two related groups, and the Kruskal-Wallis test for comparing more than two independent groups. These tests use the ranks of the data rather than the actual values to make comparisons, which allows them to be used with ordinal or continuous data that do not meet the assumptions of parametric tests.

Overall, nonparametric statistics provide a useful set of tools for analyzing data in situations where the assumptions of parametric methods are not met, and can help researchers draw valid conclusions from their data even when the data are not normally distributed or have other characteristics that violate the assumptions of parametric tests.

"Legionella pneumophila" is a species of Gram-negative, aerobic bacteria that are commonly found in freshwater environments such as lakes and streams. It can also be found in man-made water systems like hot tubs, cooling towers, and decorative fountains. This bacterium is the primary cause of Legionnaires' disease, a severe form of pneumonia, and Pontiac fever, a milder illness resembling the flu. Infection typically occurs when people inhale tiny droplets of water containing the bacteria. It is not transmitted from person to person.

In the context of medicine, and specifically in physiology and respiratory therapy, partial pressure (P or p) is a measure of the pressure exerted by an individual gas in a mixture of gases. It's commonly used to describe the concentrations of gases in the body, such as oxygen (PO2), carbon dioxide (PCO2), and nitrogen (PN2).

The partial pressure of a specific gas is calculated as the fraction of that gas in the total mixture multiplied by the total pressure of the mixture. This concept is based on Dalton's law, which states that the total pressure exerted by a mixture of gases is equal to the sum of the pressures exerted by each individual gas.

For example, in room air at sea level, the partial pressure of oxygen (PO2) is approximately 160 mmHg (mm of mercury), which represents about 21% of the total barometric pressure (760 mmHg). This concept is crucial for understanding gas exchange in the lungs and how gases move across membranes, such as from alveoli to blood and vice versa.

A gas scavenger system is a type of medical device that is used to capture and dispose of waste anesthetic gases that are exhaled by a patient during surgery. These systems typically consist of a hose or tube that is connected to the anesthesia machine, which captures the waste gases as they exit the breathing circuit. The gases are then filtered through activated carbon or other materials to remove the anesthetic agents and odors before being vented outside of the healthcare facility.

The purpose of a gas scavenger system is to protect operating room staff from exposure to potentially harmful anesthetic gases, which can cause respiratory irritation, headaches, nausea, and other symptoms. In addition, some anesthetic gases have been classified as greenhouse gases and can contribute to climate change, so scavenging systems also help to reduce the environmental impact of anesthesia.

It's important to note that gas scavenger systems are not a substitute for proper ventilation and air exchange in the operating room. They should be used in conjunction with other measures to ensure a safe and healthy work environment for healthcare professionals.

Anesthesiology is a medical specialty concerned with providing anesthesia, which is the loss of sensation or awareness, to patients undergoing surgical, diagnostic, or therapeutic procedures. Anesthesiologists are responsible for administering various types of anesthetics, monitoring the patient's vital signs during the procedure, and managing any complications that may arise. They also play a critical role in pain management before, during, and after surgery, as well as in the treatment of chronic pain conditions.

Anesthesiologists work closely with other medical professionals, including surgeons, anesthetists, nurses, and respiratory therapists, to ensure that patients receive the best possible care. They must have a thorough understanding of human physiology, pharmacology, and anatomy, as well as excellent communication skills and the ability to make quick decisions under high pressure.

The primary goal of anesthesiology is to provide safe and effective anesthesia that minimizes pain and discomfort while maximizing patient safety and comfort. This requires a deep understanding of the risks and benefits associated with different types of anesthetics, as well as the ability to tailor the anesthetic plan to each individual patient's needs and medical history.

In summary, anesthesiology is a critical medical specialty focused on providing safe and effective anesthesia and pain management for patients undergoing surgical or other medical procedures.

'Infection Control' is a set of practices, procedures, and protocols designed to prevent the spread of infectious agents in healthcare settings. It includes measures to minimize the risk of transmission of pathogens from both recognized and unrecognized sources, such as patients, healthcare workers, visitors, and the environment.

Infection control strategies may include:

* Hand hygiene (handwashing and use of alcohol-based hand sanitizers)
* Use of personal protective equipment (PPE), such as gloves, masks, gowns, and eye protection
* Respiratory etiquette, including covering the mouth and nose when coughing or sneezing
* Environmental cleaning and disinfection
* Isolation precautions for patients with known or suspected infectious diseases
* Immunization of healthcare workers
* Safe injection practices
* Surveillance and reporting of infections and outbreaks

The goal of infection control is to protect patients, healthcare workers, and visitors from acquiring and transmitting infections.

Intrinsic Positive-Pressure Respiration (IPPR) is a type of positive-pressure breathing that occurs naturally within the body, without the use of mechanical ventilation or other external devices. It is also known as "auto-PEEP" or "occult PEEP," where PEEP stands for Positive End-Expiratory Pressure.

In normal, spontaneous breathing, the pressure inside the alveoli (air sacs) in the lungs becomes slightly negative during inhalation and returns to atmospheric pressure during exhalation. However, certain lung conditions or patient efforts can lead to an increase in resistance to airflow during exhalation, causing positive pressure to persist within the alveoli at the end of expiration. This results in intrinsic PEEP or auto-PEEP.

IPPR can be caused by several factors, including:

1. Air trapping due to obstructive lung diseases like chronic obstructive pulmonary disease (COPD) or asthma
2. High respiratory rates leading to incomplete exhalation before the next inspiration begins
3. Inadequate expiratory time, often seen in mechanically ventilated patients with high tidal volumes and/or low respiratory rates
4. Dynamic hyperinflation due to increased minute ventilation or high inspiratory flow rates
5. Bronchoconstriction or airway narrowing, which can occur during an asthma attack or in certain other lung conditions

IPPR has several clinical implications, such as reduced venous return and cardiac output, increased work of breathing, and potential for lung injury due to overdistension (volutrauma). Healthcare providers must consider IPPR when managing patients with respiratory distress, especially those on mechanical ventilation, to optimize their care and prevent complications.

The prone position is a body posture in which an individual lies on their stomach, with their face down and chest facing the floor or bed. This position is often used in medical settings for various purposes, such as during certain surgical procedures, respiratory support, or to alleviate pressure ulcers. It's also important to note that the prone position can have implications for patient safety, particularly in critically ill patients, and should be carefully monitored.

Continuous Positive Airway Pressure (CPAP) is a mode of non-invasive ventilation that delivers pressurized room air or oxygen to maintain airway patency and increase functional residual capacity in patients with respiratory disorders. A CPAP device, which typically includes a flow generator, tubing, and a mask, provides a constant positive pressure throughout the entire respiratory cycle, preventing the collapse of the upper airway during inspiration and expiration.

CPAP is commonly used to treat obstructive sleep apnea (OSA), a condition characterized by repetitive narrowing or closure of the upper airway during sleep, leading to intermittent hypoxia, hypercapnia, and sleep fragmentation. By delivering positive pressure, CPAP helps to stent open the airway, ensuring unobstructed breathing and reducing the frequency and severity of apneic events.

Additionally, CPAP can be used in other clinical scenarios, such as managing acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD) exacerbations, or postoperative respiratory insufficiency, to improve oxygenation and reduce the work of breathing. The specific pressure settings and device configurations are tailored to each patient's needs based on their underlying condition, severity of symptoms, and response to therapy.

Ventilation, in the context of medicine and physiology, refers to the process of breathing, which is the exchange of air between the lungs and the environment. It involves both inspiration (inhaling) and expiration (exhaling). During inspiration, air moves into the lungs, delivering oxygen to the alveoli (air sacs) where gas exchange occurs. Oxygen is taken up by the blood and transported to the body's cells, while carbon dioxide, a waste product, is expelled from the body during expiration.

In a medical setting, ventilation may also refer to the use of mechanical devices, such as ventilators or respirators, which assist or replace the breathing process for patients who are unable to breathe effectively on their own due to conditions like respiratory failure, sedation, neuromuscular disorders, or injuries. These machines help maintain adequate gas exchange and prevent complications associated with inadequate ventilation, such as hypoxia (low oxygen levels) and hypercapnia (high carbon dioxide levels).

Biological models, also known as physiological models or organismal models, are simplified representations of biological systems, processes, or mechanisms that are used to understand and explain the underlying principles and relationships. These models can be theoretical (conceptual or mathematical) or physical (such as anatomical models, cell cultures, or animal models). They are widely used in biomedical research to study various phenomena, including disease pathophysiology, drug action, and therapeutic interventions.

Examples of biological models include:

1. Mathematical models: These use mathematical equations and formulas to describe complex biological systems or processes, such as population dynamics, metabolic pathways, or gene regulation networks. They can help predict the behavior of these systems under different conditions and test hypotheses about their underlying mechanisms.
2. Cell cultures: These are collections of cells grown in a controlled environment, typically in a laboratory dish or flask. They can be used to study cellular processes, such as signal transduction, gene expression, or metabolism, and to test the effects of drugs or other treatments on these processes.
3. Animal models: These are living organisms, usually vertebrates like mice, rats, or non-human primates, that are used to study various aspects of human biology and disease. They can provide valuable insights into the pathophysiology of diseases, the mechanisms of drug action, and the safety and efficacy of new therapies.
4. Anatomical models: These are physical representations of biological structures or systems, such as plastic models of organs or tissues, that can be used for educational purposes or to plan surgical procedures. They can also serve as a basis for developing more sophisticated models, such as computer simulations or 3D-printed replicas.

Overall, biological models play a crucial role in advancing our understanding of biology and medicine, helping to identify new targets for therapeutic intervention, develop novel drugs and treatments, and improve human health.

A cohort study is a type of observational study in which a group of individuals who share a common characteristic or exposure are followed up over time to determine the incidence of a specific outcome or outcomes. The cohort, or group, is defined based on the exposure status (e.g., exposed vs. unexposed) and then monitored prospectively to assess for the development of new health events or conditions.

Cohort studies can be either prospective or retrospective in design. In a prospective cohort study, participants are enrolled and followed forward in time from the beginning of the study. In contrast, in a retrospective cohort study, researchers identify a cohort that has already been assembled through medical records, insurance claims, or other sources and then look back in time to assess exposure status and health outcomes.

Cohort studies are useful for establishing causality between an exposure and an outcome because they allow researchers to observe the temporal relationship between the two. They can also provide information on the incidence of a disease or condition in different populations, which can be used to inform public health policy and interventions. However, cohort studies can be expensive and time-consuming to conduct, and they may be subject to bias if participants are not representative of the population or if there is loss to follow-up.

I'm sorry for any confusion, but "United States" is a geopolitical entity, specifically the name of the country consisting of 50 states, and it is not a medical term or concept. Therefore, I can't provide a medical definition for it. If you have any questions related to health, medicine, or biology, I would be happy to try to help answer those!

Obstructive lung disease is a category of respiratory diseases characterized by airflow limitation that causes difficulty in completely emptying the alveoli (tiny air sacs) of the lungs during exhaling. This results in the trapping of stale air and prevents fresh air from entering the alveoli, leading to various symptoms such as coughing, wheezing, shortness of breath, and decreased exercise tolerance.

The most common obstructive lung diseases include:

1. Chronic Obstructive Pulmonary Disease (COPD): A progressive disease that includes chronic bronchitis and emphysema, often caused by smoking or exposure to harmful pollutants.
2. Asthma: A chronic inflammatory disorder of the airways characterized by variable airflow obstruction, bronchial hyperresponsiveness, and an underlying inflammation. Symptoms can be triggered by various factors such as allergens, irritants, or physical activity.
3. Bronchiectasis: A condition in which the airways become abnormally widened, scarred, and thickened due to chronic inflammation or infection, leading to mucus buildup and impaired clearance.
4. Cystic Fibrosis: An inherited genetic disorder that affects the exocrine glands, resulting in thick and sticky mucus production in various organs, including the lungs. This can lead to chronic lung infections, inflammation, and airway obstruction.
5. Alpha-1 Antitrypsin Deficiency: A genetic condition characterized by low levels of alpha-1 antitrypsin protein, which leads to uncontrolled protease enzyme activity that damages the lung tissue, causing emphysema-like symptoms.

Treatment for obstructive lung diseases typically involves bronchodilators (to relax and widen the airways), corticosteroids (to reduce inflammation), and lifestyle modifications such as smoking cessation and pulmonary rehabilitation programs. In severe cases, oxygen therapy or even lung transplantation may be considered.

Legionella is the genus of gram-negative, aerobic bacteria that can cause serious lung infections known as legionellosis. The most common species causing disease in humans is Legionella pneumophila. These bacteria are widely found in natural freshwater environments such as lakes and streams. However, they can also be found in man-made water systems like cooling towers, hot tubs, decorative fountains, and plumbing systems. When people breathe in small droplets of water containing the bacteria, especially in the form of aerosols or mist, they may develop Legionnaires' disease, a severe form of pneumonia, or Pontiac fever, a milder flu-like illness. The risk of infection increases in individuals with weakened immune systems, chronic lung diseases, older age, and smokers. Appropriate disinfection methods and regular maintenance of water systems can help prevent the growth and spread of Legionella bacteria.

Pneumococcal infections are illnesses caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterium can infect different parts of the body, including the lungs (pneumonia), blood (bacteremia or sepsis), and the covering of the brain and spinal cord (meningitis). Pneumococcal infections can also cause ear infections and sinus infections. The bacteria spread through close contact with an infected person, who may spread the bacteria by coughing or sneezing. People with weakened immune systems, children under 2 years of age, adults over 65, and those with certain medical conditions are at increased risk for developing pneumococcal infections.

Clinical protocols, also known as clinical practice guidelines or care paths, are systematically developed statements that assist healthcare professionals and patients in making decisions about the appropriate healthcare for specific clinical circumstances. They are based on a thorough evaluation of the available scientific evidence and consist of a set of recommendations that are designed to optimize patient outcomes, improve the quality of care, and reduce unnecessary variations in practice. Clinical protocols may cover a wide range of topics, including diagnosis, treatment, follow-up, and disease prevention, and are developed by professional organizations, government agencies, and other groups with expertise in the relevant field.

A "hospitalized child" refers to a minor (an individual who has not yet reached the age of majority, which varies by country but is typically 18 in the US) who has been admitted to a hospital for the purpose of receiving medical treatment and care. This term can encompass children of all ages, from infants to teenagers, and may include those who are suffering from a wide range of medical conditions or injuries, requiring various levels of care and intervention.

Hospitalization can be necessary for a variety of reasons, including but not limited to:

1. Acute illnesses that require close monitoring, such as pneumonia, meningitis, or sepsis.
2. Chronic medical conditions that need ongoing management, like cystic fibrosis, cancer, or congenital heart defects.
3. Severe injuries resulting from accidents, such as fractures, burns, or traumatic brain injuries.
4. Elective procedures, such as surgeries for orthopedic issues or to correct congenital abnormalities.
5. Mental health disorders that necessitate inpatient care and treatment.

Regardless of the reason for hospitalization, healthcare professionals strive to provide comprehensive, family-centered care to ensure the best possible outcomes for their young patients. This may involve working closely with families to address their concerns, providing education about the child's condition and treatment plan, and coordinating care across various disciplines and specialties.

An immunocompromised host refers to an individual who has a weakened or impaired immune system, making them more susceptible to infections and decreased ability to fight off pathogens. This condition can be congenital (present at birth) or acquired (developed during one's lifetime).

Acquired immunocompromised states may result from various factors such as medical treatments (e.g., chemotherapy, radiation therapy, immunosuppressive drugs), infections (e.g., HIV/AIDS), chronic diseases (e.g., diabetes, malnutrition, liver disease), or aging.

Immunocompromised hosts are at a higher risk for developing severe and life-threatening infections due to their reduced immune response. Therefore, they require special consideration when it comes to prevention, diagnosis, and treatment of infectious diseases.

Organ dysfunction scores are measurement tools used in critical care medicine to assess and quantify the degree of physiological derangement or failure in multiple organ systems. These scoring systems are designed to evaluate the overall severity of illness in critically ill patients, providing a standardized method for comparing patient outcomes and evaluating the effectiveness of different treatments.

There are several commonly used organ dysfunction scores, including:

1. Sequential Organ Failure Assessment (SOFA) score: This score assesses six organ systems (respiratory, cardiovascular, hepatic, coagulation, renal, and neurologic) on a scale of 0 to 4, with higher scores indicating more severe dysfunction or failure.
2. Multiple Organ Dysfunction Score (MODS): This score evaluates seven organ systems (respiratory, cardiovascular, hepatic, coagulation, renal, gastrointestinal, and neurologic) on a scale of 0 to 4, with higher scores indicating more severe dysfunction or failure.
3. Logistic Organ Dysfunction Score (LODS): This score assesses six organ systems (respiratory, cardiovascular, hepatic, coagulation, renal, and neurologic) on a scale of 0 to 100, with higher scores indicating more severe dysfunction or failure.
4. Acute Physiology And Chronic Health Evaluation II (APACHE II): While not strictly an organ dysfunction score, APACHE II includes components that assess organ dysfunction and is widely used in critical care settings to predict mortality risk.

These scores are typically calculated based on clinical data such as laboratory values, vital signs, and physiological measurements, and are often used to guide clinical decision-making, allocate resources, and compare outcomes across different patient populations or treatment strategies.

A "patient transfer" is a medical procedure that involves moving a patient from one location, piece of medical equipment, or healthcare provider to another. This can include:

1. Transferring a patient from a bed to a stretcher, wheelchair, or other mobility device.
2. Moving a patient from a hospital bed to a surgical table or imaging machine such as an MRI or CT scanner.
3. Transporting a patient between healthcare facilities, such as from a hospital to a rehabilitation center or long-term care facility.
4. Transferring a patient between medical teams during the course of their treatment, like when they are moved from the emergency department to the intensive care unit.

Patient transfers require careful planning and execution to ensure the safety and comfort of the patient, as well as to prevent any potential injuries or complications for both the patient and the healthcare providers involved in the process. Proper techniques, equipment, and communication are essential for a successful patient transfer.

Pentamidine is an antimicrobial drug that is primarily used to treat and prevent certain types of pneumonia caused by the parasitic organisms Pneumocystis jirovecii (formerly known as P. carinii) and Leishmania donovani. It can also be used for the treatment of some fungal infections caused by Histoplasma capsulatum and Cryptococcus neoformans.

Pentamidine works by interfering with the DNA replication and protein synthesis of these microorganisms, which ultimately leads to their death. It is available as an injection or inhaled powder for medical use. Common side effects of pentamidine include nausea, vomiting, diarrhea, abdominal pain, and changes in blood sugar levels. More serious side effects can include kidney damage, hearing loss, and heart rhythm disturbances.

It is important to note that the use of pentamidine should be under the supervision of a healthcare professional due to its potential for serious side effects and drug interactions.

Chlamydial pneumonia is a type of lung infection caused by the bacterium Chlamydophila pneumoniae (previously known as Chlamydia pneumoniae). It is often a mild to moderate respiratory infection, but in some cases, it can be more severe and require hospitalization.

The symptoms of chlamydial pneumonia may include cough, chest pain, fever, fatigue, and difficulty breathing. The infection is usually spread through respiratory droplets when an infected person coughs or sneezes. It can also be spread by touching contaminated surfaces and then touching the mouth or nose.

Chlamydial pneumonia is often treated with antibiotics, such as azithromycin or doxycycline. In some cases, hospitalization may be necessary for more severe infections, especially in people with weakened immune systems or other underlying health conditions.

It's worth noting that chlamydial pneumonia is different from chlamydia trachomatis, which is a sexually transmitted infection caused by a different species of Chlamydia.

Sensitivity and specificity are statistical measures used to describe the performance of a diagnostic test or screening tool in identifying true positive and true negative results.

* Sensitivity refers to the proportion of people who have a particular condition (true positives) who are correctly identified by the test. It is also known as the "true positive rate" or "recall." A highly sensitive test will identify most or all of the people with the condition, but may also produce more false positives.
* Specificity refers to the proportion of people who do not have a particular condition (true negatives) who are correctly identified by the test. It is also known as the "true negative rate." A highly specific test will identify most or all of the people without the condition, but may also produce more false negatives.

In medical testing, both sensitivity and specificity are important considerations when evaluating a diagnostic test. High sensitivity is desirable for screening tests that aim to identify as many cases of a condition as possible, while high specificity is desirable for confirmatory tests that aim to rule out the condition in people who do not have it.

It's worth noting that sensitivity and specificity are often influenced by factors such as the prevalence of the condition in the population being tested, the threshold used to define a positive result, and the reliability and validity of the test itself. Therefore, it's important to consider these factors when interpreting the results of a diagnostic test.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Bacteremia is the presence of bacteria in the bloodstream. It is a medical condition that occurs when bacteria from another source, such as an infection in another part of the body, enter the bloodstream. Bacteremia can cause symptoms such as fever, chills, and rapid heart rate, and it can lead to serious complications such as sepsis if not treated promptly with antibiotics.

Bacteremia is often a result of an infection elsewhere in the body that allows bacteria to enter the bloodstream. This can happen through various routes, such as during medical procedures, intravenous (IV) drug use, or from infected wounds or devices that come into contact with the bloodstream. In some cases, bacteremia may also occur without any obvious source of infection.

It is important to note that not all bacteria in the bloodstream cause harm, and some people may have bacteria in their blood without showing any symptoms. However, if bacteria in the bloodstream multiply and cause an immune response, it can lead to bacteremia and potentially serious complications.

AIDS-related opportunistic infections (AROIs) are infections that occur more frequently or are more severe in people with weakened immune systems, such as those with advanced HIV infection or AIDS. These infections take advantage of a weakened immune system and can affect various organs and systems in the body.

Common examples of AROIs include:

1. Pneumocystis pneumonia (PCP), caused by the fungus Pneumocystis jirovecii
2. Mycobacterium avium complex (MAC) infection, caused by a type of bacteria called mycobacteria
3. Candidiasis, a fungal infection that can affect various parts of the body, including the mouth, esophagus, and genitals
4. Toxoplasmosis, caused by the parasite Toxoplasma gondii
5. Cryptococcosis, a fungal infection that affects the lungs and central nervous system
6. Cytomegalovirus (CMV) infection, caused by a type of herpes virus
7. Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis
8. Cryptosporidiosis, a parasitic infection that affects the intestines
9. Progressive multifocal leukoencephalopathy (PML), a viral infection that affects the brain

Preventing and treating AROIs is an important part of managing HIV/AIDS, as they can cause significant illness and even death in people with weakened immune systems. Antiretroviral therapy (ART) is used to treat HIV infection and prevent the progression of HIV to AIDS, which can help reduce the risk of opportunistic infections. In addition, medications to prevent specific opportunistic infections may be prescribed for people with advanced HIV or AIDS.

A "colony count" is a method used to estimate the number of viable microorganisms, such as bacteria or fungi, in a sample. In this technique, a known volume of the sample is spread onto the surface of a solid nutrient medium in a petri dish and then incubated under conditions that allow the microorganisms to grow and form visible colonies. Each colony that grows on the plate represents an individual cell (or small cluster of cells) from the original sample that was able to divide and grow under the given conditions. By counting the number of colonies that form, researchers can make a rough estimate of the concentration of microorganisms in the original sample.

The term "microbial" simply refers to microscopic organisms, such as bacteria, fungi, or viruses. Therefore, a "colony count, microbial" is a general term that encompasses the use of colony counting techniques to estimate the number of any type of microorganism in a sample.

Colony counts are used in various fields, including medical research, food safety testing, and environmental monitoring, to assess the levels of contamination or the effectiveness of disinfection procedures. However, it is important to note that colony counts may not always provide an accurate measure of the total number of microorganisms present in a sample, as some cells may be injured or unable to grow under the conditions used for counting. Additionally, some microorganisms may form clusters or chains that can appear as single colonies, leading to an overestimation of the true cell count.

Pasteurellosis, pneumonic is a specific form of pasteurellosis that is caused by the bacterium *Pasteurella multocida* and primarily affects the respiratory system. It is characterized by inflammation and infection of the lungs (pneumonia) and can result in symptoms such as cough, difficulty breathing, chest pain, fever, and decreased appetite.

This condition often occurs as a secondary infection in animals with underlying respiratory diseases, and it can be transmitted to humans through close contact with infected animals, such as through bites, scratches, or inhalation of respiratory secretions. Pneumonic pasteurellosis is more likely to occur in people who have weakened immune systems due to other health conditions.

Prompt medical treatment with antibiotics is necessary to prevent complications and improve outcomes. The prognosis for pneumonic pasteurellosis depends on the severity of the infection, the patient's overall health, and how quickly they receive appropriate medical care.

X-ray computed tomography (CT or CAT scan) is a medical imaging method that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional (tomographic) images (virtual "slices") of the body. These cross-sectional images can then be used to display detailed internal views of organs, bones, and soft tissues in the body.

The term "computed tomography" is used instead of "CT scan" or "CAT scan" because the machines take a series of X-ray measurements from different angles around the body and then use a computer to process these data to create detailed images of internal structures within the body.

CT scanning is a noninvasive, painless medical test that helps physicians diagnose and treat medical conditions. CT imaging provides detailed information about many types of tissue including lung, bone, soft tissue and blood vessels. CT examinations can be performed on every part of the body for a variety of reasons including diagnosis, surgical planning, and monitoring of therapeutic responses.

In computed tomography (CT), an X-ray source and detector rotate around the patient, measuring the X-ray attenuation at many different angles. A computer uses this data to construct a cross-sectional image by the process of reconstruction. This technique is called "tomography". The term "computed" refers to the use of a computer to reconstruct the images.

CT has become an important tool in medical imaging and diagnosis, allowing radiologists and other physicians to view detailed internal images of the body. It can help identify many different medical conditions including cancer, heart disease, lung nodules, liver tumors, and internal injuries from trauma. CT is also commonly used for guiding biopsies and other minimally invasive procedures.

In summary, X-ray computed tomography (CT or CAT scan) is a medical imaging technique that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional images of the body. It provides detailed internal views of organs, bones, and soft tissues in the body, allowing physicians to diagnose and treat medical conditions.

A pandemic is a global outbreak of a disease that spreads easily from person to person across a large region, such as multiple continents or worldwide. It is declared by the World Health Organization (WHO) when the spread of a disease poses a significant threat to the global population due to its severity and transmissibility.

Pandemics typically occur when a new strain of virus emerges that has not been previously seen in humans, for which there is little or no pre-existing immunity. This makes it difficult to control the spread of the disease, as people do not have natural protection against it. Examples of pandemics include the 1918 Spanish flu pandemic and the more recent COVID-19 pandemic caused by the SARS-CoV-2 virus.

During a pandemic, healthcare systems can become overwhelmed, and there may be significant social and economic disruption as governments take measures to slow the spread of the disease, such as travel restrictions, quarantines, and lockdowns. Effective vaccines and treatments are critical in controlling the spread of pandemics and reducing their impact on public health.

Closed-circuit anesthesia is a type of anesthesia delivery system in which the exhaled gases from the patient are rebreathed after being scrubbed of carbon dioxide and reoxygenated. This is different from open-circuit anesthesia, where the exhaled gases are vented out of the system and fresh gas is continuously supplied to the patient.

In a closed-circuit anesthesia system, the amount of anesthetic agent used can be more precisely controlled, which can lead to a reduction in overall drug usage and potentially fewer side effects for the patient. Additionally, because the exhaled gases are reused, there is less waste and a smaller environmental impact.

Closed-circuit anesthesia systems typically consist of a breathing system, an anesthetic vaporizer, a soda lime canister to remove carbon dioxide, a ventilator to assist with breathing if necessary, and monitors to track the patient's vital signs. These systems are commonly used in veterinary medicine and in human surgery where long-term anesthesia is required.

Thoracic diseases refer to a range of medical conditions that affect the thorax, which is the part of the body that includes the chest cage, lungs, pleura (lining of the lungs), mediastinum (the area between the lungs), and diaphragm. Examples of thoracic diseases include:

1. Chronic obstructive pulmonary disease (COPD): A progressive lung disease characterized by difficulty breathing, cough, and sputum production.
2. Asthma: A chronic inflammatory disorder of the airways that causes wheezing, shortness of breath, chest tightness, and coughing.
3. Lung cancer: A malignant tumor that forms in the tissues of the lungs, usually in the cells lining the air passages.
4. Pneumonia: An infection of the lung tissue that can be caused by bacteria, viruses, or fungi.
5. Tuberculosis (TB): A bacterial infection that mainly affects the lungs but can also affect other parts of the body.
6. Pleural effusion: An abnormal accumulation of fluid in the pleural space between the lungs and the chest wall.
7. Pneumothorax: A collection of air in the pleural space that causes the lung to collapse.
8. Lung fibrosis: A condition characterized by scarring and thickening of the lung tissue, leading to difficulty breathing.
9. Esophageal cancer: A malignant tumor that forms in the tissues of the esophagus, the tube that connects the throat to the stomach.
10. Thoracic aortic aneurysm: A bulging or weakened area in the wall of the thoracic aorta, the largest artery in the body.

These are just a few examples of thoracic diseases, and there are many others that can affect the chest and lungs.

Pulmonary fibrosis is a specific type of lung disease that results from the thickening and scarring of the lung tissues, particularly those in the alveoli (air sacs) and interstitium (the space around the air sacs). This scarring makes it harder for the lungs to properly expand and transfer oxygen into the bloodstream, leading to symptoms such as shortness of breath, coughing, fatigue, and eventually respiratory failure. The exact cause of pulmonary fibrosis can vary, with some cases being idiopathic (without a known cause) or related to environmental factors, medications, medical conditions, or genetic predisposition.

The Predictive Value of Tests, specifically the Positive Predictive Value (PPV) and Negative Predictive Value (NPV), are measures used in diagnostic tests to determine the probability that a positive or negative test result is correct.

Positive Predictive Value (PPV) is the proportion of patients with a positive test result who actually have the disease. It is calculated as the number of true positives divided by the total number of positive results (true positives + false positives). A higher PPV indicates that a positive test result is more likely to be a true positive, and therefore the disease is more likely to be present.

Negative Predictive Value (NPV) is the proportion of patients with a negative test result who do not have the disease. It is calculated as the number of true negatives divided by the total number of negative results (true negatives + false negatives). A higher NPV indicates that a negative test result is more likely to be a true negative, and therefore the disease is less likely to be present.

The predictive value of tests depends on the prevalence of the disease in the population being tested, as well as the sensitivity and specificity of the test. A test with high sensitivity and specificity will generally have higher predictive values than a test with low sensitivity and specificity. However, even a highly sensitive and specific test can have low predictive values if the prevalence of the disease is low in the population being tested.

Sputum is defined as a mixture of saliva and phlegm that is expelled from the respiratory tract during coughing, sneezing or deep breathing. It can be clear, mucoid, or purulent (containing pus) depending on the underlying cause of the respiratory issue. Examination of sputum can help diagnose various respiratory conditions such as infections, inflammation, or other lung diseases.

Brain death is a legal and medical determination that an individual has died because their brain has irreversibly lost all functions necessary for life. It is characterized by the absence of brainstem reflexes, unresponsiveness to stimuli, and the inability to breathe without mechanical support. Brain death is different from a vegetative state or coma, where there may still be some brain activity.

The determination of brain death involves a series of tests and examinations to confirm the absence of brain function. These tests are typically performed by trained medical professionals and may include clinical assessments, imaging studies, and electroencephalograms (EEGs) to confirm the absence of electrical activity in the brain.

Brain death is an important concept in medicine because it allows for the organ donation process to proceed, potentially saving the lives of others. In many jurisdictions, brain death is legally equivalent to cardiopulmonary death, which means that once a person has been declared brain dead, they are considered deceased and their organs can be removed for transplantation.

"Evaluation studies" is a broad term that refers to the systematic assessment or examination of a program, project, policy, intervention, or product. The goal of an evaluation study is to determine its merits, worth, and value by measuring its effects, efficiency, and impact. There are different types of evaluation studies, including formative evaluations (conducted during the development or implementation of a program to provide feedback for improvement), summative evaluations (conducted at the end of a program to determine its overall effectiveness), process evaluations (focusing on how a program is implemented and delivered), outcome evaluations (assessing the short-term and intermediate effects of a program), and impact evaluations (measuring the long-term and broad consequences of a program).

In medical contexts, evaluation studies are often used to assess the safety, efficacy, and cost-effectiveness of new treatments, interventions, or technologies. These studies can help healthcare providers make informed decisions about patient care, guide policymakers in developing evidence-based policies, and promote accountability and transparency in healthcare systems. Examples of evaluation studies in medicine include randomized controlled trials (RCTs) that compare the outcomes of a new treatment to those of a standard or placebo treatment, observational studies that examine the real-world effectiveness and safety of interventions, and economic evaluations that assess the costs and benefits of different healthcare options.

A "University Hospital" is a type of hospital that is often affiliated with a medical school or university. These hospitals serve as major teaching institutions where medical students, residents, and fellows receive their training and education. They are equipped with advanced medical technology and resources to provide specialized and tertiary care services. University hospitals also conduct research and clinical trials to advance medical knowledge and practices. Additionally, they often treat complex and rare cases and provide a wide range of medical services to the community.

Pulmonary edema is a medical condition characterized by the accumulation of fluid in the alveoli (air sacs) and interstitial spaces (the area surrounding the alveoli) within the lungs. This buildup of fluid can lead to impaired gas exchange, resulting in shortness of breath, coughing, and difficulty breathing, especially when lying down. Pulmonary edema is often a complication of heart failure, but it can also be caused by other conditions such as pneumonia, trauma, or exposure to certain toxins.

In the early stages of pulmonary edema, patients may experience mild symptoms such as shortness of breath during physical activity. However, as the condition progresses, symptoms can become more severe and include:

* Severe shortness of breath, even at rest
* Wheezing or coughing up pink, frothy sputum
* Rapid breathing and heart rate
* Anxiety or restlessness
* Bluish discoloration of the skin (cyanosis) due to lack of oxygen

Pulmonary edema can be diagnosed through a combination of physical examination, medical history, chest X-ray, and other diagnostic tests such as echocardiography or CT scan. Treatment typically involves addressing the underlying cause of the condition, as well as providing supportive care such as supplemental oxygen, diuretics to help remove excess fluid from the body, and medications to help reduce anxiety and improve breathing. In severe cases, mechanical ventilation may be necessary to support respiratory function.

Klebsiella infections are caused by bacteria called Klebsiella spp., with the most common species being Klebsiella pneumoniae. These gram-negative, encapsulated bacilli are normal inhabitants of the human gastrointestinal tract and upper respiratory tract but can cause various types of infections when they spread to other body sites.

Commonly, Klebsiella infections include:

1. Pneumonia: This is a lung infection that can lead to symptoms like cough, chest pain, difficulty breathing, and fever. It often affects people with weakened immune systems, chronic lung diseases, or those who are hospitalized.

2. Urinary tract infections (UTIs): Klebsiella can cause UTIs, particularly in individuals with compromised urinary tracts, such as catheterized patients or those with structural abnormalities. Symptoms may include pain, burning during urination, frequent urges to urinate, and lower abdominal or back pain.

3. Bloodstream infections (bacteremia/septicemia): When Klebsiella enters the bloodstream, it can cause bacteremia or septicemia, which can lead to sepsis, a life-threatening condition characterized by an overwhelming immune response to infection. Symptoms may include fever, chills, rapid heart rate, and rapid breathing.

4. Wound infections: Klebsiella can infect wounds, particularly in patients with open surgical wounds or traumatic injuries. Infected wounds may display redness, swelling, pain, pus discharge, and warmth.

5. Soft tissue infections: These include infections of the skin and underlying soft tissues, such as cellulitis and abscesses. Symptoms can range from localized redness, swelling, and pain to systemic symptoms like fever and malaise.

Klebsiella infections are increasingly becoming difficult to treat due to their resistance to multiple antibiotics, including carbapenems, which has led to the term "carbapenem-resistant Enterobacteriaceae" (CRE) or "carbapenem-resistant Klebsiella pneumoniae" (CRKP). These infections often require the use of last-resort antibiotics like colistin and tigecycline. Infection prevention measures, such as contact precautions, hand hygiene, and environmental cleaning, are crucial to controlling the spread of Klebsiella in healthcare settings.

Doxapram is a central stimulant drug that acts on the respiratory system. It is primarily used to stimulate breathing and promote wakefulness in patients who have reduced levels of consciousness or are experiencing respiratory depression due to various causes, such as anesthesia or medication overdose.

Doxapram works by stimulating the respiratory center in the brainstem, increasing the rate and depth of breathing. It also has a mild stimulant effect on the central nervous system, which can help to promote wakefulness and alertness.

The drug is available in various forms, including injectable solutions and inhaled powders. It is typically administered under medical supervision in a hospital or clinical setting due to its potential for causing adverse effects such as agitation, anxiety, and increased heart rate and blood pressure.

It's important to note that doxapram should only be used under the direction of a healthcare professional, as improper use can lead to serious complications.

Hypoalbuminemia is a medical condition characterized by having lower than normal levels of albumin in the blood. Albumin is a type of protein produced by the liver, and it plays a crucial role in maintaining oncotic pressure (the force that keeps fluid inside blood vessels) and transporting various substances throughout the body.

A serum albumin level below 3.5 g/dL (grams per deciliter) is generally considered hypoalbuminemia, although some laboratories may define it as a level below 3.4 g/dL or even lower. This condition can be caused by various factors, including liver disease, malnutrition, kidney disease, inflammation, and protein-losing enteropathy (a disorder that causes excessive loss of protein in the gastrointestinal tract).

Hypoalbuminemia is often associated with poorer clinical outcomes in several medical conditions, such as increased risk of infection, longer hospital stays, and higher mortality rates. It's essential to identify and address the underlying cause of hypoalbuminemia for appropriate treatment and improved patient outcomes.

Bronchodilators are medications that relax and widen the airways (bronchioles) in the lungs, making it easier to breathe. They work by relaxing the smooth muscle around the airways, which allows them to dilate or open up. This results in improved airflow and reduced symptoms of bronchoconstriction, such as wheezing, coughing, and shortness of breath.

Bronchodilators can be classified into two main types: short-acting and long-acting. Short-acting bronchodilators are used for quick relief of symptoms and last for 4 to 6 hours, while long-acting bronchodilators are used for maintenance therapy and provide symptom relief for 12 hours or more.

Examples of bronchodilator agents include:

* Short-acting beta-agonists (SABAs) such as albuterol, levalbuterol, and pirbuterol
* Long-acting beta-agonists (LABAs) such as salmeterol, formoterol, and indacaterol
* Anticholinergics such as ipratropium, tiotropium, and aclidinium
* Combination bronchodilators that contain both a LABA and an anticholinergic, such as umeclidinium/vilanterol and glycopyrrolate/formoterol.

"Right to Die" is not a medical term per se, but it's a concept that has significant implications in medical ethics and patient care. It generally refers to the right of a competent, terminally ill individual to choose to end their life in a humane and dignified manner, usually through physician-assisted suicide or euthanasia. This decision is typically made when the individual experiences unbearable suffering and believes that death is preferable to continued living.

The right to die raises complex ethical, legal, and medical issues related to autonomy, informed consent, palliative care, and end-of-life decision-making. It's important to note that while some jurisdictions have laws allowing physician-assisted suicide or euthanasia under specific circumstances, others do not, reflecting the ongoing debate about this issue in society.

"Klebsiella pneumoniae" is a medical term that refers to a type of bacteria belonging to the family Enterobacteriaceae. It's a gram-negative, encapsulated, non-motile, rod-shaped bacterium that can be found in various environments, including soil, water, and the gastrointestinal tracts of humans and animals.

"Klebsiella pneumoniae" is an opportunistic pathogen that can cause a range of infections, particularly in individuals with weakened immune systems or underlying medical conditions. It's a common cause of healthcare-associated infections, such as pneumonia, urinary tract infections, bloodstream infections, and wound infections.

The bacterium is known for its ability to produce a polysaccharide capsule that makes it resistant to phagocytosis by white blood cells, allowing it to evade the host's immune system. Additionally, "Klebsiella pneumoniae" has developed resistance to many antibiotics, making infections caused by this bacterium difficult to treat and a growing public health concern.

Guideline adherence, in the context of medicine, refers to the extent to which healthcare professionals follow established clinical practice guidelines or recommendations in their daily practice. These guidelines are systematically developed statements designed to assist practitioners and patient decisions about appropriate health care for specific clinical circumstances. Adherence to evidence-based guidelines can help improve the quality of care, reduce unnecessary variations in practice, and promote optimal patient outcomes. Factors that may influence guideline adherence include clinician awareness, familiarity, agreement, self-efficacy, outcome expectancy, and the complexity of the recommendation.

"Pseudomonas aeruginosa" is a medically important, gram-negative, rod-shaped bacterium that is widely found in the environment, such as in soil, water, and on plants. It's an opportunistic pathogen, meaning it usually doesn't cause infection in healthy individuals but can cause severe and sometimes life-threatening infections in people with weakened immune systems, burns, or chronic lung diseases like cystic fibrosis.

P. aeruginosa is known for its remarkable ability to resist many antibiotics and disinfectants due to its intrinsic resistance mechanisms and the acquisition of additional resistance determinants. It can cause various types of infections, including respiratory tract infections, urinary tract infections, gastrointestinal infections, dermatitis, and severe bloodstream infections known as sepsis.

The bacterium produces a variety of virulence factors that contribute to its pathogenicity, such as exotoxins, proteases, and pigments like pyocyanin and pyoverdine, which aid in iron acquisition and help the organism evade host immune responses. Effective infection control measures, appropriate use of antibiotics, and close monitoring of high-risk patients are crucial for managing P. aeruginosa infections.

Respiratory physiological phenomena refer to the various mechanical, chemical, and biological processes and functions that occur in the respiratory system during breathing and gas exchange. These phenomena include:

1. Ventilation: The movement of air into and out of the lungs, which is achieved through the contraction and relaxation of the diaphragm and intercostal muscles.
2. Gas Exchange: The diffusion of oxygen (O2) from the alveoli into the bloodstream and carbon dioxide (CO2) from the bloodstream into the alveoli.
3. Respiratory Mechanics: The physical properties and forces that affect the movement of air in and out of the lungs, such as lung compliance, airway resistance, and chest wall elasticity.
4. Control of Breathing: The regulation of ventilation by the central nervous system through the integration of sensory information from chemoreceptors and mechanoreceptors in the respiratory system.
5. Acid-Base Balance: The maintenance of a stable pH level in the blood through the regulation of CO2 elimination and bicarbonate balance by the respiratory and renal systems.
6. Oxygen Transport: The binding of O2 to hemoglobin in the red blood cells and its delivery to the tissues for metabolic processes.
7. Defense Mechanisms: The various protective mechanisms that prevent the entry and colonization of pathogens and foreign particles into the respiratory system, such as mucociliary clearance, cough reflex, and immune responses.

Haemophilus infections are caused by bacteria named Haemophilus influenzae. Despite its name, this bacterium does not cause the flu, which is caused by a virus. There are several different strains of Haemophilus influenzae, and some are more likely to cause severe illness than others.

Haemophilus infections can affect people of any age, but they are most common in children under 5 years old. The bacteria can cause a range of infections, from mild ear infections to serious conditions such as meningitis (inflammation of the membranes surrounding the brain and spinal cord) and pneumonia (infection of the lungs).

The bacterium is spread through respiratory droplets when an infected person coughs or sneezes. It can also be spread by touching contaminated surfaces and then touching the mouth, nose, or eyes.

Prevention measures include good hygiene practices such as handwashing, covering the mouth and nose when coughing or sneezing, and avoiding close contact with people who are sick. Vaccination is also available to protect against Haemophilus influenzae type b (Hib) infections, which are the most severe and common form of Haemophilus infection.

Opportunistic infections (OIs) are infections that occur more frequently or are more severe in individuals with weakened immune systems, often due to a underlying condition such as HIV/AIDS, cancer, or organ transplantation. These infections are caused by microorganisms that do not normally cause disease in people with healthy immune function, but can take advantage of an opportunity to infect and cause damage when the body's defense mechanisms are compromised. Examples of opportunistic infections include Pneumocystis pneumonia, tuberculosis, candidiasis (thrush), and cytomegalovirus infection. Preventive measures, such as antimicrobial medications and vaccinations, play a crucial role in reducing the risk of opportunistic infections in individuals with weakened immune systems.

Insufflation is a medical term that refers to the act of introducing a gas or vapor into a body cavity or passage, typically through a tube or surgical instrument. This procedure is often used in medical and surgical settings for various purposes, such as:

* To administer anesthesia during surgery (e.g., introducing nitrous oxide or other gases into the lungs)
* To introduce medication or other substances into the body (e.g., insufflating steroids into a joint)
* To perform diagnostic procedures (e.g., insufflating air or a contrast agent into the gastrointestinal tract to visualize it with X-rays)
* To clean out a body cavity (e.g., irrigating and insufflating the bladder during urological procedures).

It's important to note that insufflation should be performed under controlled conditions, as there are potential risks associated with introducing gases or vapors into the body, such as barotrauma (damage caused by changes in pressure) and infection.

Resuscitation is a medical term that refers to the process of reversing cardiopulmonary arrest or preventing further deterioration of someone in cardiac or respiratory arrest. It involves a series of interventions aimed at restoring spontaneous blood circulation and breathing, thereby preventing or minimizing tissue damage due to lack of oxygen.

The most common form of resuscitation is cardiopulmonary resuscitation (CPR), which combines chest compressions to manually pump blood through the body with rescue breaths to provide oxygen to the lungs. In a hospital setting, more advanced techniques such as defibrillation, medication administration, and intubation may also be used as part of the resuscitation process.

The goal of resuscitation is to stabilize the patient's condition and prevent further harm while treating the underlying cause of the arrest. Successful resuscitation can lead to a full recovery or, in some cases, result in varying degrees of neurological impairment depending on the severity and duration of the cardiac or respiratory arrest.

Prognosis is a medical term that refers to the prediction of the likely outcome or course of a disease, including the chances of recovery or recurrence, based on the patient's symptoms, medical history, physical examination, and diagnostic tests. It is an important aspect of clinical decision-making and patient communication, as it helps doctors and patients make informed decisions about treatment options, set realistic expectations, and plan for future care.

Prognosis can be expressed in various ways, such as percentages, categories (e.g., good, fair, poor), or survival rates, depending on the nature of the disease and the available evidence. However, it is important to note that prognosis is not an exact science and may vary depending on individual factors, such as age, overall health status, and response to treatment. Therefore, it should be used as a guide rather than a definitive forecast.

Albuterol is a medication that is used to treat bronchospasm, or narrowing of the airways in the lungs, in conditions such as asthma and chronic obstructive pulmonary disease (COPD). It is a short-acting beta-2 agonist, which means it works by relaxing the muscles around the airways, making it easier to breathe. Albuterol is available in several forms, including an inhaler, nebulizer solution, and syrup, and it is typically used as needed to relieve symptoms of bronchospasm. It may also be used before exercise to prevent bronchospasm caused by physical activity.

The medical definition of Albuterol is: "A short-acting beta-2 adrenergic agonist used to treat bronchospasm in conditions such as asthma and COPD. It works by relaxing the muscles around the airways, making it easier to breathe."

Practice guidelines, also known as clinical practice guidelines, are systematically developed statements that aim to assist healthcare professionals and patients in making informed decisions about appropriate health care for specific clinical circumstances. They are based on a thorough evaluation of the available scientific evidence, consensus of expert opinion, and consideration of patient preferences. Practice guidelines can cover a wide range of topics, including diagnosis, management, prevention, and treatment options for various medical conditions. They are intended to improve the quality and consistency of care, reduce unnecessary variations in practice, and promote evidence-based medicine. However, they should not replace clinical judgment or individualized patient care.

Home nursing, also known as home health care or homecare nursing, refers to medical care or assistance provided by registered nurses, licensed practical nurses, or nursing assistants in the patient's home. This type of care is often prescribed for patients who are recovering from surgery, illness, or injury and require skilled nursing services, wound care, medication management, pain control, or other health-related services. Home nursing can also include assistance with personal care tasks such as bathing, dressing, and grooming. The goal of home nursing is to help patients manage their health conditions, recover more quickly, and maintain their independence while receiving high-quality medical care in the comfort of their own homes.

Airway management is a set of procedures and techniques used to maintain or restore the flow of air into and out of the lungs, ensuring adequate ventilation and oxygenation of the body. This is critical in medical emergencies such as respiratory arrest, cardiac arrest, trauma, and other situations where a patient may have difficulty breathing on their own.

Airway management includes various interventions, such as:

1. Basic airway maneuvers: These include chin lift, jaw thrust, and suctioning to clear the airway of obstructions.
2. Use of adjuncts: Devices like oropharyngeal (OPA) and nasopharyngeal airways (NPA) can be used to maintain an open airway.
3. Bag-valve-mask (BVM) ventilation: This is a technique where a mask is placed over the patient's face, and positive pressure is applied to the bag to help move air in and out of the lungs.
4. Endotracheal intubation: A flexible plastic tube is inserted through the mouth or nose and advanced into the trachea (windpipe) to secure the airway and allow for mechanical ventilation.
5. Supraglottic airway devices (SADs): These are alternatives to endotracheal intubation, such as laryngeal mask airways (LMAs), that provide a temporary seal over the upper airway to facilitate ventilation.
6. Surgical airway: In rare cases, when other methods fail or are not possible, a surgical airway may be established by creating an opening through the neck (cricothyrotomy or tracheostomy) to access the trachea directly.

Proper airway management requires knowledge of anatomy, understanding of various techniques and devices, and the ability to quickly assess and respond to changing clinical situations. Healthcare professionals, such as physicians, nurses, respiratory therapists, and paramedics, receive extensive training in airway management to ensure competency in managing this critical aspect of patient care.

Multiple trauma, also known as polytrauma, is a medical term used to describe severe injuries to the body that are sustained in more than one place or region. It often involves damage to multiple organ systems and can be caused by various incidents such as traffic accidents, falls from significant heights, high-energy collisions, or violent acts.

The injuries sustained in multiple trauma may include fractures, head injuries, internal bleeding, chest and abdominal injuries, and soft tissue injuries. These injuries can lead to a complex medical situation requiring immediate and ongoing care from a multidisciplinary team of healthcare professionals, including emergency physicians, trauma surgeons, critical care specialists, nurses, rehabilitation therapists, and mental health providers.

Multiple trauma is a serious condition that can result in long-term disability or even death if not treated promptly and effectively.

Bronchopulmonary dysplasia (BPD) is a chronic lung disease that primarily affects premature infants. It is defined as the need for supplemental oxygen at 28 days of life or beyond, due to abnormal development and injury to the lungs.

The condition was first described in the 1960s, following the introduction of mechanical ventilation and high concentrations of oxygen therapy for premature infants with respiratory distress syndrome (RDS). These treatments, while lifesaving, can also cause damage to the delicate lung tissue, leading to BPD.

The pathogenesis of BPD is complex and involves an interplay between genetic factors, prenatal exposures, and postnatal injury from mechanical ventilation and oxygen toxicity. Inflammation, oxidative stress, and impaired lung development contribute to the development of BPD.

Infants with BPD typically have abnormalities in their airways, alveoli (air sacs), and blood vessels in the lungs. These changes can lead to symptoms such as difficulty breathing, wheezing, coughing, and poor growth. Treatment may include oxygen therapy, bronchodilators, corticosteroids, diuretics, and other medications to support lung function and minimize complications.

The prognosis for infants with BPD varies depending on the severity of the disease and associated medical conditions. While some infants recover completely, others may have long-term respiratory problems that require ongoing management.

The Ventilation-Perfusion (V/Q) ratio is a measure used in respiratory physiology to describe the relationship between the amount of air that enters the alveoli (ventilation) and the amount of blood that reaches the alveoli to pick up oxygen (perfusion).

In a healthy lung, these two processes are well-matched, meaning that well-ventilated areas of the lung also have good blood flow. This results in a V/Q ratio close to 1.0.

However, certain lung conditions such as emphysema or pulmonary embolism can cause ventilation and perfusion to become mismatched, leading to a V/Q ratio that is either higher (ventilation exceeds perfusion) or lower (perfusion exceeds ventilation) than normal. This mismatch can result in impaired gas exchange and lead to hypoxemia (low oxygen levels in the blood).

The V/Q ratio is often used in clinical settings to assess lung function and diagnose respiratory disorders.

Silver Sulfadiazine is a topical antimicrobial cream, primarily used for the prevention and treatment of burn wounds' infections. It has broad-spectrum activity against various bacteria, including gram-positive and gram-negative organisms, as well as some fungi. The cream creates a physical barrier that helps minimize bacterial growth and contains silver, which has antimicrobial properties. Silver Sulfadiazine is often used in combination with other burn wound care treatments to optimize healing and reduce the risk of complications such as sepsis.

The medical definition of Silver Sulfadiazine can be stated as:

A topical antimicrobial agent, chemically described as silver(I) 1-(4-amino-2-sulfonylphenyl)-2-(N-pyrimidin-2-ylsulfamoyl)ethanone dihydrate. It is primarily used for the prevention and treatment of infections associated with burn wounds due to its broad-spectrum antibacterial and antifungal properties. The compound is available as a white cream, which forms a protective layer on the wound, releasing silver ions that inhibit bacterial growth and promote healing.

Thoracic injuries refer to damages or traumas that occur in the thorax, which is the part of the body that contains the chest cavity. The thorax houses vital organs such as the heart, lungs, esophagus, trachea, and major blood vessels. Thoracic injuries can range from blunt trauma, caused by impacts or compressions, to penetrating trauma, resulting from stabbing or gunshot wounds. These injuries may cause various complications, including but not limited to:

1. Hemothorax - bleeding into the chest cavity
2. Pneumothorax - collapsed lung due to air accumulation in the chest cavity
3. Tension pneumothorax - a life-threatening condition where trapped air puts pressure on the heart and lungs, impairing their function
4. Cardiac tamponade - compression of the heart caused by blood or fluid accumulation in the pericardial sac
5. Rib fractures, which can lead to complications like punctured lungs or internal bleeding
6. Tracheobronchial injuries, causing air leaks and difficulty breathing
7. Great vessel injuries, potentially leading to massive hemorrhage and hemodynamic instability

Immediate medical attention is required for thoracic injuries, as they can quickly become life-threatening due to the vital organs involved. Treatment may include surgery, chest tubes, medications, or supportive care, depending on the severity and type of injury.

Inhalational anesthesia is a type of general anesthesia that is induced by the inhalation of gases or vapors. It is administered through a breathing system, which delivers the anesthetic agents to the patient via a face mask, laryngeal mask airway, or endotracheal tube.

The most commonly used inhalational anesthetics include nitrous oxide, sevoflurane, isoflurane, and desflurane. These agents work by depressing the central nervous system, causing a reversible loss of consciousness, amnesia, analgesia, and muscle relaxation.

The depth of anesthesia can be easily adjusted during the procedure by changing the concentration of the anesthetic agent. Once the procedure is complete, the anesthetic agents are eliminated from the body through exhalation, allowing for a rapid recovery.

Inhalational anesthesia is commonly used in a wide range of surgical procedures due to its ease of administration, quick onset and offset of action, and ability to rapidly adjust the depth of anesthesia. However, it requires careful monitoring and management by trained anesthesia providers to ensure patient safety and optimize outcomes.

Chest tubes are medical devices that are inserted into the chest cavity to drain fluid, air, or blood. They are typically used to treat conditions such as pneumothorax (collapsed lung), hemothorax (blood in the chest cavity), pleural effusion (excess fluid in the chest cavity), and chylothorax (milky fluid in the chest cavity).

Chest tubes are usually inserted between the ribs and directed into the chest cavity, allowing for drainage of the affected area. The tubes are connected to a collection system that creates negative pressure, which helps to remove the air or fluid from the chest cavity.

The size and number of chest tubes used may vary depending on the severity and location of the condition being treated. Chest tubes are typically removed once the underlying condition has been resolved and the drainage has decreased to a minimal amount.

Membrane oxygenators are medical devices used in extracorporeal life support (ECLS) systems to provide gas exchange for patients with severe respiratory or cardiac failure. These devices contain semi-permeable membranes that allow for the diffusion of oxygen and carbon dioxide between the patient's blood and the surrounding gas.

The membrane oxygenator is composed of three main components: the blood compartment, the gas compartment, and the membrane itself. The blood compartment is where the patient's blood flows and comes into contact with the membrane. The gas compartment contains a sweep gas (usually pure oxygen) that flows on the other side of the membrane.

The semi-permeable membrane allows for the diffusion of gases between the two compartments, with oxygen moving from the gas compartment to the blood compartment and carbon dioxide moving in the opposite direction. This process helps to maintain adequate oxygenation and ventilation for the patient while their own respiratory or cardiac function is compromised.

Membrane oxygenators are often used in procedures such as extracorporeal membrane oxygenation (ECMO) and cardiopulmonary bypass (CPB) during heart surgery. They offer several advantages over traditional bubble oxygenators, including reduced risk of hemolysis, improved gas exchange efficiency, and lower priming volumes. However, they also require careful monitoring and maintenance to ensure proper function and prevent complications such as clotting or infection.

Pneumovirus infections refer to respiratory illnesses caused by viruses belonging to the Pneumoviridae family, specifically human respirovirus (hRSV) and human metapneumovirus (hMPV). These viruses primarily infect the respiratory tract and can cause a wide range of symptoms, from mild upper respiratory tract infections to severe lower respiratory tract illnesses such as bronchiolitis and pneumonia.

Human respirovirus (hRSV) is a leading cause of bronchiolitis and pneumonia in infants and young children, while human metapneumovirus (hMPV) tends to infect older children and adults, causing similar respiratory symptoms. Both viruses can also cause more severe disease in immunocompromised individuals, the elderly, and those with underlying medical conditions.

Transmission of these viruses typically occurs through close contact with infected individuals or contaminated surfaces, and they are highly contagious. Preventive measures include good hygiene practices, such as frequent handwashing and avoiding close contact with sick individuals. Currently, there are no vaccines available to prevent pneumovirus infections, but antiviral treatments and supportive care can help manage the symptoms and reduce the risk of complications.

"Pneumocystis infection" is most commonly caused by the microorganism Pneumocystis jirovecii, which can lead to a serious lung infection known as pneumocystis pneumonia (PCP). This infection primarily affects individuals with weakened immune systems, such as those with HIV/AIDS, cancer, or organ transplant recipients.

The microorganism that causes Pneumocystis infections was previously classified as a protozoan but is now considered a fungus. It exists in the environment and can be found in the lungs of healthy individuals without causing illness. However, in people with compromised immune systems, it can replicate and cause pneumonia, which can be life-threatening if not treated promptly.

Symptoms of PCP include cough, shortness of breath, fever, and difficulty breathing. Diagnosis typically involves microscopic examination of respiratory samples, such as sputum or lung fluid, to detect the presence of the organism. Treatment usually consists of antimicrobial medications, such as trimethoprim-sulfamethoxazole (TMP-SMX), pentamidine, or atovaquone. Preventive measures, such as prophylaxis with TMP-SMX or other medications, may be recommended for individuals at high risk of developing PCP.

Medical survival rate is a statistical measure used to determine the percentage of patients who are still alive for a specific period of time after their diagnosis or treatment for a certain condition or disease. It is often expressed as a five-year survival rate, which refers to the proportion of people who are alive five years after their diagnosis. Survival rates can be affected by many factors, including the stage of the disease at diagnosis, the patient's age and overall health, the effectiveness of treatment, and other health conditions that the patient may have. It is important to note that survival rates are statistical estimates and do not necessarily predict an individual patient's prognosis.

Hypoventilation is a medical condition that refers to the decreased rate and depth of breathing, which leads to an inadequate exchange of oxygen and carbon dioxide in the lungs. As a result, there is an increase in the levels of carbon dioxide (hypercapnia) and a decrease in the levels of oxygen (hypoxemia) in the blood. Hypoventilation can occur due to various reasons such as respiratory muscle weakness, sedative or narcotic overdose, chest wall deformities, neuromuscular disorders, obesity hypoventilation syndrome, and sleep-disordered breathing. Prolonged hypoventilation can lead to serious complications such as respiratory failure, cardiac arrhythmias, and even death.

A lung abscess is a localized collection of pus in the lung parenchyma caused by an infectious process, often due to bacterial infection. It's characterized by necrosis and liquefaction of pulmonary tissue, resulting in a cavity filled with purulent material. The condition can develop as a complication of community-acquired or nosocomial pneumonia, aspiration of oral secretions containing anaerobic bacteria, septic embolism, or contiguous spread from a nearby infected site.

Symptoms may include cough with foul-smelling sputum, chest pain, fever, weight loss, and fatigue. Diagnosis typically involves imaging techniques such as chest X-ray or CT scan, along with microbiological examination of the sputum to identify the causative organism(s). Treatment often includes antibiotic therapy tailored to the identified pathogen(s), as well as supportive care such as bronchoscopy, drainage, or surgery in severe cases.

Benchmarking in the medical context refers to the process of comparing healthcare services, practices, or outcomes against a widely recognized standard or within best practice recommendations, with the aim of identifying areas for improvement and implementing changes to enhance the quality and efficiency of care. This can involve comparing data on various metrics such as patient satisfaction, clinical outcomes, costs, and safety measures. The goal is to continuously monitor and improve the quality of healthcare services provided to patients.

Low birth weight is a term used to describe babies who are born weighing less than 5 pounds, 8 ounces (2,500 grams). It's often defined as a birth weight of 2,499 grams or less. This can be further categorized into very low birth weight (less than 1,500 grams) and extremely low birth weight (less than 1,000 grams). Low birth weight is most commonly caused by premature birth, but it can also be caused by growth restriction in the womb. These babies are at risk for numerous health complications, both in the short and long term.

Technology Assessment, Biomedical is defined as the systematic evaluation of biomedical technologies and techniques for their scientific validity, efficacy, effectiveness, cost-benefit, and impact on patient care, health system, and society. It involves a multidisciplinary and systematic approach to examining the medical, social, ethical, and economic implications of the use of new and existing biomedical technologies. The goal is to provide unbiased, evidence-based information to healthcare providers, patients, policymakers, and other stakeholders to inform decision making about the adoption, implementation, and dissemination of these technologies in clinical practice and health policy.

Postoperative care refers to the comprehensive medical treatment and nursing attention provided to a patient following a surgical procedure. The goal of postoperative care is to facilitate the patient's recovery, prevent complications, manage pain, ensure proper healing of the incision site, and maintain overall health and well-being until the patient can resume their normal activities.

This type of care includes monitoring vital signs, managing pain through medication or other techniques, ensuring adequate hydration and nutrition, helping the patient with breathing exercises to prevent lung complications, encouraging mobility to prevent blood clots, monitoring for signs of infection or other complications, administering prescribed medications, providing wound care, and educating the patient about postoperative care instructions.

The duration of postoperative care can vary depending on the type and complexity of the surgical procedure, as well as the individual patient's needs and overall health status. It may be provided in a hospital setting, an outpatient surgery center, or in the patient's home, depending on the level of care required.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

Hypnotics and sedatives are classes of medications that have depressant effects on the central nervous system, leading to sedation (calming or inducing sleep), reduction in anxiety, and in some cases, decreased awareness or memory. These agents work by affecting the neurotransmitter GABA (gamma-aminobutyric acid) in the brain, which results in inhibitory effects on neuronal activity.

Hypnotics are primarily used for the treatment of insomnia and other sleep disorders, while sedatives are often prescribed to manage anxiety or to produce a calming effect before medical procedures. Some medications can function as both hypnotics and sedatives, depending on the dosage and specific formulation. Common examples of these medications include benzodiazepines (such as diazepam and lorazepam), non-benzodiazepine hypnotics (such as zolpidem and eszopiclone), barbiturates, and certain antihistamines.

It is essential to use these medications under the guidance of a healthcare professional, as they can have potential side effects, such as drowsiness, dizziness, confusion, and impaired coordination. Additionally, long-term use or high doses may lead to tolerance, dependence, and withdrawal symptoms upon discontinuation.

"Swine" is a common term used to refer to even-toed ungulates of the family Suidae, including domestic pigs and wild boars. However, in a medical context, "swine" often appears in the phrase "swine flu," which is a strain of influenza virus that typically infects pigs but can also cause illness in humans. The 2009 H1N1 pandemic was caused by a new strain of swine-origin influenza A virus, which was commonly referred to as "swine flu." It's important to note that this virus is not transmitted through eating cooked pork products; it spreads from person to person, mainly through respiratory droplets produced when an infected person coughs or sneezes.

The Injury Severity Score (ISS) is a medical scoring system used to assess the severity of trauma in patients with multiple injuries. It's based on the Abbreviated Injury Scale (AIS), which classifies each injury by body region on a scale from 1 (minor) to 6 (maximum severity).

The ISS is calculated by summing the squares of the highest AIS score in each of the three most severely injured body regions. The possible ISS ranges from 0 to 75, with higher scores indicating more severe injuries. An ISS over 15 is generally considered a significant injury, and an ISS over 25 is associated with a high risk of mortality. It's important to note that the ISS has limitations, as it doesn't consider the number or type of injuries within each body region, only the most severe one.

Pasteurella infections are diseases caused by bacteria belonging to the genus Pasteurella, with P. multocida being the most common species responsible for infections in humans. These bacteria are commonly found in the upper respiratory tract and gastrointestinal tracts of animals, particularly domestic pets such as cats and dogs.

Humans can acquire Pasteurella infections through animal bites, scratches, or contact with contaminated animal secretions like saliva. The infection can manifest in various forms, including:

1. Skin and soft tissue infections: These are the most common types of Pasteurella infections, often presenting as cellulitis, abscesses, or wound infections after an animal bite or scratch.
2. Respiratory tract infections: Pasteurella bacteria can cause pneumonia, bronchitis, and other respiratory tract infections, especially in individuals with underlying lung diseases or weakened immune systems.
3. Ocular infections: Pasteurella bacteria can infect the eye, causing conditions like conjunctivitis, keratitis, or endophthalmitis, particularly after an animal scratch to the eye or face.
4. Septicemia: In rare cases, Pasteurella bacteria can enter the bloodstream and cause septicemia, a severe and potentially life-threatening condition.
5. Other infections: Pasteurella bacteria have also been known to cause joint infections (septic arthritis), bone infections (osteomyelitis), and central nervous system infections (meningitis or brain abscesses) in some cases.

Prompt diagnosis and appropriate antibiotic treatment are crucial for managing Pasteurella infections, as they can progress rapidly and lead to severe complications, particularly in individuals with compromised immune systems.

"Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU]) Event" (PDF). Centers for Disease ... "Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an update". ... Ventilator-associated pneumonia (VAP) is a type of lung infection that occurs in people who are on mechanical ventilation ... Diagnosis of ventilator-associated pneumonia is difficult and is not standardized. The criteria used for diagnosis of VAP ...
... ventilator-associated pneumonia; and norovirus. The MTG called on the government to develop a strategy for using technology for ...
Ventilator-associated pneumonia is specifically defined as pneumonia that arises more than 48 to 72 hours after endotracheal ... Pneumonia seen by ultrasound Pneumonia seen by ultrasound Pneumonia seen by ultrasound Right middle lobe pneumonia in a child ... Viral pneumonia presents more commonly with wheezing than bacterial pneumonia. Pneumonia was historically divided into "typical ... X-ray presentations of pneumonia may be classified as lobar pneumonia, bronchopneumonia, lobular pneumonia, and interstitial ...
Uc Kay, I.; Ahmed, Q. A.; Sax, H.; Pittet, D. (2008). "Ventilator-Associated Pneumonia as a Quality Indicator for Patient ... Ventilator-associated pneumonia Fischer, Joachim E; Janousek, Martin; Nadal, David; Fanconi, Sergio (1998). "Diagnostic ... 2006). "A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia". American Journal of ... Pittet, D; Zingg, W (2010). "Reducing ventilator-associated pneumonia: When process control allows outcome improvement and even ...
Bouadma, L.; Wolff, M.; Lucet, J.C. (August 2012). "Ventilator-associated pneumonia and its prevention". Current Opinion in ... where evidence suggests it reduces ventilator-associated pneumonia). The silver ion is bioactive and in sufficient ...
Ventilator-associated pneumonia (VAP) is a sub-type of hospital-acquired pneumonia (HAP) which occurs in people who are ... Hospital-acquired pneumonia (HAP) or nosocomial pneumonia refers to any pneumonia contracted by a patient in a hospital at ... than community-acquired pneumonia but more frequently than hospital-acquired pneumonia and ventilator-associated pneumonia. In ... In suspected ventilator-associated pneumonia it has been suggested that bronchoscopy or bronchoalveolar lavage is necessary ...
Bouadma L, Wolff M, Lucet JC (August 2012). "Ventilator-associated pneumonia and its prevention". Current Opinion in Infectious ... "Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia". ... "Silver-coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patients". The Cochrane ... "Silver-coated endotracheal tube versus non-coated endotracheal tube for preventing ventilator-associated pneumonia among adults ...
On December 9, 2022, it was reported that Margera was hospitalized and put on a ventilator in a San Diego ICU due to pneumonia ... "Bam Margera Hospitalized with Pneumonia and Put On Ventilator". TMZ. December 9, 2022. Retrieved December 9, 2022. Margera, Bam ...
January 2021). "Ventilator-associated pneumonia in critically ill patients with COVID-19". Critical Care. 25 (1): 25. doi: ... June 2022). "Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 ... press release announcing preliminary results that the drug could reduce deaths by about a third in participants on ventilators ... stating that dexamethasone improves survival rates of hospitalized patients with COVID-19 receiving oxygen or on a ventilator. ...
Besides having cardiac problems, Thilakan was suffering from pneumonia. He was put on a ventilator and died on 24 September ...
"Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study". The European Respiratory ... Liu D, Su LX, Guan W, Xiao K, Xie LX (February 2016). "Prognostic value of procalcitonin in pneumonia: A systematic review and ... This was apparent without an increase in ventilator days or risk of intubation. Be that acute asthma exacerbation is one ... The value in these protocols are evident since a high PCT level correlates with increased mortality in critically ill pneumonia ...
... aureus ventilator-associated pneumonia). Antibody treatments act by binding to and neutralizing bacterial exotoxins and other ... Antisense RNA-based treatment has been shown to be effective in in vivo models of P. aeruginosa pneumonia. In addition to ... "Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults". The Cochrane ... particularly in HIV cases to prevent pneumonia), those taking immunosuppressive drugs, cancer patients, and those having ...
... bacterial pneumonia: Oral hygiene care for critically ill patients has been reported to reduce the risk of ventilator- ... "Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia". The Cochrane Database of Systematic ... For the elderly, wearing a denture during sleep has been proven to greatly increase the risk of pneumonia. It is now ... March 2015). "Denture wearing during sleep doubles the risk of pneumonia in the very elderly". Journal of Dental Research. 94 ( ...
He had pneumonia in both the lungs along with liver and kidney dysfunction. There was no cold exposure related frostbite or ... He was placed on Ventilator. His health was critical, but news of his survival gave family members a chance to celebrate. Nine ...
He was admitted to Max Saket and was later put on a ventilator. He died after 4 days on the ventilator, on 4 February 2020.[[ ... He also suffered a spinal injury and later developed pneumonia in January 2020. ...
He was on a ventilator for several days while also suffering from pneumonia. In response, King's X compiled an exclusive live ...
2012). "Bilateral versus unilateral bronchoalveolar lavage for the diagnosis of ventilator-associated pneumonia". Surgical ... pneumonia in people on ventilators, and acute respiratory distress syndrome (ARDS). It is the most common method used to sample ... Nieto, J.M.S.; Alcaraz, A.C. (1995). "The role of bronchoalveolar lavage in the diagnosis of bacterial pneumonia". European ... amplicons characterizes bacterial composition in bronchoalveolar lavage fluid in patients with ventilator-associated pneumonia ...
He was admitted to the hospital and eventually put on a ventilator. He credited his use of the Living Love methods with ... Late in 1986, during the college's first nine-month training course, Keyes developed pneumonia. ...
Currently, problems arise with the extended use of ventilators, including fatal infections and pneumonia. Most people with CCHS ... An alternative to a mechanical ventilator is diaphragm pacing. CCHS was first described in 1962 by Severinghaus and Mitchell in ... Associated complications may also include gastro-esophageal reflux, ophthalmologic issues, seizures, recurrent pneumonia, ... People generally require tracheostomy and lifetime mechanical ventilation on a ventilator in order to survive. However, it has ...
2008). "Positive-end expiratory pressure reduces incidence of ventilator-associated pneumonia in nonhypoxemic patients". Crit ... It is set directly on the ventilator. A small amount of applied PEEP (4 to 5 cmH2O) is used in most mechanically ventilated ... The two types of PEEP are extrinsic PEEP (PEEP applied by a ventilator) and intrinsic PEEP (PEEP caused by an incomplete ... A higher level of applied PEEP (>5 cmH2O) is sometimes used to improve hypoxemia or reduce ventilator-associated lung injury in ...
MetaNeb is typically used on patients with pneumonia. It attaches to a ventilator and helps to clear the lungs from mucus ... In April 2020, Atlanta's Emory University reported the successful use of MetaNeb with coronavirus patients on ventilators. In ... such as ventilators and vital signs monitoring systems. Surgical Solutions: The company provides a line of surgical products, ...
She became dependent on a medical ventilator. In May 1990, she suffered severe brain damage while hospitalized at Hennepin ... Wanglie suffered a fall on December 14, 1989, and subsequently developed respiratory problems and pneumonia. ...
Some studies have suggested that linezolid is better than vancomycin against nosocomial pneumonia, particularly ventilator- ... BTS Pneumonia Guidelines Committee (30 April 2004). "BTS guidelines for the management of community acquired pneumonia in ... ventilator-associated, and healthcare-associated pneumonia". American Journal of Respiratory and Critical Care Medicine. 171 (4 ... nosocomial pneumonia (hospital-acquired) and community-acquired pneumonia caused by S. aureus or S. pneumoniae; complicated ...
As this is a non-invasive therapy, it avoids the risk of ventilator-associated pneumonia. Use of nasal high flow in acute ... pneumonia, and congestive heart failure are all possible situations where high-flow therapy may be indicated. High-flow therapy ... which causes decreased days on a mechanical ventilator, faster weight gain, and overall decreased hospital stay entirely. High- ...
... as one of several first-line therapy options for people with late-onset hospital-acquired or ventilator-associated pneumonia, ... Carbapenems are less commonly used in the treatment of community-acquired pneumonia, as community-acquired strains of the most ... Infectious Diseases Society of America (2005). "Guidelines for the management of adults with hospital-acquired, ventilator- ... and hospital-acquired pneumonia. Beta lactam resistance in these pathogens is most commonly due to the expression of beta ...
A. baumannii is a frequent cause of hospital-acquired pneumonia, especially of late-onset, ventilator-associated pneumonia. It ... In most cases of ventilator-associated pneumonia, the equipment used for artificial ventilation such as endotracheal tubes or ... "Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of Acinetobacter ventilator-associated pneumonia ... In particular, A. baumannii is frequently isolated as the cause of hospital-acquired pneumonia among patients admitted to the ...
... ventilator-associated, and healthcare-associated pneumonia". American Journal of Respiratory and Critical Care Medicine. 171 (4 ... It has been recommended that fluoroquinolones not be used as a first-line agent for community-acquired pneumonia, instead ... MacDougall C, Guglielmo BJ, Maselli J, Gonzales R (March 2005). "Antimicrobial drug prescribing for pneumonia in ambulatory ... quinolones for community-acquired pneumonia: meta-analysis of randomized controlled trials". Clinical Microbiology and ...
The hospital has an international reputation for the research into prevention of ventilator-associated pneumonia. The Accident ...
File TM (August 2010). "Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of ... It is used to treat a number of bacterial infections including acute bacterial sinusitis, pneumonia, H. pylori (in combination ... also plays an important role in recommended treatment regimens for ventilator-associated and healthcare-associated pneumonia. ... Wispelwey B, Schafer KR (November 2010). "Fluoroquinolones in the management of community-acquired pneumonia in primary care". ...
Shimura was hospitalized for severe pneumonia on 20 March 2020; he lost consciousness after being anesthetized and hooked up to ... a ventilator on the following day. Then, on 23 March it was confirmed that he had COVID-19. He was the first Japanese tarento ... "Japanese comedian Ken Shimura dies of coronavirus-related pneumonia". Kyodo News+. Retrieved 30 March 2020. Frishberg, Hannah ( ...
Case Study: Implementing the Ventilator-associated Pneumonia (VAP) Prevention Bundle. Published by the USAID Health Care ...
Ventilator-associated pneumonia (VAP) is a subset of hospital-acquired pneumonia. VAP is pneumonia which occurs after at least ... Hospital-acquired pneumonia, also called nosocomial pneumonia, is pneumonia acquired during or after hospitalization for ... When the toxic substance is an oil, the pneumonia may be called lipoid pneumonia. Aspiration pneumonia (or aspiration ... There are two broad categories of pneumonia in this scheme: community-acquired pneumonia and hospital-acquired pneumonia. A ...
Low SpO2 may indicate severe COVID-19-related pneumonia, requiring a ventilator. Pulse oximetry solely measures hemoglobin ...
On 1 September, he was flown to Martinique for treatment of his pneumonia. While there, his condition worsened and he was ... placed on a ventilator. On 4 September, doctors decided that his condition was hopeless; on 5 September, he was returned to the ... Compton was admitted to the Tapion Hospital in Castries because he was having trouble breathing due to pneumonia. While there, ...
2008). "Positive-end expiratory pressure reduces incidence of ventilator-associated pneumonia in nonhypoxemic patients". Crit ... ventilators'), ventilator tubing connectors, and ventilator accessories." This was done in accordance with its February 4 ... Open Source Ventilator / OpenLung Emergency Medical Ventilator Project / OpenLung BVM Ventilator". GitLab. Bender, Maddie (2020 ... An open-source ventilator is a disaster-situation ventilator made using a freely licensed (open-source) design, and ideally, ...
... dilution during BAL procedures influence the diagnosis of and therapeutic decision related to ventilator-associated pneumonia? ... Patients and Setting: A total of 47 patients with ventilator-associated pneumonia in two medical intensive care units at the ... Ventilator-Associated Pneumonia: Increased Bacterial Counts in Bronchoalveolar Lavage by Using Urea as an Endogenous Marker of ... Cite this: Ventilator-Associated Pneumonia: Increased Bacterial Counts in Bronchoalveolar Lavage by Using Urea as an Endogenous ...
Ventilator-associated pneumonia is a lung infection that develops in a person who is on a ventilator. A ventilator is a machine ... FAQs about Ventilator-associated Pneumonia (VAP). *Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care ... CDC provides guidelines and tools to the healthcare community to help end ventilator-associated pneumonia and resources to help ... Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia, ...
Ventilator-associated pneumonia (VAP) results from the invasion of the lower respiratory tract and lung parenchyma by ... ... is pneumonia that develops 48 hours or longer after mechanical ventilation is given by means of an endotracheal tube or ... Ventilator-associated and hospital-acquired pneumonia Ventilator-associated pneumonia (VAP) ... encoded search term (Ventilator-Associated Pneumonia) and Ventilator-Associated Pneumonia What to Read Next on Medscape ...
"Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU]) Event" (PDF). Centers for Disease ... "Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an update". ... Ventilator-associated pneumonia (VAP) is a type of lung infection that occurs in people who are on mechanical ventilation ... Diagnosis of ventilator-associated pneumonia is difficult and is not standardized. The criteria used for diagnosis of VAP ...
George DL, Falk PS, Wunderink RG, Leeper KVJ, Meduri GU, Steere EL, Epidemiology of ventilator-acquired pneumonia based on ... Amoeba-Resisting Bacteria and Ventilator-Associated Pneumonia On This Page Materials and Methods Results Discussion Cite This ... Ventilator-associated pneumonia, a multivariate analysis. JAMA. 1993;270:1965-70. DOIPubMedGoogle Scholar ... La Scola B, Boyadjiev I, Greub G, Khamis A, Martin C, Raoult D. Amoeba-Resisting Bacteria and Ventilator-Associated Pneumonia. ...
Ventilator-associated pneumonia (VAP) continues to complicate the course of 8 to 28% of patients receiving mechanical ... Ventilator-associated pneumonia Jean Chastre et al. Am J Respir Crit Care Med. 2002. . ... Ventilator-associated pneumonia (VAP) continues to complicate the course of 8 to 28% of patients receiving mechanical ... Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early ...
... N Engl J Med. 2006 Dec 21;355(25):2691-3. doi: 10.1056/NEJMe068231. ...
To evaluate the role of amoeba-associated bacteria as agents of ventilator-associated pneumonia (VAP), we tested the water from ... Title : Amoeba-Resisting Bacteria and Ventilator-Associated Pneumonia Personal Author(s) : La Scola, Bernard;Boyadjiev, Ioanna; ... Tropheryma whipplei in Patients with Pneumonia Cite CITE. Title : Tropheryma whipplei in Patients with Pneumonia Personal ... Ameba-associated Microorganisms and Diagnosis of Nosocomial Pneumonia Cite CITE. Title : Ameba-associated Microorganisms and ...
The Role of Oral Microbiome in the Prevention of Ventilator-Associated Pneumonia ... The role of oral microbiome in the prevention of ventilator-associated pneumonia / Nancy J. Ames, Patrick R. Murray, and Naomi ... CC Grand Rounds - The Role of Oral Microbiome in the Prevention of Ventilator-Associated Pneumonia. ... CC Grand Rounds - The Role of Oral Microbiome in the Prevention of Ventilator-Associated Pneumonia ...
Infectious Disease > Pneumonia Probiotic Flops for Ventilator-Associated Pneumonia Prevention. - No benefit seen versus placebo ... "These findings do not support the use of L. rhamnosus GG for prevention of ventilator-associated pneumonia or other clinically ... Source Reference: Johnstone J, et al "Effect of probiotics on incident ventilator-associated pneumonia in critically ill ... administration of a probiotic failed to prevent ventilator-associated pneumonia (VAP), a multinational randomized trial showed. ...
Technical patient safety solutions for ventilator-associated pneumonia in adults ... Technical patient safety solutions for ventilator-associated pneumonia in adults. Patient safety guidance [PSG2]. Published: 23 ... NICE has withdrawn technical patient safety solutions for ventilator-associated pneumonia in adults, because the recommended ...
Cause of Ventilator-Associated Pneumonia- VAP is directly linked to the aspiration of colonized secretions. View our fact sheet ... New endotracheal tubes designed to prevent ventilator-associated pneumonia: do they make a difference? Respir Care. 2010;55(8): ... The most common causes of Ventilator Associated Pneumonia are oropharyngeal colonizing flora which is often the source of the ... Topical chlorhexidine for prevention of ventilator-associated pneumonia: a meta-analysis. Crit Care Med. 2007;35(2):595-602.],[ ...
Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial Lee E Morrow 1 , Marin H ... Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial Lee E Morrow et al. Am J ... Prevention of ventilator-associated pneumonia: bugs or drugs? Bonten MJ. Bonten MJ. Am J Respir Crit Care Med. 2010 Oct 15;182( ... Probiotics for preventing ventilator-associated pneumonia. Bo L, Li J, Tao T, Bai Y, Ye X, Hotchkiss RS, Kollef MH, Crooks NH, ...
Ventilator-Associated Pneumonia - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - ... Etiology of Ventilator-Associated Pneumonia The most common cause of ventilator-associated pneumonia is microaspiration of ... Prognosis for Ventilator-Associated Pneumonia The mortality in ventilator-associated pneumonia is high despite the availability ... Prevention of Ventilator-Associated Pneumonia There are a number of measures that can help prevent ventilator-associated ...
Pneumonia (ventilator-associated [VAP] and non-ventilator-associated pneumonia [PNEU]) event. In: Centers for Disease Control ... Ventilator bundle approach for reduction of ventilator associated pneumonia in respiratory intensive care unit at Ain Shams ... Ventilator-associated pneumonia (VAP) has been reported to be the most serious healthcare-associated infection in intensive ... Ventilator-associated pneumonia in intensive care units in Hubei Province, China: a multicentre prospective cohort survey. J ...
1994) Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med 149: ... Two subjects had no histological evidence of pneumonia, three had unilateral pneumonia, 17 others (68%) had bilateral pneumonia ... 1995) Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care ... 1992) The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest 101:458-463, . ...
Hoffmann-La Roche and currently in Phase I for Ventilator Associated Pneumonia (VAP). ... Zosurabalpin by F. Hoffmann-La Roche for Ventilator Associated Pneumonia (VAP): Likelihood of Approval. Brought to you by ... Zosurabalpin is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Ventilator Associated Pneumonia ... Premium Insights Likelihood of Approval and Phase Transition Success Rate Model - RG-6006 in Ventilator Associated Pneumonia ( ...
Koker, A., Gok, F., Erayman, I. et al. Effect of subglottic secretion drainage for preventing ventilator-associated pneumonia. ... Effect of subglottic secretion drainage for preventing ventilator-associated pneumonia. *A Koker1, ... Continuous aspiration of subglottic secretions in the prevention of ventilator-associated pneumonia in the postoperative period ... 25%, P = 0.046). The growth rate of VAP (VAP number/ventilator-day × 1,000) in Group C was 17.48, while in Group S it was 11.62 ...
Ventilator-Associated Pneumonia. Description of Collaborative Activity:. A series of meetings were held to develop a practical ... new national surveillance definition for ventilator-associated pneumonia.. Type of Collaborative Activity:. Select Type of ...
Ventilator-associated Pneumonia and MRSA ST398, Italy. Emerging Infectious Diseases. 2010;16(4):730-731. doi:10.3201/ ... On the 14th day in the ICU, clinical signs of ventilator-associated pneumonia developed in the patient. He had increased sputum ... P. damselae Pneumonia in Bottlenose Dolphin OXA-232 Klebsiella pneumoniae, France, 2013-2021 Severe Pneumonia Caused by C. ... Ventilator-associated Pneumonia and MRSA ST398, Italy. Volume 16, Number 4-April 2010 ...
A Ventilator-associated Pneumonia Prediction Model in Patients With Acute Respiratory Distress Syndrome.. ... Cite As: Wu Z, Liu Y, Xu J, Xie J, Zhang S, Huang L, Huang Y, Yang Y, Qiu H. A Ventilator-associated Pneumonia Prediction Model ... Home Publications A Ventilator-associated Pneumonia Prediction Model in Patients With Acute Respiratory Distress Syndrome. ... patients and diagnosis of ventilator-associated pneumonia (VAP) in ARDS patients is challenging. Hence, an effective model to ...
Ventilator-associated pneumonia (VAP) is a form of nosocomial pneumonia that begins more than 48 hours after the patient is ... nosocomial pneumonia or hospital-acquired pneumonia (HAP) is defined as a lung infection that begins in a nonintubated patient ... and Ventilator-Associated Pneumonia) and Hospital-Acquired Pneumonia (Nosocomial Pneumonia) and Ventilator-Associated Pneumonia ... Hospital-Acquired Pneumonia (Nosocomial Pneumonia) and Ventilator-Associated Pneumonia * Sections Hospital-Acquired Pneumonia ( ...
This type of pneumonia can be very severe. Sometimes, it can be fatal. ... Hospital-acquired pneumonia is an infection of the lungs that occurs during a hospital stay. ... Ventilator-associated pneumonia. In: Broaddus VC, Ernst JD, King TE, et al, eds. Murray and Nadels Textbook of Respiratory ... Pneumonia occurs more often in people who are using a ventilator, which is a machine that helps them breathe. ...
Room F, 10/17/2000 9: 00 AM - 11: 00 AM (PS) Does Atelectasis (ATL) Precede Ventilator-Associated Pneumonia (VAP)? : A-446 ... Is Ventilator-associated Pneumonia an Independent Risk Factor for Death? Anesthesiology (April 2001) ... Risk Factors for Ventilator-associated Pneumonia by Pseudomonas aeruginosa in Presence of Recent Antibiotic Exposure ... An Evaluation of the Role of Gene Expression in the Prediction and Diagnosis of Ventilator-associated Pneumonia Anesthesiology ...
You may also need a ventilator during surgery. ... You may need a ventilator in an emergency if a condition, such ... Pneumonia. * sepsis , which is an infection in your bloodstream. *Spinal cord injuries, polio, amyotrophic lateral sclerosis ( ... Book traversal links for Who Needs a Ventilator * Previous. What Is a Ventilator? ... You may need a ventilator if you are going to have surgery with general anesthesia (medicine that makes you sleepy and stops ...
Randomized Trial of Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia - Prevent 2 Study Clinical Trial Grant ...
Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management. Curr Opin Pulm ... ventilator settings, patient-ventilator synchrony, and severity of pneumonia.55 Jet nebulizers, for example, create highly ... Interobserver variability in ventilator-associated pneumonia surveillance. Am J Infect Control 2010;38(3):237-239. ... Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis. Crit Care 2015;19:150. ...
... chlorhexidine in combination with toothbrushing to prevent ventilator-associated pneumonia (VAP) in mechanically ventilated ... Humanos Pneumonia Associada à Ventilação Mecânica/prevenção & controle Respiração Artificial Escovação Dentária Clorexidina ... and chlorhexidine compared with exclusive use of chlorhexidine to reduce the risk of ventilator-associated pneumonia: A ...
Examples include: accidental dislodging and hemorrhage; ventilator-associated pneumonia; microbial colonization within and ...
  • This factsheet provides information about how to prevent ventilator-associated pneumonia (VAP) using an evidence-based practice VAP bundle. (hqsc.govt.nz)
  • ECRI is also trying to draw attention to the urgent issue of non-ventilator healthcare-associated pneumonia. (medscape.com)
  • Updated recommendations on how to prevent central line-associated bloodstream infections (CLABSIs), as well as ventilator-associated pneumonia, ventilator-associated events (VAEs), and non-ventilator healthcare-associated pneumonia (NV-HAP) were recently published. (cdc.gov)
  • Ventilator-associated pneumonia is a lung infection that develops in a person who is on a ventilator. (cdc.gov)
  • Hospital-acquired pneumonia (HAP), or nosocomial pneumonia, is a lower respiratory infection that was not incubating at the time of hospital admission and that presents clinically 2 or more days after hospitalization. (medscape.com)
  • Ventilator-associated pneumonia (VAP) is a type of lung infection that occurs in people who are on mechanical ventilation breathing machines in hospitals. (wikipedia.org)
  • A different less studied infection found in mechanically ventilated people is ventilator-associated tracheobronchitis (VAT). (wikipedia.org)
  • As the most common health care-associated infection in the United States, hospital-acquired pneumonia is associated with high morbidity, mortality, and health care use. (pharmacytimes.com)
  • Most infections (84 percent) were one of four types:pneumonia, sinusitis, catheter-related infection, or urinary tract infection. (nih.gov)
  • Radiographic densities were caused by an infection in only 20 patients (19 pneumonia, 1 empyema). (nih.gov)
  • Overview of Pneumonia Pneumonia is acute inflammation of the lungs caused by infection. (msdmanuals.com)
  • This pneumonia is identified by a new infiltrate, with signs of infection such as fever and elevated white blood count. (acardiacnurse.com)
  • Ventilator associated pneumonia (VAP) is the second most common nosocomial infection diagnosed in mechanically ventilated patients with incidence of 20-36%, mainly caused by Gram-negative organisms in our country. (jpnim.com)
  • Mechanically ventilated patients are at risk of developing the iatrogenic infection ventilator-associated pneumonia (VAP). (traumamon.com)
  • According to the new CDC definition algorithm, VAP is an Infection-related Ventilator-Associated Complication (IVAC) occurring after 3 days of mechanical ventilation and 2 days before or after the onset of worsening oxygenation, if purulent respiratory secretions with positive cultures or objective signs of respiratory infection have been found [ 1 ]. (springeropen.com)
  • Rapid biomarker-based exclusion of infection may improve antibiotic stewardship in ventilator-acquired pneumonia (VAP). (cam.ac.uk)
  • Patients with hospital-acquired pneumonia present similarly to patients with CAP although they are often sicker due to a combination of greater comorbidities and an increased likelihood of colonization and infection with virulent pathogens. (mhmedical.com)
  • Patients on mechanical ventilation in the intensive care unit (ICU) frequently develop ventilator-associated pneumonia (VAP), an acquired lung infection. (pakjns.org)
  • Ventilator-associated pneumonia (VAP) is the most common nosocomial infection diagnosed in intensive care units (ICU) worldwide. (publichealthmy.org)
  • Fig. 2: Recovery from infection is followed by susceptibility to secondary pneumonia and reduction in phagocytosis by alveolar macrophages in mice. (nature.com)
  • Objective: Patients in Intensive Care Units (ICU) may present ventilator-associated pneumonia (VAP), which is a severe infection related to bacterial colonization in the oropharynx. (bvsalud.org)
  • Ventilator-associated pneumonia (VAP) is the most frequent intensive care unit (ICU)-acquired infection that is independently associated with mortality. (medscape.com)
  • Ventilator-associated tracheobronchitis (VAT) is very common in intubated critically ill patients. (springeropen.com)
  • Chorath K, Hoang A, Rajasekaran K, Moreira A. Association of Early vs Late Tracheostomy Placement With Pneumonia and Ventilator Days in Critically Ill Patients: A Meta-analysis. (pakjns.org)
  • Antibody blockade of SIRPα restored phagocytosis in monocytes of critically ill patients in vitro, which suggests a potential strategy to prevent hospital-acquired pneumonia. (nature.com)
  • In conclusion, in patients mechanically ventilated for stroke or head injury early gastrostomy is associated with a lower frequency of ventilator-associated pneumonia compared with a nasogastric tube. (ersjournals.com)
  • [ 1 , 2 ] Ventilator-associated pneumonia (VAP) is defined as pneumonia that presents more than 48 hours after endotracheal intubation. (medscape.com)
  • Ventilator-associated pneumonia (VAP) develops at least 48 hours after endotracheal intubation. (msdmanuals.com)
  • Endotracheal intubation is the major risk factor for ventilator-associated pneumonia. (msdmanuals.com)
  • Methicillin-sensitive S. aureus , Streptococcus pneumoniae , and Haemophilus influenzae are most commonly implicated when pneumonia develops within 4 to 7 days of hospitalization, whereas P. aeruginosa , MRSA, and enteric gram-negative organisms become more common with increasing duration of intubation or hospitalization. (msdmanuals.com)
  • V AP is a pneumonia which occurs within 48 hours of intubation. (und.edu)
  • Ventilator-associated pneumonia (VAP) is pneumonia that occurs within 48-96 hours following intubation. (acardiacnurse.com)
  • Hypothesis: In an emergency medical system with established rapid-sequence intubation protocols, prehospital (PH) intubation of patients with trauma is not associated with a higher rate of ventilator-associated pneumonia (VAP) than emergency department (ED) intubation. (elsevierpure.com)
  • CDC provides guidelines and tools to the healthcare community to help end ventilator-associated pneumonia and resources to help the public understand these infections and take measures to safeguard their own health when possible. (cdc.gov)
  • Concomitant infections were frequent (62 percent), particularly in patients with sinusitis (100 percent), catheter-related infections (93 percent), and pneumonia (74 percent). (nih.gov)
  • Ventilator-associated pneumonia (VAP) caries a morbidity and mortality risk in the preterm neonate, particularly in the context of rising global antimicrobial resistance driving infections due to multidrug-resistant Gram-negative bacteria. (nih.gov)
  • The researchers examined about 600 patients with severe pneumonia and found that the COVID-19 patients who remained intubated longer than other patients, developed secondary bacterial infections more often. (newstarget.com)
  • The clinical course included multiple hospital admissions for pneumonia and urinary tract infections. (cdc.gov)
  • Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP), are the most common infections in hospitalized patients, particularly those in the intensive care units. (chennaijournal.org)
  • Background: Ventilator-associated pneumonia refers to bacterial pneumonia developed in patients who have been mechanically ventilated for duration of more than 48 hours. (paediatricjournal.com)
  • This study aims to describe the aetiological agents causing bacterial ventilator-associated pneumonia. (publichealthmy.org)
  • The Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. (chennaijournal.org)
  • Furthermore, launching various multiple-stage Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia pipeline products will significantly revolutionize the Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia market dynamics. (chennaijournal.org)
  • DelveInsight's "Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia, historical and forecasted epidemiology as well as the Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. (chennaijournal.org)
  • The Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. (chennaijournal.org)
  • Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia market report covers a descriptive overview and comprehensive insight of the Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia Epidemiology and Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan. (chennaijournal.org)
  • The Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia market report provides insights on the current and emerging therapies. (chennaijournal.org)
  • Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia market report provides a global historical and forecasted market covering drug outreach in 7MM. (chennaijournal.org)
  • Pneumonia that presents sooner should be regarded as community- acquired pneumonia. (medscape.com)
  • The microbiologic flora responsible for VAP is different from that of the more common community-acquired pneumonia (CAP). (wikipedia.org)
  • Ventilator-associated pneumonia, a leading cause of sepsis in patients with acute respiratory failure, is difficult to distinguish clinically from other processes affecting patients receiving mechanical ventilation. (nih.gov)
  • the latter includes severe pneumonia, ARDS, sepsis and septic shock. (who.int)
  • The Pneumonia and Sepsis in Critical Care: Navigating a Complex Patient Diagnostic Workup activity has been approved by the California Board of Registered Nursing, Provider No. 8181, for up to 1.0 contact hours. (sccm.org)
  • Sepsis and trauma cause inflammation and elevated susceptibility to hospital-acquired pneumonia. (nature.com)
  • Despite most cases of hospital-acquired pneumonia occurring in nonventilated patients, there is often only surveillance and prevention programs for ventilator-associated pneumonia and not NV-HAP at most hospitals. (pharmacytimes.com)
  • Should oral chlorhexidine remain in ventilator-associated pneumonia prevention bundles? (medintensiva.org)
  • Since VAP diagnosis founded on radiographic findings of pneumonia, which have intrinsic variability in technique, interpretation, and reporting, and on clinical signs and symptoms- that are subjective- in 2011 a Working Group of the CDC (Centers for Disease Control and Prevention) proposed a new approach to surveillance for Ventilator-Associated Events (VAE). (springeropen.com)
  • Mayhall, CG 2007, ' In pursuit of ventilator-associated pneumonia prevention: The right path ', Clinical Infectious Diseases , vol. 45, no. 6, pp. 712-714. (utmb.edu)
  • Ventilator-associated pneumonia: diagnosis, treatment, and prevention. (pakjns.org)
  • Early vs late tracheotomy for prevention of pneumonia in mechanically ventilated adult ICU patients: a randomized controlled trial. (pakjns.org)
  • Guidelines for the prevention of ventilator-associated pneumonia and their implementation. (bvsalud.org)
  • BACKGROUND: ""Zero-VAP"" is a proposal for the implementation of a simultaneous multimodal intervention in Spanish intensive care units (ICU) consisting of a bundle of ventilator-associated pneumonia (VAP) prevention measures. (bvsalud.org)
  • Pneumonia is defined as "new lung infiltrates plus clinical evidence that the infiltrate is of an infectious origin, which include the new onset of fever, purulent sputum, leukocytosis, and decline in oxygenation. (medscape.com)
  • On the 14th day in the ICU, clinical signs of ventilator-associated pneumonia developed in the patient. (cdc.gov)
  • The "Hospital / Ventilator acquired Pneumonia Market: Pipeline Review, Developer Landscape and Competitive Insights, 2020-2030" report features an extensive study on the clinical and preclinical molecules being developed for the treatment of ventilator associated pneumonia. (rootsanalysis.com)
  • Ventilator-associated pneumonia (VAP) remains a common problem in the intensive care unit (ICU) despite early diagnosis and appropriate treatment 1 . (ersjournals.com)
  • Early-onset ventilator-associated pneumonia incidence in intensive care units: a surveillance-based study. (insa-lyon.fr)
  • Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: incidence of nephrotoxicity and outcomes. (jhsmr.org)
  • Early-onset pneumonia occurs within the first 4 days of hospitalization, whereas late-onset VAP develops 5 or more days after admission. (medscape.com)
  • VAP occurs when a patient is connected to a mechanical ventilator, and bacteria from the mouth or equipment moves into the lungs. (mlmic.com)
  • Ventilator-associated pneumonia occurs in 9 to 27% of mechanically ventilated patients. (msdmanuals.com)
  • Ventilator-associated pneumonia occurs in 10%-30% of all intubated patients. (acardiacnurse.com)
  • Non-ventilator-associated hospital-acquired pneumonia (NV-HAP) is a common and deadly complication of hospitalization that could account for up to 1 in 14 hospital deaths, according to a study published in JAMA Network Open . (pharmacytimes.com)
  • Ventilator-associated pneumonia (VAP) is pneumonia that develops 48 hours or longer after mechanical ventilation is given by means of an endotracheal tube or tracheostomy. (medscape.com)
  • The level of oxygen in the blood can stay dangerously low, even if the person receives oxygen from a breathing machine ( ventilator ) through a breathing tube (endotracheal tube). (medlineplus.gov)
  • Ventilator-associated pneumonia is associated with very high morbidity and mortality. (acardiacnurse.com)
  • Ventilator-associated tracheobronchitis may be a risk factor for VAP, though not all cases of VAT progress to VAP. (wikipedia.org)
  • We believe that, given recent results obtained in the study of the so-called ventilator-associated tracheobronchitis as well as our own conclusions, it is necessary to shift the methodology of studies on VAP. (biomedcentral.com)
  • Ventilator-associated pneumonia (VAP) is a complication in as many as 28% of patients who receive mechanical ventilation. (medscape.com)
  • Multidrug-resistant Acinetobacter baumanii (MDR-AB) ventilator-associated pneumonia (VAP) is the major complication following hospital admission in Thailand, increasing morbidity and prolonging hospital stay duration. (jhsmr.org)
  • VAP refers to nosocomial pneumonia that develops among patients on ventilators. (medscape.com)
  • Typical chest radiograph of a patient with nosocomial pneumonia. (medscape.com)
  • Because aerobic gram-negative bacilli (eg, Pseudomonas aeruginosa) are the major pathogens associated with HAP, the pathophysiology of nosocomial pneumonia relates to the destructive effect on lung tissue. (medscape.com)
  • [ 9 ] Alternatively, other non-necrotizing gram-negative bacilli (eg, Serratia marcescens) may be responsible for nosocomial pneumonia. (medscape.com)
  • As such, VAP typically affects critically ill persons that are in an intensive care unit (ICU) and have been on a mechanical ventilator for at least 48 hours. (wikipedia.org)
  • Hospital-Acquired Pneumonia Hospital-acquired pneumonia (HAP) develops at least 48 hours after hospital admission. (msdmanuals.com)
  • [ 9 ] Pseudomonas or Acinetobacter pneumonia is associated with higher mortality rates than those associated with other organisms. (medscape.com)
  • In vitro activity of colistin in combination with tigecycline against carbapenem-resistant Acinetobacter baumannii strains isolated from patients with ventilator-associated pneumonia. (jhsmr.org)
  • Considering that any type of pneumonia causes air volume changes in the lungs, accumulating evidence has shown that LUS effectively measures the presence of VAP as well as dynamic changes in VAP. (medscape.com)
  • Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia. (cam.ac.uk)
  • Ventilator-associated pneumonia (VAP) is serious, deadly and not uncommon for individuals connected to a mechanical ventilator. (mlmic.com)
  • In some cases, a healthy person has severe pneumonia that gets worse and becomes ARDS. (medlineplus.gov)
  • Severe shortness of breath (dyspnea) can be very distressing and uncomfortable, but a ventilator can help ease the breathing process, allowing the patient to rest and heal. (agingcare.com)
  • Primary inhalation pneumonia develops when these organisms bypass normal respiratory defense mechanisms or when the patient inhales aerobic gram-negative organisms that colonize the upper respiratory tract or respiratory support equipment. (medscape.com)
  • Hospital-acquired pneumonia (HAP) is pneumonia that develops 48 hours or longer after admission to a hospital in nonventilated patients. (medscape.com)
  • Hospital-acquired pneumonia is defined as pneumonia that develops ≥ 48 hours after hospital admission. (mhmedical.com)
  • Aspiration pneumonia results from aspiration of colonized upper respiratory tract secretions. (medscape.com)
  • Author and former New York Times reporter Alex Berenson wrote in his Substack newsletter that the new finding is particularly troubling because media outlets and hospitals both pressed ventilator use for COVID-19 patients back in 2020. (newstarget.com)
  • Nurses' Knowledge on Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis', Trauma Monthly , 25(4), pp. 180-187. (traumamon.com)
  • VAP often involves more resistant pathogens and poorer outcomes than other forms of hospital-acquired pneumonia. (msdmanuals.com)
  • We conducted a prospective study of patients with suspected ventilator-associated pneumonia to identify the causes of fever and densities on chest radiographs and to evaluate the diagnostic yield and efficiency of tests used alone and in combination. (nih.gov)
  • OBJECTIVES: We sought to validate the capacity for specific host inflammatory mediators to exclude pneumonia in patients with suspected VAP. (cam.ac.uk)
  • The most common cause of ventilator-associated pneumonia is microaspiration of bacteria that colonize the oropharynx and upper airways in seriously ill patients. (msdmanuals.com)
  • What Bacteria is Responsible for Ventilator-Associated Pneumonia? (acardiacnurse.com)
  • A new paper by researchers from Northwestern University in Illinois offered new shreds of evidence that ventilator-acquired pneumonia , and not the Wuhan coronavirus (COVID-19), killed patients as SARS-CoV-2 has a "relatively low mortality rate" compared to other respiratory illnesses. (newstarget.com)
  • Conclusion: Ventilator-associated pneumonia is major cause of mortality and morbidity in pediatrics. (paediatricjournal.com)
  • Patients who develop a VAP have significantly more ventilator days, hospital days, and antibiotic days and higher hospital mortality than patients who have not this condition. (springeropen.com)
  • An increased risk of mortality should be assumed for patients with septic shock, those requiring ventilator support, or new-onset renal replacement therapy. (mhmedical.com)
  • Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. (nature.com)
  • Early antibiotic treatment for gradual ventilator-associated pneumonia: yes or no? (biomedcentral.com)
  • Macrophages depletion alleviates lung injury by modulating AKT3/GXP4 following ventilator associated pneumonia. (bvsalud.org)
  • Therefore, this study aimed to investigate the role of AKT3 in macrophages during ventilator-associated pneumonia . (bvsalud.org)
  • After resolution of primary pneumonia, murine alveolar macrophages (AMs) exhibited poor phagocytic capacity for several weeks. (nature.com)
  • Ventilators can be life-saving, but they can also increase a patient's chance of getting pneumonia by making it easier for germs to get into the patient's lungs. (cdc.gov)
  • A ventilator is used to deliver high doses of oxygen and positive pressure to the damaged lungs. (medlineplus.gov)
  • Invasive ventilators gently force normal air (or a mixture of air and added oxygen) through a breathing tube, into a patient's airways and down into their lungs. (agingcare.com)
  • The development of hospital-acquired pneumonia (HAP) represents an imbalance between normal host defenses and the ability of microorganisms to colonize and then invade the lower respiratory tract. (medscape.com)
  • [ 1 ] Ventilator-associated pneumonia (VAP) results from the invasion of the lower respiratory tract and lung parenchyma by microorganisms. (medscape.com)
  • He was put on ventilator support early this (Wednesday) morning as he was having respiratory problems," said the bulletin from AMRI Hospital. (visionmp.com)
  • Patients who can't breathe on their own at all also use ventilators while undergoing treatment for the underlying condition(s) that caused respiratory failure or respiratory arrest. (agingcare.com)
  • Cefiderocol, a siderophilic cephalosporin, has broad Gram-negative antimicrobial activity and central nervous system penetration and is used for the treatment of hospital-acquired pneumonia or VAP in adults. (nih.gov)
  • Ventilator-associated pneumonia, one of the leading causes of death in the intensive care unit despite the advances in treatment. (acardiacnurse.com)

No images available that match "pneumonia ventilator associated"